data_1m94_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m94 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.9299999999999999 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 1.1499999999999999 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.83999999999999997 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.559 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 1.1799999999999999 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 1.3200000000000001 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 1.04 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.51 109.518 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.57999999999999996 109.697 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.211 -0.662 . . . . 1.6000000000000001 109.211 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 1.21 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.8799999999999999 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 1.05 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 3.6099999999999999 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 1.01 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.6899999999999999 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 1.0600000000000001 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55000000000000004 109.338 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 1.03 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 1.1899999999999999 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.484 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.5 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.8700000000000001 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' A' ' 4' ' ' VAL . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.88 109.427 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 1.26 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 2.0099999999999998 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 1.1200000000000001 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 1.1699999999999999 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.409 ' HB2' HD13 ' A' ' 42' ' ' ILE . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.75 110.654 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.4199999999999999 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.72999999999999998 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.63 HG22 HG21 ' A' ' 14' ' ' VAL . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 1.1599999999999999 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52000000000000002 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 1.1100000000000001 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 3.02 109.797 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 1.0800000000000001 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 2.0600000000000001 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.9299999999999999 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HD13 ' A' ' 35' ' ' ILE . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 1.1399999999999999 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 1.1399999999999999 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 1.47 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.477 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.3300000000000001 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 1.6100000000000001 109.529 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.1100000000000001 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.46 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 1.4099999999999999 110.367 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 44' ' ' LEU . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.6600000000000001 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79000000000000004 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 1.22 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 1.1100000000000001 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 1.1699999999999999 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.85999999999999999 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67000000000000004 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.71999999999999997 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 1.1299999999999999 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.5 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65000000000000002 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG12 ' A' ' 4' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.98999999999999999 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.26 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.5700000000000001 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.73999999999999999 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.97999999999999998 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.55 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 1.3500000000000001 109.925 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.8700000000000001 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.8999999999999999 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 1.03 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 1.1100000000000001 109.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 1.1499999999999999 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 1.1799999999999999 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.77000000000000002 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.685 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.593 . . . . 1.3700000000000001 109.4 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 1.21 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 2.3100000000000001 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 30' ' ' VAL . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 1.1100000000000001 109.699 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.77 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 1.3600000000000001 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 1.55 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 1.1399999999999999 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.56999999999999995 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 1.0600000000000001 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 51' ' ' LEU . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 1.1200000000000001 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.5900000000000001 109.044 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HB2' HD12 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.60999999999999999 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 42' ' ' ILE . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 2.2200000000000002 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.585 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 3.0299999999999998 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 16' ' ' VAL . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 1.05 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 1.26 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.65000000000000002 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 1.27 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.85999999999999999 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 1.26 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.60999999999999999 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 1.1699999999999999 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 2.48 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.98999999999999999 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.9399999999999999 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.79 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 1.1399999999999999 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 1.23 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.76 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.3500000000000001 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.436 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 2.25 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.21 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.81999999999999995 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.3999999999999999 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 1.4299999999999999 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 24' ' ' VAL . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 1.29 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.7599999999999998 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.69999999999999996 110.513 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.46 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 1.23 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.87 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 62' ' ' VAL . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 1.24 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.6200000000000001 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.1499999999999999 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.96999999999999997 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.1599999999999999 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HD22 ' A' ' 57' ' ' LEU . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 1.1699999999999999 108.769 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.6600000000000001 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78000000000000003 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.67000000000000004 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.475 HG22 HG12 ' A' ' 62' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 1.03 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.54 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.78 109.726 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.85999999999999999 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 1.1299999999999999 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 1.1100000000000001 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.403 ' CE1' HG23 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.3300000000000001 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 2.1299999999999999 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.6699999999999999 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 1.1100000000000001 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.1899999999999999 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.98999999999999999 110.223 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 1.23 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 31' ' ' LEU . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 1.1699999999999999 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.93000000000000005 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81000000000000005 109.834 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 121.221 0.534 . . . . 2.3999999999999999 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.8400000000000001 109.659 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.524 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.9300000000000002 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 30' ' ' VAL . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.75 110.542 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 1.3 109.525 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.74 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.79000000000000004 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.80000000000000004 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67000000000000004 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 1.0 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 1.1899999999999999 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34000000000000002 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.83999999999999997 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.71999999999999997 109.128 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' A' ' 44' ' ' LEU . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 1.25 109.562 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 2.3399999999999999 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 16' ' ' VAL . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 1.1000000000000001 109.219 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 1.29 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.41 ' HB3' HD13 ' A' ' 42' ' ' ILE . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.87 111.101 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 1.28 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.04 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 1.1899999999999999 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52000000000000002 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 1.0800000000000001 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.6000000000000001 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.78000000000000003 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 2.0499999999999998 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG2' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 1.1499999999999999 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 1.1699999999999999 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' A' ' 28' ' ' LYS . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 1.0700000000000001 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 1.0900000000000001 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 2.1299999999999999 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.70999999999999996 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.80000000000000004 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.97999999999999998 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 1.1699999999999999 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 1.1899999999999999 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HB3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 2.3900000000000001 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66000000000000003 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.96999999999999997 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 1.1599999999999999 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 1.29 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 1.24 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.81999999999999995 110.045 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 1.1200000000000001 108.477 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 2.5 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67000000000000004 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.96999999999999997 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 1.1000000000000001 109.347 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.4099999999999999 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.8500000000000001 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 1.1799999999999999 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.6599999999999999 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 1.1399999999999999 109.561 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.535 HD13 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.71 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.77 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 1.26 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92000000000000004 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 1.1100000000000001 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 1.1899999999999999 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 1.3400000000000001 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.88 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.59999999999999998 109.398 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.293 -0.632 . . . . 2.0600000000000001 109.293 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 35' ' ' ILE . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.84999999999999998 110.06 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.6099999999999999 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 1.1200000000000001 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 1.3400000000000001 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 1.2 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.73 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 1.1200000000000001 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.81999999999999995 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 1.1000000000000001 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 51' ' ' LEU . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 1.1599999999999999 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.35999999999999999 108.64 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.98999999999999999 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 1.02 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HG2' HD13 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 1.47 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.4900000000000002 109.702 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 1.1200000000000001 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 1.1299999999999999 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.76000000000000001 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 1.3799999999999999 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.93000000000000005 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 1.1799999999999999 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.48999999999999999 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 1.0800000000000001 110.633 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.8100000000000001 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.05 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.77 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.71 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.414 HG12 HD12 ' A' ' 35' ' ' ILE . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 1.24 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 1.1599999999999999 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 1.55 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.4399999999999999 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.77 109.842 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 1.1000000000000001 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.80000000000000004 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.6200000000000001 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 1.45 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 24' ' ' VAL . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 1.22 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.7400000000000002 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.73999999999999999 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.5900000000000001 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.93000000000000005 109.392 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 1.2 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 1.27 109.646 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.3100000000000001 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76000000000000001 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.72999999999999998 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.7400000000000002 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 1.1499999999999999 108.549 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 2.3599999999999999 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.81999999999999995 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 1.03 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 HG11 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 1.1200000000000001 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 1.03 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 1.23 109.304 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54000000000000004 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 1.0700000000000001 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.75 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.28 109.681 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 2.3300000000000001 109.752 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 2.1099999999999999 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 1.26 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 27' ' ' PHE . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 1.1100000000000001 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 1.03 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 1.1000000000000001 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.6499999999999999 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.90000000000000002 110.439 -179.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.78 109.02 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 1.1499999999999999 109.888 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.8399999999999999 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 1.0700000000000001 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 2.0299999999999998 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 1.3 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.6599999999999999 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 1.0800000000000001 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.96999999999999997 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76000000000000001 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 1.1599999999999999 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 1.1499999999999999 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.46000000000000002 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.647 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.70999999999999996 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.67000000000000004 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 2.3599999999999999 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.9199999999999999 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 1.1699999999999999 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 1.24 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.93000000000000005 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 1.28 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.84999999999999998 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' LEU . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 1.2 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.46999999999999997 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 1.1699999999999999 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.47 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89000000000000001 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 2.1200000000000001 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 3.0600000000000001 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 1.0900000000000001 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD11 ' HG2' ' A' ' 28' ' ' LYS . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 1.1399999999999999 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.4299999999999999 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 2.1299999999999999 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89000000000000001 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.83999999999999997 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 1.04 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 1.29 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.533 ' HB3' HG22 ' A' ' 24' ' ' VAL . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 1.22 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.6899999999999999 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.70999999999999996 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.6299999999999999 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 56' ' ' SER . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 1.29 109.668 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 1.04 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 1.1499999999999999 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.2400000000000002 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.69999999999999996 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.83999999999999997 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 1.1899999999999999 108.878 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.4299999999999999 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91000000000000003 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 1.05 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 1.1299999999999999 109.746 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.75 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 1.51 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 1.1599999999999999 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.3400000000000001 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 2.1099999999999999 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.8300000000000001 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.6100000000000001 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 64' ' ' ASP . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 1.1499999999999999 109.813 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 1.03 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.556 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 1.0800000000000001 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 1.25 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.83999999999999997 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.27 0.557 . . . . 2.25 109.805 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 1.1399999999999999 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.46 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 1.1100000000000001 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.6499999999999999 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 1.4399999999999999 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.72 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 1.1599999999999999 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.68999999999999995 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.91000000000000003 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 51' ' ' LEU . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.40999999999999998 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.93000000000000005 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 1.55 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 2.2200000000000002 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 1.1399999999999999 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 1.1699999999999999 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.81000000000000005 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 1.48 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 1.22 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.48999999999999999 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 1.1100000000000001 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 2.48 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.69999999999999996 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.6599999999999999 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.9900000000000002 110.174 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 28' ' ' LYS . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 1.1599999999999999 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 1.0800000000000001 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 1.1599999999999999 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.5700000000000001 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.8200000000000001 109.638 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.69999999999999996 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 1.1399999999999999 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.3100000000000001 109.866 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.496 ' HB3' HG23 ' A' ' 24' ' ' VAL . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 1.1499999999999999 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.6200000000000001 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.69999999999999996 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 2.3500000000000001 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 1.26 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 1.0600000000000001 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 62' ' ' VAL . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 1.25 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77000000000000002 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.1599999999999999 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.93000000000000005 109.897 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.83999999999999997 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 1.1699999999999999 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.6299999999999999 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' HD11 ' A' ' 2' ' ' ILE . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.57999999999999996 109.429 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.72999999999999998 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 1.1100000000000001 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.92000000000000004 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 1.4199999999999999 109.615 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.80000000000000004 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 1.1399999999999999 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.1000000000000001 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.90000000000000002 109.998 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.75 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 2.0600000000000001 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 1.1699999999999999 109.92 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93000000000000005 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.8300000000000001 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 1.23 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 HG23 HD21 ' A' ' 31' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 1.1799999999999999 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 1.0600000000000001 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.349 0.595 . . . . 3.1800000000000002 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 1.1699999999999999 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.6000000000000001 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 1.1100000000000001 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.8400000000000001 109.569 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 1.0900000000000001 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 1.4299999999999999 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 1.1399999999999999 110.108 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.71999999999999997 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51000000000000001 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.80000000000000004 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 1.1699999999999999 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.34999999999999998 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.90000000000000002 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.64000000000000001 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HG2' HD11 ' A' ' 44' ' ' LEU . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 1.3200000000000001 109.766 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.8200000000000001 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 1.1100000000000001 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 HD21 HG23 ' A' ' 6' ' ' VAL . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 1.1200000000000001 109.545 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.67000000000000004 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 1.3100000000000001 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.81999999999999995 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 1.1299999999999999 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.523 ' CB ' HG22 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.95999999999999996 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 2.0899999999999999 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.56000000000000005 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.25 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 3.4300000000000002 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.523 HG22 ' CB ' ' A' ' 37' ' ' THR . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 73' ' ' LEU . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 1.1200000000000001 107.956 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 28' ' ' LYS . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 1.24 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 1.04 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.8300000000000001 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.78000000000000003 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.84999999999999998 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.3799999999999999 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 1.1799999999999999 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 24' ' ' VAL . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 1.1799999999999999 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 1.4199999999999999 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56000000000000005 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 2.4199999999999999 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 1.1599999999999999 109.588 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.97999999999999998 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 1.1599999999999999 109.8 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66000000000000003 109.342 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.94999999999999996 110.12 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.3300000000000001 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 1.1200000000000001 108.671 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.6499999999999999 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 1.05 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.478 ' CG2' HG11 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 2.0099999999999998 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 68' ' ' LEU . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52000000000000002 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 70' ' ' LEU . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 1.1899999999999999 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 1.1699999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.94999999999999996 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.8899999999999999 109.579 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 2.1899999999999999 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 1.25 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.72999999999999998 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 109.921 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.507 HG11 ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 1.5600000000000001 108.678 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 1.24 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.4299999999999999 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66000000000000003 110.173 -179.622 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.193 0.521 . . . . 1.8 109.708 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 1.4299999999999999 109.688 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.507 ' HG2' HG11 ' A' ' 5' ' ' VAL . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.54 109.21 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 1.0800000000000001 110.162 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.8500000000000001 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 1.27 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.5900000000000001 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 1.3799999999999999 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.85999999999999999 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 1.1200000000000001 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.46000000000000002 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.65000000000000002 109.393 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' HG11 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.8100000000000001 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 3.25 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 1.0800000000000001 108.605 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 1.4199999999999999 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.88 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 1.3600000000000001 109.897 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 1.0700000000000001 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 37' ' ' THR . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 1.1499999999999999 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.58999999999999997 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 1.0600000000000001 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.6299999999999999 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.1399999999999999 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 2.3900000000000001 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.7400000000000002 111.183 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.498 HG21 ' HG2' ' A' ' 28' ' ' LYS . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 1.2 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 1.1599999999999999 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD22 HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 1.25 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.3500000000000001 109.45 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 1.5700000000000001 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.90000000000000002 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1000000000000001 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 1.1200000000000001 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 1.1399999999999999 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 24' ' ' VAL . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 1.1299999999999999 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.5 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.84999999999999998 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.8399999999999999 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 1.3100000000000001 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 1.1799999999999999 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 1.1699999999999999 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79000000000000004 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.97999999999999998 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 1.1699999999999999 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.9399999999999999 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.59999999999999998 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.424 HG21 HG11 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.81000000000000005 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 1.0700000000000001 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 44' ' ' LEU . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 1.24 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 109.57 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 1.1599999999999999 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 1.1299999999999999 109.21 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.87 109.788 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.8799999999999999 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 2.0 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 62' ' ' VAL . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 1.1100000000000001 109.829 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.90000000000000002 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 1.1599999999999999 110.15 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 1.1899999999999999 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 1.3300000000000001 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.87 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52000000000000002 110.058 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.409 0.623 . . . . 2.8199999999999998 110.447 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 1.26 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.8700000000000001 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 30' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 1.22 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.8700000000000001 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.96999999999999997 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 1.45 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 1.0900000000000001 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76000000000000001 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.94999999999999996 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 51' ' ' LEU . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 1.2 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.42999999999999999 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.97999999999999998 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.65000000000000002 109.356 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HG2' HD12 ' A' ' 44' ' ' LEU . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 2.25 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.75 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 16' ' ' VAL . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 1.1299999999999999 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 1.3400000000000001 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.63 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 1.54 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.58999999999999997 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 1.1399999999999999 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54000000000000004 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 1.1499999999999999 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 2.6200000000000001 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79000000000000004 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.74 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 35' ' ' ILE . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 1.1499999999999999 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 1.1599999999999999 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 1.29 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 2.0499999999999998 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 1.26 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.1200000000000001 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 1.04 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.5600000000000001 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 1.3600000000000001 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 ' CD2' ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 1.21 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.8899999999999999 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65000000000000002 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 1.0600000000000001 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' SER . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.92000000000000004 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 1.26 109.514 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.95999999999999996 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.3100000000000001 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.89000000000000001 109.868 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 2' ' ' ILE . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 1.1200000000000001 109.161 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.4299999999999999 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78000000000000003 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.85999999999999999 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.98999999999999999 109.62 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 2.0 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 1.4199999999999999 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.3799999999999999 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 1.1499999999999999 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 1.3500000000000001 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.21 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.8799999999999999 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.5600000000000001 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 1.1200000000000001 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.916 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' HE3' ' A' ' 13' ' ' LYS . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 1.1100000000000001 109.58 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG11 ' HB2' ' A' ' 68' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 1.2 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.70999999999999996 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.221 0.534 . . . . 2.23 109.732 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 1.1100000000000001 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 2.3399999999999999 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 27' ' ' PHE . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 1.21 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.71 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 1.05 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 1.3300000000000001 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79000000000000004 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.81999999999999995 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 51' ' ' LEU . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 1.1100000000000001 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.45000000000000001 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93000000000000005 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.64000000000000001 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 1.3899999999999999 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 3.48 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 1.1699999999999999 109.406 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 1.3100000000000001 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.92000000000000004 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 1.3700000000000001 109.912 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.91000000000000003 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 31' ' ' LEU . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 1.1299999999999999 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.56999999999999995 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 1.0800000000000001 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.4199999999999999 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.82999999999999996 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.29 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.5499999999999998 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.438 HG12 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 1.01 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 1.1499999999999999 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 27' ' ' PHE . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 1.21 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.502 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.85999999999999999 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 2.27 109.912 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.3999999999999999 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 1.0900000000000001 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.6100000000000001 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 1.53 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 24' ' ' VAL . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 1.1499999999999999 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 2.3900000000000001 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.57999999999999996 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 2.1299999999999999 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 1.25 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 1.1599999999999999 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 1.0800000000000001 109.427 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.8400000000000001 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.68999999999999995 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 1.3700000000000001 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.1299999999999999 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 1.1899999999999999 109.072 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.5900000000000001 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66000000000000003 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 1.04 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 1.0900000000000001 109.5 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 1.28 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.8600000000000001 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.4299999999999999 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 1.1299999999999999 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 1.04 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.93000000000000005 109.883 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.9199999999999999 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 2.0699999999999998 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.567 HD11 HG13 ' A' ' 62' ' ' VAL . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 1.0900000000000001 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 1.1000000000000001 109.566 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 1.1499999999999999 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 1.0900000000000001 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78000000000000003 110.077 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.172 0.511 . . . . 2.2999999999999998 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 1.22 109.611 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 16' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 1.23 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.8 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 1.1699999999999999 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.8200000000000001 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 1.2 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.471 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.84999999999999998 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.82999999999999996 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 1.01 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 51' ' ' LEU . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 1.1100000000000001 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.38 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.80000000000000004 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.71999999999999997 109.138 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 1.1599999999999999 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 2.1299999999999999 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 1.1599999999999999 109.671 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 1.1699999999999999 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.81000000000000005 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 1.3899999999999999 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.78000000000000003 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 1.1699999999999999 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.46999999999999997 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.486 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 1.0700000000000001 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.8700000000000001 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68999999999999995 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 2.0499999999999998 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.78 110.151 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.545 HG22 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 1.0800000000000001 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 1.1200000000000001 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 1.1499999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 1.0700000000000001 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.8100000000000001 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.96999999999999997 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.90000000000000002 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.3999999999999999 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 1.2 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 24' ' ' VAL . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 1.1799999999999999 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.8599999999999999 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.69999999999999996 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.45 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 1.27 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.5600000000000001 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 1.21 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.3100000000000001 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.471 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.72999999999999998 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HG23 ' A' ' 66' ' ' THR . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 1.1599999999999999 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.6899999999999999 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.69999999999999996 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.83999999999999997 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.582 HG23 HG12 ' A' ' 62' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.80000000000000004 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.8500000000000001 110.141 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 1.2 109.619 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 1.0800000000000001 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.55 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.90000000000000002 109.722 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.8899999999999999 110.133 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 2.1499999999999999 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 1.03 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65000000000000002 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 1.1200000000000001 110.065 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 1.1699999999999999 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 1.5600000000000001 109.745 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.81000000000000005 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.83999999999999997 110.307 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.121 0.486 . . . . 2.3500000000000001 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 1.29 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 1.29 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 1.23 109.754 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 3.04 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 1.1499999999999999 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 1.49 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 1.22 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79000000000000004 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.58999999999999997 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.85999999999999999 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 1.0700000000000001 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.35999999999999999 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52000000000000002 108.815 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.64000000000000001 109.223 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.6200000000000001 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.8700000000000001 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 1.1599999999999999 108.992 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 1.23 109.622 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.69999999999999996 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.6499999999999999 109.656 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 1.26 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55000000000000004 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 1.22 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.99 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 1.0800000000000001 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 2.0800000000000001 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 2.4199999999999999 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 28' ' ' LYS . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 1.1399999999999999 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 1.1899999999999999 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 1.22 110.059 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.635 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.6299999999999999 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.76 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.1000000000000001 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.98999999999999999 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 1.0 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 1.29 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 1.1499999999999999 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.79 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67000000000000004 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 1.0800000000000001 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 1.1499999999999999 109.492 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 1.1599999999999999 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 1.1399999999999999 109.653 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.3100000000000001 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.69999999999999996 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.41 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.83999999999999997 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 1.1799999999999999 108.325 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.71 110.462 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.57999999999999996 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.95999999999999996 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 1.1100000000000001 109.517 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 1.1899999999999999 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 1.3300000000000001 109.433 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 1.21 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 1.1599999999999999 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 1.0700000000000001 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 2.0 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 2.0800000000000001 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 1.1000000000000001 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.85999999999999999 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.97999999999999998 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.8999999999999999 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 1.1200000000000001 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.72999999999999998 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.0700000000000001 111.341 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 2.3999999999999999 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 1.24 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.97 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 1.1499999999999999 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 3.4100000000000001 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 1.3200000000000001 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.77 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 1.01 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.4199999999999999 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.69999999999999996 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.85999999999999999 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 51' ' ' LEU . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 1.0700000000000001 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.40999999999999998 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 44' ' ' LEU . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.71999999999999997 109.402 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.76 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 3.3999999999999999 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 1.0800000000000001 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 1.1799999999999999 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB3' HD12 ' A' ' 42' ' ' ILE . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.85999999999999999 111.386 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 1.4099999999999999 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' THR . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 1.01 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45000000000000001 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.535 ' HB ' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 1.1799999999999999 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.4099999999999999 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.56999999999999995 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.5 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.46 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 32' ' ' SER . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 1.1299999999999999 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 1.0600000000000001 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 1.3899999999999999 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.87 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HA ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 2.7200000000000002 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.73999999999999999 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.51 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 1.1599999999999999 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB3' HG23 ' A' ' 24' ' ' VAL . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 1.1399999999999999 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.6400000000000001 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.401 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.4099999999999999 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 1.3600000000000001 109.325 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 1.27 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 62' ' ' VAL . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 1.21 109.549 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.80000000000000004 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 1.05 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.94999999999999996 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 57' ' ' LEU . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 1.1299999999999999 109.273 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.26 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64000000000000001 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.25 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.404 HG22 ' CG1' ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 1.0800000000000001 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.3600000000000001 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 46' ' ' LYS . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 1.3300000000000001 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.69999999999999996 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 1.1000000000000001 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.22 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 1.0900000000000001 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.6899999999999999 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.8899999999999999 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 64' ' ' ASP . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 1.1399999999999999 109.76 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 1.02 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 1.1499999999999999 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 1.2 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.59999999999999998 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 21.7 t70 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46000000000000002 109.368 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.572 -0.529 . . . . 1.9199999999999999 109.572 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 1.1799999999999999 109.65 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 2.3900000000000001 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 30' ' ' VAL . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 1.0900000000000001 109.758 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.6799999999999999 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 1.0900000000000001 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.6200000000000001 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 1.0 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.58999999999999997 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 1.0900000000000001 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28000000000000003 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66000000000000003 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.60999999999999999 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HE2' HG11 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 1.4199999999999999 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.99 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 16' ' ' VAL . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 1.1100000000000001 109.283 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.449 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 1.0900000000000001 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 42' ' ' ILE . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.73999999999999999 110.736 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 1.3 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52000000000000002 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.42999999999999999 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 1.1200000000000001 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 2.3199999999999998 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46000000000000002 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 2.1299999999999999 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 1.3899999999999999 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 32' ' ' SER . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 1.05 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 1.0900000000000001 108.752 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 1.4199999999999999 109.865 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.3 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 1.4299999999999999 109.442 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.93999999999999995 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64000000000000001 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.48 109.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 1.22 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' HB3' HG23 ' A' ' 24' ' ' VAL . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 1.1299999999999999 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.6099999999999999 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53000000000000003 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 1.0600000000000001 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 1.21 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 1.0700000000000001 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 1.1299999999999999 109.47 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.83999999999999997 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.96999999999999997 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.1499999999999999 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 66' ' ' THR . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 1.23 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.9199999999999999 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 2' ' ' ILE . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.95999999999999996 109.616 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 1.1299999999999999 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 HG13 ' A' ' 62' ' ' VAL . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 1.1000000000000001 109.341 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 1.4399999999999999 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.57999999999999996 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 8' ' ' ASP . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 1.0900000000000001 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.81000000000000005 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 1.1799999999999999 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.78 109.729 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 2.21 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 1.1599999999999999 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.72999999999999998 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.521 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 1.1699999999999999 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 1.1499999999999999 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 1.22 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.91000000000000003 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67000000000000004 110.092 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.232 0.539 . . . . 1.73 109.921 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 1.1699999999999999 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.8500000000000001 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 1.1499999999999999 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.71 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 1.26 109.606 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 1.47 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 1.1000000000000001 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68000000000000005 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64000000000000001 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 1.02 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 1.1599999999999999 109.391 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.45000000000000001 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.80000000000000004 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.77000000000000002 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.5900000000000001 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.4900000000000002 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 1.0800000000000001 109.333 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 1.3200000000000001 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.84999999999999998 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 1.3 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.22 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 1.1899999999999999 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.48999999999999999 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 1.1299999999999999 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.96 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.77000000000000002 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.0600000000000001 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 2.2799999999999998 110.532 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 1.1499999999999999 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 1.1799999999999999 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 HD21 HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 1.47 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HD2' HD21 ' A' ' 68' ' ' LEU . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 1.48 109.602 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.93000000000000005 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89000000000000001 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.48 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 1.29 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 68' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 1.26 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.8999999999999999 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.68999999999999995 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 1.3100000000000001 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 1.29 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 1.05 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 62' ' ' VAL . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 1.1499999999999999 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.92000000000000004 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG11 HG22 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 1.21 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.71 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.84999999999999998 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 1.0 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.521 ' CG2' HG13 ' A' ' 4' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 1.03 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.55 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 1.22 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.575 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 1.1200000000000001 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.6200000000000001 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.8500000000000001 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.5900000000000001 110.09 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.423 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 2.04 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 64' ' ' ASP . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 1.1299999999999999 109.922 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92000000000000004 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 27' ' ' PHE . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 1.1100000000000001 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 1.1699999999999999 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 70' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 1.1299999999999999 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.65000000000000002 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.69999999999999996 110.153 -179.329 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.103 0.478 . . . . 1.54 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 3.6600000000000001 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 1.0600000000000001 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.5 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.93000000000000005 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 1.53 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 1.1100000000000001 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92000000000000004 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.69999999999999996 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.71 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 1.0600000000000001 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.38 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.80000000000000004 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' CG ' HD13 ' A' ' 44' ' ' LEU . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 1.5600000000000001 110.236 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.7799999999999998 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 1.1100000000000001 108.866 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 1.1499999999999999 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.82999999999999996 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.45 109.842 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.56000000000000005 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 70' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 1.1799999999999999 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.41999999999999998 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 1.0700000000000001 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 3.04 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.3799999999999999 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.79 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.8500000000000001 110.673 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 1.1299999999999999 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 1.1200000000000001 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 28' ' ' LYS . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 1.29 110.173 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.1399999999999999 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.98 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.1599999999999999 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.5900000000000001 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 1.3500000000000001 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HB3' HG22 ' A' ' 24' ' ' VAL . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 1.1699999999999999 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.5099999999999998 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.59999999999999998 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 1.26 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 1.1599999999999999 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 1.1100000000000001 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 1.1499999999999999 109.443 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.5900000000000001 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.69999999999999996 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.97999999999999998 109.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.1899999999999999 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 1.1699999999999999 108.751 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.95 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54000000000000004 109.289 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.82999999999999996 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 1.05 109.625 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.69999999999999996 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.6699999999999999 109.748 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65000000000000002 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 35' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.45 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 1.3600000000000001 109.871 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.8700000000000001 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 2.1499999999999999 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 1.1899999999999999 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91000000000000003 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 1.04 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 1.21 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 1.1000000000000001 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.96999999999999997 110.001 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.72 -0.474 . . . . 1.49 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 1.26 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 2.1400000000000001 109.468 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG22 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 1.0900000000000001 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 3.27 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 1.3400000000000001 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 1.3500000000000001 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 1.21 109.933 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78000000000000003 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 1.1200000000000001 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 51' ' ' LEU . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 1.1499999999999999 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.34999999999999998 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.81999999999999995 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 16' ' ' VAL . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.55000000000000004 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HG2' HD13 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 1.49 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.9900000000000002 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 16' ' ' VAL . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 1.1599999999999999 109.285 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.541 ' HG ' HG22 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 1.26 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.89000000000000001 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 1.3500000000000001 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.69999999999999996 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 1.1499999999999999 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.40000000000000002 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 1.0700000000000001 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.5600000000000001 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.70999999999999996 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 2.21 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 3.3100000000000001 110.991 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.502 HG21 HD12 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 1.1200000000000001 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 1.0600000000000001 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 28' ' ' LYS . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 1.26 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.585 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 1.24 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 2.3700000000000001 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78000000000000003 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.94999999999999996 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 1.05 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 1.1499999999999999 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB3' HG22 ' A' ' 24' ' ' VAL . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 1.1699999999999999 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.73 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.68999999999999995 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.48 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 1.27 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.81999999999999995 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 62' ' ' VAL . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 1.24 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.437 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.3700000000000001 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.93000000000000005 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.3500000000000001 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 HG23 HD23 ' A' ' 57' ' ' LEU . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 1.1399999999999999 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 2.3700000000000001 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.84999999999999998 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' CG1' ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 1.0600000000000001 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.6499999999999999 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.486 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.8899999999999999 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 1.1299999999999999 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.6799999999999999 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.91000000000000003 109.737 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.6699999999999999 109.547 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 2.46 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 62' ' ' VAL . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 1.1899999999999999 109.775 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 1.1299999999999999 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 1.1399999999999999 109.123 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.482 HG13 HD21 ' A' ' 44' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 1.1799999999999999 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.48999999999999999 109.522 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.6100000000000001 108.943 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 1.5 109.94 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.9100000000000001 110.141 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.461 HG13 ' CZ ' ' A' ' 27' ' ' PHE . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 1.1100000000000001 109.341 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 2.5600000000000001 110.235 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 1.24 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.6100000000000001 109.784 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 1.1299999999999999 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.82999999999999996 109.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.97999999999999998 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 51' ' ' LEU . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 1.1599999999999999 108.969 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.38 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.97999999999999998 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.72999999999999998 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 1.3799999999999999 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 2.3999999999999999 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 16' ' ' VAL . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 1.1299999999999999 109.124 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 35' ' ' ILE . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 1.25 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' HD13 ' A' ' 42' ' ' ILE . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.87 111.222 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.73 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.68000000000000005 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 1.1299999999999999 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39000000000000001 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.48 HG22 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 1.1100000000000001 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.6699999999999999 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.72999999999999998 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.8600000000000001 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.9500000000000002 110.513 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.91000000000000003 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 1.21 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 1.3400000000000001 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 1.1100000000000001 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.97 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.83999999999999997 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.54 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 1.29 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 1.2 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 3.3799999999999999 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66000000000000003 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.4299999999999999 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 1.26 109.429 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 1.28 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68000000000000005 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.71999999999999997 110.209 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.0600000000000001 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 62' ' ' VAL . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 1.04 108.981 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 1.1499999999999999 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.68999999999999995 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.67000000000000004 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.533 HG23 HG11 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 1.0800000000000001 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.45 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 1.3899999999999999 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.0900000000000001 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 1.1399999999999999 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.25 109.304 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.48 ' CD1' HG22 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.80000000000000004 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 2.1200000000000001 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.97 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 1.1299999999999999 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.85999999999999999 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 1.1200000000000001 110.357 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 1.1699999999999999 109.544 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.68999999999999995 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.72999999999999998 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 121.04 0.448 . . . . 2.9100000000000001 110.117 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 1.5600000000000001 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 2.1699999999999999 109.151 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 1.1399999999999999 109.439 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 3.1699999999999999 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 1.1899999999999999 109.756 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 1.48 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 110.241 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.58999999999999997 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 1.23 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 1.1399999999999999 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.35999999999999999 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.71999999999999997 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' CE2' HD13 ' A' ' 31' ' ' LEU . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.63 109.193 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 1.46 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 3.2200000000000002 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' SG ' ' A' ' 18' ' ' CYS . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 1.1100000000000001 109.268 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.479 HD13 ' CE2' ' A' ' 27' ' ' PHE . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 1.1299999999999999 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.98999999999999999 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 1.3799999999999999 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67000000000000004 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.47999999999999998 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 1.1699999999999999 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.7599999999999998 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.88 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.45 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HB3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 2.4199999999999999 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 37' ' ' THR . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 1.1599999999999999 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 1.1399999999999999 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.469 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 1.1699999999999999 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 1.1299999999999999 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 1.6699999999999999 109.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.90000000000000002 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 1.03 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 1.1599999999999999 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 3.3999999999999999 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65000000000000002 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.6099999999999999 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 1.1899999999999999 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 1.01 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 1.1599999999999999 109.35 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.69999999999999996 109.58 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.70999999999999996 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.57999999999999996 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 66' ' ' THR . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 1.1299999999999999 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 1.22 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.81999999999999995 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.82999999999999996 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 62' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 1.0600000000000001 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.9099999999999999 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 1.3400000000000001 109.719 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 1.1799999999999999 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.5 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 1.23 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.9199999999999999 109.417 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 2.0499999999999998 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 1.1799999999999999 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.68999999999999995 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 27' ' ' PHE . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 1.1000000000000001 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 1.05 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 1.52 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.85999999999999999 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56000000000000005 110.016 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.695 -0.483 . . . . 2.6000000000000001 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.7 109.838 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 2.1699999999999999 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 30' ' ' VAL . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 1.2 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 3.1499999999999999 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 1.25 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 1.2 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.72999999999999998 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55000000000000004 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 1.04 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 1.0800000000000001 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33000000000000002 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51000000000000001 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.48999999999999999 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HG2' HG23 ' A' ' 42' ' ' ILE . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.49 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.6099999999999999 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 16' ' ' VAL . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 1.1299999999999999 109.638 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 1.1699999999999999 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.505 ' HB3' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.92000000000000004 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 1.3300000000000001 110.006 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.91000000000000003 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 1.21 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 1.27 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.8399999999999999 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79000000000000004 111.502 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.1499999999999999 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.76 110.546 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 28' ' ' LYS . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 1.25 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 1.29 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 1.4199999999999999 109.938 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.6299999999999999 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.76 109.225 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.1399999999999999 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.88 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 1.1000000000000001 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 1.4099999999999999 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD13 ' CD2' ' A' ' 68' ' ' LEU . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 1.25 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 2.1200000000000001 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54000000000000004 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 1.1599999999999999 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 1.1000000000000001 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 1.0900000000000001 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 109.349 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.3200000000000001 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.6200000000000001 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 1.01 109.777 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.6699999999999999 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 1.1599999999999999 108.752 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.8999999999999999 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66000000000000003 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 1.05 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 1.0700000000000001 109.775 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.3500000000000001 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.542 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 1.6299999999999999 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.85999999999999999 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 1.1299999999999999 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.52 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.6899999999999999 109.451 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.9299999999999999 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 1.1499999999999999 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.83999999999999997 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.559 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 1.1799999999999999 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 1.3200000000000001 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 1.04 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.51 109.518 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.22 141.34 35.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.57999999999999996 109.697 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -33.8 76.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.707 -0.621 . . . . 1.72 109.789 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -46.3 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.6 -0.688 . . . . 2.0600000000000001 109.243 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.56 64.8 0.01 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.01 -1.236 . . . . 0.72999999999999998 110.01 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 101.08 3.27 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.639 -0.918 . . . . 3.3199999999999998 109.646 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 100.48 10.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 1.6000000000000001 109.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 1.21 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.8799999999999999 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 1.05 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 3.6099999999999999 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 1.01 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.6899999999999999 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 1.0600000000000001 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55000000000000004 109.338 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 1.03 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 1.1899999999999999 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.484 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.5 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.8700000000000001 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' A' ' 4' ' ' VAL . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.88 109.427 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 1.26 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 2.0099999999999998 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 1.1200000000000001 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 1.1699999999999999 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.409 ' HB2' HD13 ' A' ' 42' ' ' ILE . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.75 110.654 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.4199999999999999 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.72999999999999998 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.63 HG22 HG21 ' A' ' 14' ' ' VAL . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 1.1599999999999999 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52000000000000002 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 1.1100000000000001 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 3.02 109.797 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 1.0800000000000001 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 2.0600000000000001 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.9299999999999999 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HD13 ' A' ' 35' ' ' ILE . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 1.1399999999999999 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 1.1399999999999999 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 1.47 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.477 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.3300000000000001 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 1.6100000000000001 109.529 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.1100000000000001 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.46 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 1.4099999999999999 110.367 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 44' ' ' LEU . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.6600000000000001 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79000000000000004 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 1.22 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 1.1100000000000001 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 1.1699999999999999 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.85999999999999999 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67000000000000004 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.71999999999999997 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 1.1299999999999999 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.5 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65000000000000002 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.559 HG22 HG12 ' A' ' 4' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.98999999999999999 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.26 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.5700000000000001 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.73999999999999999 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.97999999999999998 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.55 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 1.3500000000000001 109.925 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.8700000000000001 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.8999999999999999 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 1.03 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 1.1100000000000001 109.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 1.1499999999999999 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 1.1799999999999999 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.77000000000000002 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 -76.89 142.45 40.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.685 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.31 -35.78 81.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 3.29 109.773 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -48.51 74.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.503 -0.748 . . . . 2.1600000000000001 109.266 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.84 66.85 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.72 -1.352 . . . . 0.68999999999999995 109.72 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.74 104.48 3.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.905 . . . . 2.0600000000000001 109.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 114.53 27.76 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 1.3700000000000001 109.4 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 1.21 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 2.3100000000000001 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 30' ' ' VAL . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 1.1100000000000001 109.699 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.77 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 1.3600000000000001 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 1.55 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 1.1399999999999999 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.56999999999999995 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 1.0600000000000001 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 51' ' ' LEU . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 1.1200000000000001 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.5900000000000001 109.044 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HB2' HD12 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.60999999999999999 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 42' ' ' ILE . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 2.2200000000000002 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.585 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 3.0299999999999998 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 16' ' ' VAL . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 1.05 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 1.26 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.65000000000000002 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 1.27 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.85999999999999999 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 1.26 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.60999999999999999 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 1.1699999999999999 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 2.48 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.98999999999999999 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.9399999999999999 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.79 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 1.1399999999999999 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 1.23 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.76 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.3500000000000001 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.436 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 2.25 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.21 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.81999999999999995 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.3999999999999999 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 1.4299999999999999 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 24' ' ' VAL . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 1.29 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.7599999999999998 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.69999999999999996 110.513 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.46 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 1.23 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.87 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 62' ' ' VAL . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 1.24 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.6200000000000001 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.1499999999999999 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.96999999999999997 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.1599999999999999 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HD22 ' A' ' 57' ' ' LEU . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 1.1699999999999999 108.769 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.6600000000000001 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78000000000000003 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.67000000000000004 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.475 HG22 HG12 ' A' ' 62' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 1.03 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.54 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.78 109.726 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.85999999999999999 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 1.1299999999999999 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.465 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 1.1100000000000001 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.403 ' CE1' HG23 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.3300000000000001 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 2.1299999999999999 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.6699999999999999 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 1.1100000000000001 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.1899999999999999 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.98999999999999999 110.223 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG11 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 1.23 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 31' ' ' LEU . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 1.1699999999999999 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.93000000000000005 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -78.3 -77.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81000000000000005 109.834 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.11 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 3.2599999999999998 110.066 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -68.86 0.36 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.489 -0.757 . . . . 2.52 109.31 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.69 57.14 0.16 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.213 -1.555 . . . . 0.93000000000000005 109.213 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.42 107.67 5.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.772 -0.84 . . . . 2.6200000000000001 109.718 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -126.27 156.0 41.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.698 -0.626 . . . . 2.3999999999999999 110.258 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.8400000000000001 109.659 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.524 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.9300000000000002 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 30' ' ' VAL . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.75 110.542 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 1.3 109.525 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.74 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.79000000000000004 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.80000000000000004 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67000000000000004 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 1.0 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 1.1899999999999999 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34000000000000002 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.83999999999999997 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.71999999999999997 109.128 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' A' ' 44' ' ' LEU . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 1.25 109.562 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 2.3399999999999999 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 16' ' ' VAL . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 1.1000000000000001 109.219 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 1.29 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.41 ' HB3' HD13 ' A' ' 42' ' ' ILE . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.87 111.101 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 1.28 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.04 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 1.1899999999999999 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52000000000000002 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 1.0800000000000001 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.6000000000000001 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.78000000000000003 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 2.0499999999999998 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HG2' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 1.1499999999999999 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 1.1699999999999999 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' A' ' 28' ' ' LYS . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 1.0700000000000001 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 1.0900000000000001 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 2.1299999999999999 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.70999999999999996 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.80000000000000004 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.97999999999999998 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 1.1699999999999999 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 1.1899999999999999 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HB3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 2.3900000000000001 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66000000000000003 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.96999999999999997 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 1.1599999999999999 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 1.29 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 1.24 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.81999999999999995 110.045 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 1.1200000000000001 108.477 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 2.5 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67000000000000004 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.96999999999999997 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 1.1000000000000001 109.347 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.4099999999999999 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.8500000000000001 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 1.1799999999999999 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.6599999999999999 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 1.1399999999999999 109.561 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.535 HD13 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.71 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.77 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 1.26 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92000000000000004 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 1.1100000000000001 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 1.1899999999999999 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 1.3400000000000001 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.88 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 -76.72 143.67 39.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.59999999999999998 109.398 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -37.79 85.41 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.693 -0.629 . . . . 4.7000000000000002 110.276 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -48.85 76.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.448 -0.783 . . . . 2.3500000000000001 109.56 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 64.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.394 -1.483 . . . . 0.81000000000000005 109.394 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.13 113.18 8.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 2.7599999999999998 109.832 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 112.67 25.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 2.0600000000000001 109.293 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 35' ' ' ILE . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.84999999999999998 110.06 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.6099999999999999 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 1.1200000000000001 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 1.3400000000000001 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 1.2 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.73 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 1.1200000000000001 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.81999999999999995 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 1.1000000000000001 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 51' ' ' LEU . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 1.1599999999999999 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.35999999999999999 108.64 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.98999999999999999 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 1.02 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HG2' HD13 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 1.47 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.4900000000000002 109.702 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 1.1200000000000001 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 1.1299999999999999 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.76000000000000001 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 1.3799999999999999 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.93000000000000005 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 1.1799999999999999 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.48999999999999999 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 1.0800000000000001 110.633 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.8100000000000001 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.05 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.77 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.71 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.414 HG12 HD12 ' A' ' 35' ' ' ILE . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 1.24 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 1.1599999999999999 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 1.55 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.4399999999999999 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.77 109.842 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 1.1000000000000001 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.80000000000000004 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.6200000000000001 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 1.45 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 24' ' ' VAL . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 1.22 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.7400000000000002 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.73999999999999999 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.5900000000000001 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.93000000000000005 109.392 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 1.2 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 1.27 109.646 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.3100000000000001 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76000000000000001 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.72999999999999998 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.7400000000000002 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 1.1499999999999999 108.549 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 2.3599999999999999 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.81999999999999995 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 1.03 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 HG11 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 1.1200000000000001 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 1.03 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 1.23 109.304 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54000000000000004 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 1.0700000000000001 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.75 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.28 109.681 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 2.3300000000000001 109.752 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 2.1099999999999999 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 1.26 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 27' ' ' PHE . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 1.1100000000000001 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 1.03 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 1.1000000000000001 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.6499999999999999 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.92 148.88 29.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.90000000000000002 110.439 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.8 ttm180 -62.29 -42.95 99.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.941 -0.474 . . . . 2.3500000000000001 110.068 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -44.16 96.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.492 -0.755 . . . . 2.27 109.458 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.11 69.89 0.05 OUTLIER Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.214 -1.554 . . . . 0.92000000000000004 109.214 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -145.16 116.66 8.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.718 -0.872 . . . . 2.75 109.95 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 113.89 27.68 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.78 109.02 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 1.1499999999999999 109.888 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.8399999999999999 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 1.0700000000000001 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 2.0299999999999998 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 1.3 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.6599999999999999 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 1.0800000000000001 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.96999999999999997 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76000000000000001 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 1.1599999999999999 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 1.1499999999999999 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.46000000000000002 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.647 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.70999999999999996 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.67000000000000004 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 2.3599999999999999 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.9199999999999999 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 1.1699999999999999 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 1.24 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.93000000000000005 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 1.28 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.84999999999999998 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' LEU . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 1.2 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.46999999999999997 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 1.1699999999999999 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.47 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89000000000000001 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 2.1200000000000001 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 3.0600000000000001 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 1.0900000000000001 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD11 ' HG2' ' A' ' 28' ' ' LYS . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 1.1399999999999999 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.4299999999999999 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 2.1299999999999999 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89000000000000001 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.83999999999999997 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 1.04 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 1.29 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.533 ' HB3' HG22 ' A' ' 24' ' ' VAL . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 1.22 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.6899999999999999 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.70999999999999996 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.6299999999999999 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 56' ' ' SER . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 1.29 109.668 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 1.04 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 1.1499999999999999 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.2400000000000002 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.69999999999999996 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.83999999999999997 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 1.1899999999999999 108.878 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.4299999999999999 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91000000000000003 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 1.05 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 1.1299999999999999 109.746 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.75 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 1.51 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 1.1599999999999999 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.3400000000000001 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 2.1099999999999999 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.8300000000000001 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.6100000000000001 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 64' ' ' ASP . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 1.1499999999999999 109.813 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 1.03 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.556 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 1.0800000000000001 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 1.25 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.83999999999999997 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -11.47 59.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.4 19.81 7.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.478 -0.764 . . . . 1.4299999999999999 110.474 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.06 -57.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.69 -0.856 . . . . 1.74 108.69 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.79 47.22 0.15 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.501 -1.44 . . . . 0.71999999999999997 109.501 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -157.57 137.78 12.66 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.635 -0.921 . . . . 3.0699999999999998 109.985 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -140.21 117.48 11.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.557 -0.714 . . . . 2.25 109.805 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 1.1399999999999999 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.46 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 1.1100000000000001 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.6499999999999999 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 1.4399999999999999 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.72 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 1.1599999999999999 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.68999999999999995 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.91000000000000003 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 51' ' ' LEU . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.40999999999999998 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.93000000000000005 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 1.55 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 2.2200000000000002 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 1.1399999999999999 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 1.1699999999999999 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.81000000000000005 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 1.48 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 1.22 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.48999999999999999 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 1.1100000000000001 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 2.48 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.69999999999999996 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.6599999999999999 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.9900000000000002 110.174 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 28' ' ' LYS . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 1.1599999999999999 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 1.0800000000000001 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 1.1599999999999999 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.5700000000000001 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.8200000000000001 109.638 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.69999999999999996 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 1.1399999999999999 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.3100000000000001 109.866 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.496 ' HB3' HG23 ' A' ' 24' ' ' VAL . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 1.1499999999999999 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.6200000000000001 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.69999999999999996 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 2.3500000000000001 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 1.26 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 1.0600000000000001 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 62' ' ' VAL . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 1.25 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77000000000000002 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.1599999999999999 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.93000000000000005 109.897 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.83999999999999997 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 1.1699999999999999 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.6299999999999999 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' HD11 ' A' ' 2' ' ' ILE . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.57999999999999996 109.429 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.72999999999999998 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 1.1100000000000001 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.92000000000000004 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 1.4199999999999999 109.615 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.80000000000000004 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 1.1399999999999999 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.1000000000000001 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.90000000000000002 109.998 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.75 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 2.0600000000000001 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 1.1699999999999999 109.92 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93000000000000005 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.8300000000000001 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 1.23 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 HG23 HD21 ' A' ' 31' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 1.1799999999999999 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 1.0600000000000001 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.67 156.27 33.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -31.65 69.58 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 2.3900000000000001 110.457 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -46.13 83.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.445 -0.784 . . . . 2.21 109.829 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.12 54.2 0.05 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.356 -1.498 . . . . 1.3200000000000001 109.356 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.46 153.16 35.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.846 -0.796 . . . . 3.6299999999999999 109.108 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt -121.31 146.34 46.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.097 -1.002 . . . . 3.1800000000000002 110.353 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 1.1699999999999999 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.6000000000000001 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 1.1100000000000001 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.8400000000000001 109.569 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 1.0900000000000001 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 1.4299999999999999 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 1.1399999999999999 110.108 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.71999999999999997 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51000000000000001 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.80000000000000004 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 1.1699999999999999 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.34999999999999998 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.90000000000000002 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.64000000000000001 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HG2' HD11 ' A' ' 44' ' ' LEU . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 1.3200000000000001 109.766 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.8200000000000001 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 1.1100000000000001 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 HD21 HG23 ' A' ' 6' ' ' VAL . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 1.1200000000000001 109.545 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.67000000000000004 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 1.3100000000000001 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.81999999999999995 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 1.1299999999999999 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.523 ' CB ' HG22 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.95999999999999996 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 2.0899999999999999 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.56000000000000005 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.25 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 3.4300000000000002 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.523 HG22 ' CB ' ' A' ' 37' ' ' THR . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 73' ' ' LEU . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 1.1200000000000001 107.956 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 28' ' ' LYS . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 1.24 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 1.04 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.8300000000000001 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.78000000000000003 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.84999999999999998 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.3799999999999999 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 1.1799999999999999 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 24' ' ' VAL . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 1.1799999999999999 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 1.4199999999999999 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56000000000000005 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 2.4199999999999999 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 1.1599999999999999 109.588 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.97999999999999998 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 1.1599999999999999 109.8 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66000000000000003 109.342 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.94999999999999996 110.12 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.3300000000000001 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 1.1200000000000001 108.671 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.6499999999999999 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 1.05 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.478 ' CG2' HG11 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 2.0099999999999998 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 68' ' ' LEU . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52000000000000002 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 70' ' ' LEU . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 1.1899999999999999 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 1.1699999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.94999999999999996 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.8899999999999999 109.579 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 2.1899999999999999 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 1.25 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.72999999999999998 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 109.921 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.507 HG11 ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 1.5600000000000001 108.678 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 1.24 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.4299999999999999 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.08 152.01 33.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66000000000000003 110.173 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.408 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -63.87 -36.93 85.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.771 -0.581 . . . . 2.48 109.85 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -47.38 78.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.506 -0.746 . . . . 2.2400000000000002 109.046 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.55 69.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.319 -1.512 . . . . 0.75 109.319 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -147.97 109.64 4.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.723 -0.869 . . . . 2.1499999999999999 109.682 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 125.68 43.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 1.8 109.708 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 1.4299999999999999 109.688 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.507 ' HG2' HG11 ' A' ' 5' ' ' VAL . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.54 109.21 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 1.0800000000000001 110.162 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.8500000000000001 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 1.27 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.5900000000000001 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 1.3799999999999999 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.85999999999999999 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 1.1200000000000001 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.46000000000000002 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.65000000000000002 109.393 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' HG11 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.8100000000000001 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 3.25 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 1.0800000000000001 108.605 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 1.4199999999999999 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.88 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 1.3600000000000001 109.897 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 1.0700000000000001 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 37' ' ' THR . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 1.1499999999999999 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.58999999999999997 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 1.0600000000000001 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.6299999999999999 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.1399999999999999 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 2.3900000000000001 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.7400000000000002 111.183 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.498 HG21 ' HG2' ' A' ' 28' ' ' LYS . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 1.2 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 1.1599999999999999 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD22 HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 1.25 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.3500000000000001 109.45 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 1.5700000000000001 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.90000000000000002 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1000000000000001 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 1.1200000000000001 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 1.1399999999999999 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 24' ' ' VAL . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 1.1299999999999999 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.5 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.84999999999999998 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.8399999999999999 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 1.3100000000000001 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 1.1799999999999999 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 1.1699999999999999 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79000000000000004 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.97999999999999998 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 1.1699999999999999 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.9399999999999999 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.59999999999999998 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.424 HG21 HG11 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.81000000000000005 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 1.0700000000000001 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 44' ' ' LEU . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 1.24 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 109.57 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 1.1599999999999999 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 1.1299999999999999 109.21 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.87 109.788 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.8799999999999999 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 2.0 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 62' ' ' VAL . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 1.1100000000000001 109.829 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.90000000000000002 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 1.1599999999999999 110.15 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 1.1899999999999999 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 1.3300000000000001 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.87 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.45 147.64 39.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52000000000000002 110.058 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -34.22 77.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.747 -0.596 . . . . 4.0300000000000002 110.302 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -49.21 77.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 1.8700000000000001 109.723 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.28 72.89 0.01 OUTLIER Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.231 -1.548 . . . . 0.77000000000000002 109.231 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -152.22 151.0 30.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.746 -0.855 . . . . 2.71 109.865 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp -150.29 123.89 9.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.401 -0.812 . . . . 2.8199999999999998 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 1.26 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.8700000000000001 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 30' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 1.22 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.8700000000000001 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.96999999999999997 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 1.45 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 1.0900000000000001 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76000000000000001 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.94999999999999996 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 51' ' ' LEU . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 1.2 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.42999999999999999 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.97999999999999998 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.65000000000000002 109.356 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HG2' HD12 ' A' ' 44' ' ' LEU . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 2.25 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.75 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 16' ' ' VAL . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 1.1299999999999999 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 1.3400000000000001 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.63 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 1.54 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.58999999999999997 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 1.1399999999999999 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54000000000000004 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 1.1499999999999999 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 2.6200000000000001 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79000000000000004 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 2.04 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.74 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 35' ' ' ILE . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 1.1499999999999999 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 1.1599999999999999 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 1.29 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 2.0499999999999998 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 1.26 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.1200000000000001 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 1.04 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.5600000000000001 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 1.3600000000000001 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 ' CD2' ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 1.21 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.8899999999999999 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65000000000000002 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 1.0600000000000001 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' SER . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.92000000000000004 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 1.26 109.514 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.95999999999999996 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.3100000000000001 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.89000000000000001 109.868 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 2' ' ' ILE . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 1.1200000000000001 109.161 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.4299999999999999 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78000000000000003 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.85999999999999999 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.98999999999999999 109.62 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 2.0 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 1.4199999999999999 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.3799999999999999 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 1.1499999999999999 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 1.3500000000000001 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.21 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.8799999999999999 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.5600000000000001 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 1.1200000000000001 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.916 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' HE3' ' A' ' 13' ' ' LYS . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 1.1100000000000001 109.58 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG11 ' HB2' ' A' ' 68' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 1.2 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.70999999999999996 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 1.1 m-20 -82.49 -60.27 2.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.26 -64.46 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.557 -0.715 . . . . 1.6200000000000001 109.855 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 130.07 22.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.643 -0.66 . . . . 2.0699999999999998 109.462 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.58 39.36 96.36 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.003 -1.239 . . . . 0.87 110.003 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -145.62 113.25 6.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.608 -0.936 . . . . 2.6800000000000002 109.903 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -145.8 117.78 8.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.642 -0.661 . . . . 2.23 109.732 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 1.1100000000000001 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 2.3399999999999999 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 27' ' ' PHE . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 1.21 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.71 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 1.05 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 1.3300000000000001 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79000000000000004 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.81999999999999995 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 51' ' ' LEU . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 1.1100000000000001 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.45000000000000001 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93000000000000005 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.64000000000000001 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 1.3899999999999999 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 3.48 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 1.1699999999999999 109.406 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 1.3100000000000001 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.92000000000000004 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 1.3700000000000001 109.912 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.91000000000000003 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 31' ' ' LEU . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 1.1299999999999999 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.56999999999999995 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 1.0800000000000001 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.4199999999999999 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.82999999999999996 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.29 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.5499999999999998 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.438 HG12 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 1.01 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 1.1499999999999999 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 27' ' ' PHE . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 1.21 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.502 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.85999999999999999 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 2.27 109.912 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.3999999999999999 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 1.0900000000000001 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.6100000000000001 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 1.53 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 24' ' ' VAL . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 1.1499999999999999 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 2.3900000000000001 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.57999999999999996 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 2.1299999999999999 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 1.25 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 1.1599999999999999 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 1.0800000000000001 109.427 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.8400000000000001 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.68999999999999995 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 1.3700000000000001 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.1299999999999999 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 1.1899999999999999 109.072 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.5900000000000001 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66000000000000003 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 1.04 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 1.0900000000000001 109.5 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 1.28 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.8600000000000001 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.4299999999999999 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 1.1299999999999999 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 1.04 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.93000000000000005 109.883 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.9199999999999999 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 2.0699999999999998 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.567 HD11 HG13 ' A' ' 62' ' ' VAL . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 1.0900000000000001 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 1.1000000000000001 109.566 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 1.1499999999999999 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 1.0900000000000001 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 -72.72 -61.74 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78000000000000003 110.077 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.96 -66.66 0.47 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 1.5600000000000001 109.587 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.54 109.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.619 -0.676 . . . . 2.1099999999999999 109.297 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.65 -51.59 1.35 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.644 -1.383 . . . . 0.68999999999999995 109.644 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -75.31 123.89 26.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.861 . . . . 2.4700000000000002 109.896 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.7 154.21 41.16 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.649 -0.657 . . . . 2.2999999999999998 109.753 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 1.22 109.611 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 16' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 1.23 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.8 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 1.1699999999999999 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.8200000000000001 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 1.2 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.84999999999999998 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.82999999999999996 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 1.01 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 51' ' ' LEU . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 1.1100000000000001 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.38 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.80000000000000004 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.71999999999999997 109.138 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 1.1599999999999999 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 2.1299999999999999 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 1.1599999999999999 109.671 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 1.1699999999999999 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.81000000000000005 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 1.3899999999999999 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.78000000000000003 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 1.1699999999999999 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.46999999999999997 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.486 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 1.0700000000000001 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.8700000000000001 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68999999999999995 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 2.0499999999999998 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.78 110.151 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.545 HG22 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 1.0800000000000001 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 1.1200000000000001 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 1.1499999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 1.0700000000000001 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.8100000000000001 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.96999999999999997 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.90000000000000002 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.3999999999999999 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 1.2 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' HB3' HG22 ' A' ' 24' ' ' VAL . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 1.1799999999999999 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.8599999999999999 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.69999999999999996 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.45 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 1.27 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.5600000000000001 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 1.21 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.3100000000000001 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.471 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.72999999999999998 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HG23 ' A' ' 66' ' ' THR . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 1.1599999999999999 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.6899999999999999 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.69999999999999996 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.83999999999999997 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.582 HG23 HG12 ' A' ' 62' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.80000000000000004 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.8500000000000001 110.141 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 1.2 109.619 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 1.0800000000000001 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.55 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.90000000000000002 109.722 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.8899999999999999 110.133 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 2.1499999999999999 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 1.03 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65000000000000002 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 1.1200000000000001 110.065 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 1.1699999999999999 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 1.5600000000000001 109.745 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.81000000000000005 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -74.69 -63.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.83999999999999997 110.307 -179.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.31 -66.63 0.54 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.738 . . . . 1.99 109.746 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.65 114.44 1.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.525 -0.734 . . . . 1.8799999999999999 109.713 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.27 -26.54 23.26 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.38 -1.088 . . . . 1.48 110.38 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.98 121.86 42.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -1.019 . . . . 1.99 109.928 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 149.12 35.37 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.668 -0.645 . . . . 2.3500000000000001 109.944 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 1.29 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 1.29 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 1.23 109.754 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 3.04 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 1.1499999999999999 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 1.49 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 1.22 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79000000000000004 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.58999999999999997 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.85999999999999999 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 1.0700000000000001 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.35999999999999999 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52000000000000002 108.815 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.64000000000000001 109.223 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.6200000000000001 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.8700000000000001 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 1.1599999999999999 108.992 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 1.23 109.622 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.69999999999999996 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.6499999999999999 109.656 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 1.26 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55000000000000004 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 1.22 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.99 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 1.0800000000000001 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 2.0800000000000001 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 2.4199999999999999 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 28' ' ' LYS . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 1.1399999999999999 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 1.1899999999999999 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 1.22 110.059 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.635 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.6299999999999999 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.76 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.1000000000000001 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.98999999999999999 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 1.0 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 1.29 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 1.1499999999999999 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.79 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67000000000000004 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 1.0800000000000001 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 1.1499999999999999 109.492 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 1.1599999999999999 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 1.1399999999999999 109.653 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.3100000000000001 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.69999999999999996 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.83999999999999997 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 1.1799999999999999 108.325 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.71 110.462 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.57999999999999996 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.95999999999999996 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 1.1100000000000001 109.517 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 1.1899999999999999 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 1.3300000000000001 109.433 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 1.21 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 1.1599999999999999 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 1.0700000000000001 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 2.0 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 2.0800000000000001 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 1.1000000000000001 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.85999999999999999 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.97999999999999998 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.8999999999999999 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 1.1200000000000001 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.72999999999999998 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -8.36 59.26 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.0700000000000001 111.341 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 64.6 34.66 9.72 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.31 -0.869 . . . . 1.76 110.039 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -60.64 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.781 . . . . 1.8999999999999999 108.937 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.61 46.92 0.14 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.561 -1.415 . . . . 1.1299999999999999 109.561 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -156.05 132.79 10.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.926 . . . . 1.99 109.909 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -134.92 109.88 8.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 2.3999999999999999 109.105 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 1.24 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.97 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 1.1499999999999999 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 3.4100000000000001 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 1.3200000000000001 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.77 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 1.01 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.4199999999999999 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.69999999999999996 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.85999999999999999 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 51' ' ' LEU . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 1.0700000000000001 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.40999999999999998 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 44' ' ' LEU . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.71999999999999997 109.402 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.76 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 3.3999999999999999 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 1.0800000000000001 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 1.1799999999999999 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.552 ' HB3' HD12 ' A' ' 42' ' ' ILE . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.85999999999999999 111.386 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 1.4099999999999999 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' THR . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 1.01 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45000000000000001 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.535 ' HB ' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 1.1799999999999999 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.4099999999999999 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.56999999999999995 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.5 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.46 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 32' ' ' SER . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 1.1299999999999999 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 1.0600000000000001 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 1.3899999999999999 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.87 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HA ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 2.7200000000000002 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.73999999999999999 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.51 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 1.1599999999999999 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HB3' HG23 ' A' ' 24' ' ' VAL . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 1.1399999999999999 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.6400000000000001 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.4099999999999999 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 1.3600000000000001 109.325 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 1.27 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 62' ' ' VAL . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 1.21 109.549 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.80000000000000004 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 1.05 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.94999999999999996 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 57' ' ' LEU . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 1.1299999999999999 109.273 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.26 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64000000000000001 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.25 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.404 HG22 ' CG1' ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 1.0800000000000001 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.3600000000000001 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 46' ' ' LYS . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 1.3300000000000001 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.69999999999999996 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 1.1000000000000001 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.22 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 1.0900000000000001 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.6899999999999999 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.8899999999999999 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 64' ' ' ASP . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 1.1399999999999999 109.76 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 1.02 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 1.1499999999999999 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 1.2 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.59999999999999998 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 21.7 t70 -75.53 -57.24 4.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46000000000000002 109.368 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.55 -175.99 3.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.704 -0.623 . . . . 1.6499999999999999 109.589 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 109.31 3.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 2.1600000000000001 109.535 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 -38.45 3.25 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.918 -1.273 . . . . 0.80000000000000004 109.918 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.33 128.43 34.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.635 -0.92 . . . . 1.77 110.192 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -141.63 133.59 27.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.796 -0.565 . . . . 1.9199999999999999 109.572 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 1.1799999999999999 109.65 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 2.3900000000000001 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 30' ' ' VAL . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 1.0900000000000001 109.758 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.6799999999999999 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 1.0900000000000001 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.6200000000000001 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 1.0 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.58999999999999997 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 1.0900000000000001 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28000000000000003 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66000000000000003 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.60999999999999999 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HE2' HG11 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 1.4199999999999999 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.99 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 16' ' ' VAL . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 1.1100000000000001 109.283 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.449 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 1.0900000000000001 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 42' ' ' ILE . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.73999999999999999 110.736 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 1.3 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52000000000000002 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.42999999999999999 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 1.1200000000000001 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 2.3199999999999998 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46000000000000002 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 2.1299999999999999 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 1.3899999999999999 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 32' ' ' SER . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 1.05 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 1.0900000000000001 108.752 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 1.4199999999999999 109.865 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.3 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 1.4299999999999999 109.442 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.93999999999999995 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64000000000000001 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.48 109.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 1.22 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' HB3' HG23 ' A' ' 24' ' ' VAL . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 1.1299999999999999 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.6099999999999999 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53000000000000003 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 1.0600000000000001 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 1.21 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 1.0700000000000001 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 1.1299999999999999 109.47 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.83999999999999997 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.96999999999999997 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.1499999999999999 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 66' ' ' THR . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 1.23 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.9199999999999999 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 2' ' ' ILE . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.95999999999999996 109.616 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 1.1299999999999999 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 HG13 ' A' ' 62' ' ' VAL . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 1.1000000000000001 109.341 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 1.4399999999999999 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.57999999999999996 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 8' ' ' ASP . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 1.0900000000000001 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.81000000000000005 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 1.1799999999999999 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.78 109.729 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 2.21 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 1.1599999999999999 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.72999999999999998 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.521 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 1.1699999999999999 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 1.1499999999999999 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 1.22 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.91000000000000003 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 -82.68 173.2 12.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67000000000000004 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HG3' HD13 ' A' ' 10' ' ' LEU . 1.7 ptp85 -59.49 -35.86 74.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.634 -0.666 . . . . 1.46 110.203 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -82.96 -171.91 3.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.424 -0.798 . . . . 2.0800000000000001 109.623 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.31 65.3 4.03 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.25 -1.14 . . . . 0.81000000000000005 110.25 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -154.53 150.53 27.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.895 . . . . 3.8100000000000001 109.893 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 153.41 50.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.598 -0.689 . . . . 1.73 109.921 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 1.1699999999999999 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.8500000000000001 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 1.1499999999999999 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.71 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 1.26 109.606 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 1.47 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 1.1000000000000001 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68000000000000005 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64000000000000001 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 1.02 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 1.1599999999999999 109.391 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.45000000000000001 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.80000000000000004 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.77000000000000002 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.5900000000000001 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.4900000000000002 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 1.0800000000000001 109.333 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 1.3200000000000001 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.84999999999999998 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 1.3 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.22 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 1.1899999999999999 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.48999999999999999 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 1.1299999999999999 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.96 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.77000000000000002 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.0600000000000001 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 2.2799999999999998 110.532 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 1.1499999999999999 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 1.1799999999999999 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 HD21 HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 1.47 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HD2' HD21 ' A' ' 68' ' ' LEU . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 1.48 109.602 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.93000000000000005 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89000000000000001 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.48 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 1.29 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 68' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 1.26 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.8999999999999999 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.68999999999999995 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 1.3100000000000001 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 1.29 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 1.05 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 62' ' ' VAL . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 1.1499999999999999 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.92000000000000004 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG11 HG22 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 1.21 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.71 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.84999999999999998 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 1.0 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.521 ' CG2' HG13 ' A' ' 4' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 1.03 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.55 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 1.22 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.575 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 1.1200000000000001 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.6200000000000001 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.8500000000000001 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.5900000000000001 110.09 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 2.04 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 64' ' ' ASP . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 1.1299999999999999 109.922 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92000000000000004 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 27' ' ' PHE . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 1.1100000000000001 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 1.1699999999999999 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 70' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 1.1299999999999999 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.65000000000000002 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.34 -67.73 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.69999999999999996 110.153 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.07 55.36 1.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.652 -0.655 . . . . 1.6000000000000001 109.394 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.556 -0.715 . . . . 2.04 109.49 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.37 -56.85 0.35 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.514 -1.434 . . . . 0.97999999999999998 109.514 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 111.12 16.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.812 -0.816 . . . . 2.5499999999999998 109.512 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -112.5 125.44 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.749 -0.594 . . . . 1.54 109.927 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 3.6600000000000001 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 1.0600000000000001 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.5 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.93000000000000005 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 1.53 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 1.1100000000000001 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92000000000000004 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.69999999999999996 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.71 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 1.0600000000000001 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.38 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.80000000000000004 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.51000000000000001 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' CG ' HD13 ' A' ' 44' ' ' LEU . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 1.5600000000000001 110.236 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.7799999999999998 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 1.1100000000000001 108.866 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 1.1499999999999999 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.82999999999999996 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.45 109.842 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.56000000000000005 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 70' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 1.1799999999999999 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.41999999999999998 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 1.0700000000000001 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 3.04 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.3799999999999999 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.79 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.8500000000000001 110.673 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.587 HG21 HD13 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 1.1299999999999999 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 1.1200000000000001 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 28' ' ' LYS . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 1.29 110.173 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.1399999999999999 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.98 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.1599999999999999 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.5900000000000001 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 1.3500000000000001 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HB3' HG22 ' A' ' 24' ' ' VAL . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 1.1699999999999999 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.5099999999999998 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.59999999999999998 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 1.26 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 1.1599999999999999 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 1.1100000000000001 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 1.1499999999999999 109.443 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.5900000000000001 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.69999999999999996 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.97999999999999998 109.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.1899999999999999 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 1.1699999999999999 108.751 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.95 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54000000000000004 109.289 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.82999999999999996 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 1.05 109.625 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.69999999999999996 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.6699999999999999 109.748 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65000000000000002 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 35' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.45 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 1.3600000000000001 109.871 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.8700000000000001 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 2.1499999999999999 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 1.1899999999999999 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91000000000000003 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 1.04 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 1.21 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 1.1000000000000001 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -79.27 -56.12 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.96999999999999997 110.001 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.461 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -128.79 -63.06 0.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.684 -0.635 . . . . 1.8200000000000001 109.664 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.36 -63.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.561 -0.712 . . . . 2.04 109.84 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.21 51.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.16 -1.176 . . . . 0.83999999999999997 110.16 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 129.35 37.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -1.018 . . . . 3.1899999999999999 110.074 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.33 124.44 8.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 1.49 109.72 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 1.26 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 2.1400000000000001 109.468 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG22 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 1.0900000000000001 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 3.27 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 1.3400000000000001 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 1.3500000000000001 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 1.21 109.933 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78000000000000003 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 1.1200000000000001 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 51' ' ' LEU . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 1.1499999999999999 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.34999999999999998 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.81999999999999995 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 16' ' ' VAL . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.55000000000000004 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HG2' HD13 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 1.49 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.9900000000000002 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 16' ' ' VAL . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 1.1599999999999999 109.285 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.541 ' HG ' HG22 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 1.26 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.89000000000000001 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 1.3500000000000001 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.69999999999999996 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 1.1499999999999999 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.40000000000000002 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 1.0700000000000001 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.5600000000000001 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.70999999999999996 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 2.21 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 3.3100000000000001 110.991 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.502 HG21 HD12 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 1.1200000000000001 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 1.0600000000000001 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 28' ' ' LYS . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 1.26 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.585 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 1.24 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 2.3700000000000001 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78000000000000003 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.94999999999999996 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 1.05 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 1.1499999999999999 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB3' HG22 ' A' ' 24' ' ' VAL . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 1.1699999999999999 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.73 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.68999999999999995 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.48 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 1.27 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.81999999999999995 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 62' ' ' VAL . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 1.24 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 20' ' ' ALA . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.437 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.3700000000000001 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.93000000000000005 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.3500000000000001 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 HG23 HD23 ' A' ' 57' ' ' LEU . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 1.1399999999999999 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 2.3700000000000001 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.84999999999999998 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' CG1' ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 1.0600000000000001 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.6499999999999999 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.8899999999999999 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 8' ' ' ASP . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 1.1299999999999999 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.6799999999999999 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.91000000000000003 109.737 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.6699999999999999 109.547 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 2.46 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 62' ' ' VAL . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 1.1899999999999999 109.775 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 1.1299999999999999 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 1.1399999999999999 109.123 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.482 HG13 HD21 ' A' ' 44' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 1.1799999999999999 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.48999999999999999 109.522 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -87.85 147.84 24.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 71' ' ' TYR . 8.1 mmt-85 -65.97 -37.63 86.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.713 -0.617 . . . . 1.52 110.039 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -48.35 81.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.581 -0.7 . . . . 1.74 109.416 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.99 61.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.011 -1.236 . . . . 0.62 110.011 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.52 100.56 3.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.966 . . . . 1.53 109.525 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.28 118.62 37.07 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.6100000000000001 108.943 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 1.5 109.94 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.9100000000000001 110.141 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.461 HG13 ' CZ ' ' A' ' 27' ' ' PHE . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 1.1100000000000001 109.341 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 2.5600000000000001 110.235 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 1.24 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.6100000000000001 109.784 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 1.1299999999999999 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.82999999999999996 109.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.97999999999999998 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 51' ' ' LEU . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 1.1599999999999999 108.969 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.38 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.97999999999999998 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.72999999999999998 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 1.3799999999999999 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 2.3999999999999999 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 16' ' ' VAL . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 1.1299999999999999 109.124 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 35' ' ' ILE . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 1.25 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' HD13 ' A' ' 42' ' ' ILE . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.87 111.222 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.73 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.68000000000000005 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 1.1299999999999999 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39000000000000001 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.48 HG22 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 1.1100000000000001 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.6699999999999999 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.72999999999999998 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.8600000000000001 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.9500000000000002 110.513 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.91000000000000003 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 1.21 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 1.3400000000000001 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 1.1100000000000001 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.97 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.83999999999999997 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.54 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 1.29 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 1.2 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 3.3799999999999999 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66000000000000003 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.4299999999999999 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 1.26 109.429 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 1.28 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68000000000000005 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.71999999999999997 110.209 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.0600000000000001 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 62' ' ' VAL . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 1.04 108.981 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 1.1499999999999999 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.68999999999999995 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.67000000000000004 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.533 HG23 HG11 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 1.0800000000000001 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.45 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 1.3899999999999999 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.0900000000000001 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 1.1399999999999999 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 9' ' ' ARG . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.25 109.304 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.48 ' CD1' HG22 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.80000000000000004 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 2.1200000000000001 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.97 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 1.1299999999999999 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.85999999999999999 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 1.1200000000000001 110.357 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 1.1699999999999999 109.544 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.68999999999999995 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.72999999999999998 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.89 -43.05 72.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.29 -63.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.658 -0.651 . . . . 2.4700000000000002 109.417 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.46 113.93 0.87 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 1.8200000000000001 109.353 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -60.03 0.36 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.837 -1.305 . . . . 0.83999999999999997 109.837 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 125.47 29.16 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.591 -0.946 . . . . 1.27 109.792 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.2 154.52 43.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.636 -0.665 . . . . 2.9100000000000001 110.117 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 1.5600000000000001 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 2.1699999999999999 109.151 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 1.1399999999999999 109.439 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 3.1699999999999999 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 1.1899999999999999 109.756 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 1.48 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 110.241 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.58999999999999997 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 1.23 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 1.1399999999999999 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.35999999999999999 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.71999999999999997 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' CE2' HD13 ' A' ' 31' ' ' LEU . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.63 109.193 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 1.46 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 3.2200000000000002 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' SG ' ' A' ' 18' ' ' CYS . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 1.1100000000000001 109.268 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.479 HD13 ' CE2' ' A' ' 27' ' ' PHE . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 1.1299999999999999 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.98999999999999999 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 1.3799999999999999 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67000000000000004 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.47999999999999998 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 1.1699999999999999 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.7599999999999998 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.88 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.45 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HB3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 2.4199999999999999 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 37' ' ' THR . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 1.1599999999999999 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 1.1399999999999999 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.469 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 1.1699999999999999 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 1.1299999999999999 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 1.6699999999999999 109.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.90000000000000002 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 1.03 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 1.1599999999999999 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 3.3999999999999999 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65000000000000002 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.6099999999999999 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 1.1899999999999999 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 1.01 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 1.1599999999999999 109.35 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.69999999999999996 109.58 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.70999999999999996 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.57999999999999996 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 66' ' ' THR . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 1.1299999999999999 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 1.22 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.81999999999999995 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.82999999999999996 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 62' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 1.0600000000000001 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.9099999999999999 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 1.3400000000000001 109.719 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 1.1799999999999999 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.5 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 1.23 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.9199999999999999 109.417 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 2.0499999999999998 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 1.1799999999999999 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.68999999999999995 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.401 HG22 ' CE2' ' A' ' 27' ' ' PHE . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 1.1000000000000001 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 1.05 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 1.52 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.85999999999999999 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 -78.14 -80.79 0.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56000000000000005 110.016 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -55.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.547 -0.72 . . . . 2.1499999999999999 110.145 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -62.11 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.69 . . . . 2.1699999999999999 109.622 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.92 55.11 0.14 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.729 -1.349 . . . . 1.0600000000000001 109.729 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.76 107.42 10.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.755 -0.85 . . . . 2.3300000000000001 109.406 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.81 117.44 28.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.576 -0.703 . . . . 2.6000000000000001 109.695 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.7 109.838 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 2.1699999999999999 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 30' ' ' VAL . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 1.2 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 3.1499999999999999 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 1.25 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 1.2 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.72999999999999998 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55000000000000004 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 1.04 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 1.0800000000000001 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33000000000000002 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51000000000000001 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.48999999999999999 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HG2' HG23 ' A' ' 42' ' ' ILE . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.49 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.6099999999999999 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 16' ' ' VAL . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 1.1299999999999999 109.638 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 1.1699999999999999 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.505 ' HB3' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.92000000000000004 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 1.3300000000000001 110.006 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.91000000000000003 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 1.21 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 1.27 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.8399999999999999 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79000000000000004 111.502 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.1499999999999999 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.76 110.546 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 28' ' ' LYS . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 1.25 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 1.29 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 1.4199999999999999 109.938 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.6299999999999999 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.76 109.225 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.1399999999999999 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.88 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 1.1000000000000001 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 1.4099999999999999 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD13 ' CD2' ' A' ' 68' ' ' LEU . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 1.25 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 2.1200000000000001 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54000000000000004 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 1.1599999999999999 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 1.1000000000000001 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 1.0900000000000001 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 109.349 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.3200000000000001 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.6200000000000001 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 1.01 109.777 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.6699999999999999 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 1.1599999999999999 108.752 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.8999999999999999 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66000000000000003 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 1.05 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 1.0700000000000001 109.775 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.3500000000000001 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.542 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 1.6299999999999999 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.85999999999999999 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 1.1299999999999999 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.52 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.6899999999999999 109.451 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.46 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 0.45 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.84 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 0.46 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 0.55 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 0.6 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.27 109.518 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.58 109.697 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.211 -0.662 . . . . 0.91 109.211 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.55 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.36 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 0.41 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 2.9 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 0.48 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.06 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 0.43 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 57' ' ' LEU . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55 109.338 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 0.48 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 0.41 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.44 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.87 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.61 109.427 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 0.77 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.45 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 0.34 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 0.59 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.53 110.654 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 0.91 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.68 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' LEU . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 0.47 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 0.4 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' THR . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 2.34 109.797 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 0.96 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 1.81 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.38 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.662 HG23 HD11 ' A' ' 70' ' ' LEU . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 0.38 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 0.46 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 0.86 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.04 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CB ' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 0.93 109.529 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.05 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.14 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' VAL . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 0.83 110.367 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 60' ' ' TYR . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 0.61 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.23 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 0.98 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 0.53 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.64 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 0.45 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.86 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CG ' HD22 ' A' ' 51' ' ' LEU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.48 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.33 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 66' ' ' THR . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 0.48 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.23 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 0.95 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 HG13 ' A' ' 62' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.42 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.03 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.05 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.74 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.826 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.4 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.17 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 37' ' ' THR . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 0.93 109.925 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.27 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.36 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 0.39 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 66' ' ' THR . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 0.43 109.764 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 0.41 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD21 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 0.51 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.63 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.59 109.685 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.593 . . . . 0.76 109.4 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 0.54 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 1.86 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 0.52 109.699 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.31 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 0.9 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 0.9 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 0.63 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.573 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.57 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 0.64 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.744 HG12 ' HE3' ' A' ' 28' ' ' LYS . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 0.48 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.42 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.59 109.044 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.45 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.744 ' HE3' HG12 ' A' ' 24' ' ' VAL . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 1.6 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.599 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 2.5 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 26' ' ' ASP . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.55 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.47 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 0.72 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.74 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 0.67 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.61 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 0.61 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 1.86 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.99 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.57 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.38 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 0.51 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 0.55 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.08 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.08 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 1.65 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.0 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.75 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.13 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 0.84 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD12 ' HB3' ' A' ' 44' ' ' LEU . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 0.6 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.31 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.7 110.513 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.16 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.58 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.53 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 27' ' ' PHE . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 0.59 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.62 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.15 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CG ' HD22 ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.54 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.16 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 0.44 108.769 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.12 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.56 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.554 HG22 HG12 ' A' ' 4' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 0.48 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.28 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.04 109.726 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.86 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 HG23 ' A' ' 42' ' ' ILE . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.5 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.473 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 0.81 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 1.58 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.12 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 0.48 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.19 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.51 110.223 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 0.64 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 14' ' ' VAL . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 0.57 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.77 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81 109.834 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 121.221 0.534 . . . . 1.92 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.26 109.659 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.36 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 31' ' ' LEU . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.46 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.31 110.542 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 0.85 109.525 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.1 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.55 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.8 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 0.53 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 0.45 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.84 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 44' ' ' LEU . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.55 109.128 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 0.81 109.562 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 1.73 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 0.38 109.219 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 0.63 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.48 111.101 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 0.64 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.03 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 0.59 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.679 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 0.44 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.0 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.74 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 1.61 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.24 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 0.45 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 0.55 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 0.5 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 0.88 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.744 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 1.65 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.68 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.8 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.6 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 0.68 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 0.49 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 1.93 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.82 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 0.49 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.72 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 0.58 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.62 110.045 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 0.64 108.477 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 1.69 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.97 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.5 109.347 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.15 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.3 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.51 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.14 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.679 ' CD1' HG21 ' A' ' 37' ' ' THR . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.78 109.561 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.12 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.23 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 0.58 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 0.48 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 0.58 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 0.71 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.72 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.6 109.398 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.293 -0.632 . . . . 1.48 109.293 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.47 110.06 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.15 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.44 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 0.94 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 0.83 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.25 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 0.55 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.82 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.73 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 0.48 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.35 108.64 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.99 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 0.7 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' HD12 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 0.85 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.02 109.702 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 0.42 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 0.48 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.51 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 0.79 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.72 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.53 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.49 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' TYR . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 0.47 110.633 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.5 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.02 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.57 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.29 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 70' ' ' LEU . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 0.49 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 73' ' ' LEU . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 0.55 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.99 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.06 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.11 109.842 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 0.98 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.8 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.22 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 0.74 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 0.46 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.24 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.74 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.32 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.52 109.392 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.79 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 62' ' ' VAL . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 0.73 109.646 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.31 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.58 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.74 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 46' ' ' LYS . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 1.83 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.82 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 0.89 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.805 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 0.55 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 0.92 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 0.57 109.304 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.865 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.45 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.37 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 37' ' ' THR . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.08 109.681 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 1.94 109.752 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 1.7 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 0.54 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 66' ' ' THR . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.41 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.45 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 0.43 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.65 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.9 110.439 -179.45 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 35' ' ' ILE . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.52 109.888 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.21 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 0.46 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 1.39 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 0.82 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.12 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 0.47 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.97 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.7 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 0.47 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.43 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.71 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 57' ' ' LEU . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.5 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 1.79 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.38 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 0.42 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 0.63 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.42 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 0.65 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.68 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 14' ' ' VAL . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 0.52 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.45 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 35' ' ' ILE . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 0.48 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.25 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 1.62 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 2.52 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 70' ' ' LEU . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 0.47 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 0.5 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.45 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.22 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 1.66 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.84 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 0.63 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 0.75 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 46' ' ' LYS . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 0.54 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.31 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.71 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.09 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 0.59 109.668 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 0.63 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 0.48 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.24 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.7 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.6 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 57' ' ' LEU . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 0.55 108.878 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.33 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 0.92 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 4' ' ' VAL . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 0.42 109.746 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.35 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 0.87 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 42' ' ' ILE . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.46 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.04 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 1.27 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.36 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.04 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 0.39 109.813 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 0.34 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 0.5 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 0.54 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.73 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.614 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.27 0.557 . . . . 1.62 109.805 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 0.6 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.06 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 0.49 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.13 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 0.92 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.12 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 0.46 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.24 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.69 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.49 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 0.49 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.34 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' LEU . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.63 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 0.96 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 1.69 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 0.39 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 0.56 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.454 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.39 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 0.87 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.77 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 42' ' ' ILE . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 0.53 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.48 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 72' ' ' TYR . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 0.38 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 1.95 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.59 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.32 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.53 110.174 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.73 HG21 HD11 ' A' ' 35' ' ' ILE . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.48 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 0.42 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 0.44 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.27 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.12 109.638 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.62 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 0.76 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' VAL . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 0.76 109.866 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.52 HD11 HD21 ' A' ' 68' ' ' LEU . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 0.48 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.21 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.7 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 1.91 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 0.65 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 0.75 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 27' ' ' PHE . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 0.6 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.16 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HD13 ' A' ' 55' ' ' ILE . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.52 109.897 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.84 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG22 ' HD3' ' A' ' 46' ' ' LYS . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 0.5 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.31 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.58 109.429 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.66 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 0.43 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.8 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 0.8 109.615 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.8 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.42 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 37' ' ' THR . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.55 109.998 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.54 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 1.51 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 0.49 109.92 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 66' ' ' THR . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.12 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 0.5 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 68' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 0.48 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 0.83 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.349 0.595 . . . . 2.64 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 0.58 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.12 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 0.44 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.31 109.569 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 0.65 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 0.74 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.42 110.108 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.72 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.41 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 0.42 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.32 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.9 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.46 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 0.67 109.766 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.37 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.35 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 0.47 109.545 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.37 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 0.79 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.73 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 0.48 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.42 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 1.6 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.5 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.01 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 2.95 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 0.46 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 0.43 107.956 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' A' ' 27' ' ' PHE . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 0.56 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 0.77 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.24 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.74 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.85 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.05 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 0.51 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 60' ' ' TYR . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 0.45 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HE2' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 0.89 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 1.89 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 0.48 109.588 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.62 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 62' ' ' VAL . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 0.51 109.8 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66 109.342 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' HD22 ' A' ' 51' ' ' LEU . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.54 110.12 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.33 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 57' ' ' LEU . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 0.57 108.671 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.47 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 0.89 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.922 HG22 HG12 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.43 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.52 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 6' ' ' VAL . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 0.56 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 42' ' ' ILE . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 0.42 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 0.99 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.68 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.31 109.579 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 1.71 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.51 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.73 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 68' ' ' LEU . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.42 109.921 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.89 108.678 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 0.57 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.05 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66 110.173 -179.622 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.193 0.521 . . . . 1.18 109.708 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 35' ' ' ILE . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 0.8 109.688 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.23 109.21 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 30' ' ' VAL . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 0.56 110.162 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.21 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.73 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.1 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 0.69 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.9 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.5 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.637 HG12 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 0.43 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.4 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HE2' HG21 ' A' ' 4' ' ' VAL . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.49 109.393 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HD2' HG12 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.24 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 2.77 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.465 HG12 HG23 ' A' ' 16' ' ' VAL . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 0.36 108.605 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 0.73 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.69 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.84 109.897 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 0.83 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 14' ' ' VAL . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 0.55 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.59 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 41' ' ' LYS . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 0.56 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.4 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.01 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 1.9 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.722 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.2 111.183 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 70' ' ' LEU . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 0.53 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 0.49 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 0.78 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.03 109.45 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.95 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.9 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 0.68 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 0.57 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 44' ' ' LEU . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 0.55 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.09 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.85 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.25 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 0.66 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 0.68 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 0.53 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 51' ' ' LEU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.6 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 0.56 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.62 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.6 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.48 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.87 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD12 HG11 ' A' ' 4' ' ' VAL . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 0.61 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.18 109.57 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.693 ' HB2' HG12 ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 0.46 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.59 109.788 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.35 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 1.45 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 0.49 109.829 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.9 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 66' ' ' THR . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 0.37 110.15 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 0.55 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.73 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.449 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.74 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52 110.058 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.409 0.623 . . . . 2.3 110.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 0.69 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.1 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 4' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 0.6 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.37 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.68 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 0.91 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 0.42 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.48 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HE3' ' A' ' 28' ' ' LYS . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 0.49 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.41 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.98 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HB2' HD11 ' A' ' 57' ' ' LEU . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.5 109.356 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 1.62 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.19 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 33' ' ' LEU . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 0.46 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 0.63 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.36 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 0.91 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.59 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 0.51 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 0.48 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 1.97 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 1.68 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.15 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.61 HG23 HD11 ' A' ' 70' ' ' LEU . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 0.46 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 0.58 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 27' ' ' PHE . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 0.65 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 1.62 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 0.78 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.07 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 0.98 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.15 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.88 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.34 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 0.92 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.459 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 0.53 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.56 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 27' ' ' PHE . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 0.66 109.514 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.96 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.31 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.44 109.868 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 0.41 109.161 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.13 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.82 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.757 HG22 HG12 ' A' ' 4' ' ' VAL . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.47 109.62 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 1.6 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 0.84 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.38 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.48 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 0.93 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.01 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.4 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.06 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 0.38 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 66' ' ' THR . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 0.35 109.916 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.46 109.58 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 0.51 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.61 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.221 0.534 . . . . 1.78 109.732 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 0.52 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 1.97 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 31' ' ' LEU . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 0.52 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.16 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 0.5 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 0.65 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 0.48 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.51 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.41 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.49 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HG2' HD12 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 0.77 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 2.98 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 0.45 109.406 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 0.66 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.47 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 33' ' ' LEU . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 0.78 109.912 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.73 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 HD12 ' OG1' ' A' ' 37' ' ' THR . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 0.6 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.5 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.511 ' OG1' HD12 ' A' ' 35' ' ' ILE . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 0.45 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.36 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.76 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.08 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.04 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 70' ' ' LEU . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 0.43 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 0.47 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.624 HD12 ' HG2' ' A' ' 28' ' ' LYS . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 0.52 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.83 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 51' ' ' LEU . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 1.64 109.912 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.13 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 0.97 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.34 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.84 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 46' ' ' LYS . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 0.61 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 1.84 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.58 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 1.31 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 0.58 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 0.76 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 62' ' ' VAL . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 0.46 109.427 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.84 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.69 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 0.73 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.13 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.469 HG21 HD22 ' A' ' 57' ' ' LEU . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 0.51 109.072 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.23 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 0.87 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 4' ' ' VAL . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 0.44 109.5 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 0.98 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.32 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.43 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 42' ' ' ILE . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 0.4 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 0.7 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.64 109.883 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.46 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 1.61 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.65 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 27' ' ' PHE . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 0.42 109.566 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 0.47 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 68' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 0.4 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78 110.077 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.172 0.511 . . . . 1.79 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' CG2' ' A' ' 35' ' ' ILE . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 0.5 109.611 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 0.99 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 30' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 0.58 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.28 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 0.7 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.28 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 0.57 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.85 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.83 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 0.53 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.46 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.34 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.8 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 4' ' ' VAL . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.54 109.138 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 0.9 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 1.65 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 0.48 109.671 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 0.55 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.42 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 0.72 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.71 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.649 HD11 HG21 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 0.5 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.47 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 0.36 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.2 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 1.77 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.01 110.151 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 0.45 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 0.52 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.48 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.85 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.15 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.91 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.9 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.02 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 0.6 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 46' ' ' LYS . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 0.52 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.23 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.7 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.15 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.56 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.13 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 0.49 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.31 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.57 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG12 HD11 ' A' ' 2' ' ' ILE . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 0.49 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.28 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.7 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.74 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.45 ' CG2' HG13 ' A' ' 4' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.46 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.42 110.141 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 0.57 109.619 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 0.41 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.06 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.603 ' CD1' HG21 ' A' ' 37' ' ' THR . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.61 109.722 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' HE3' ' A' ' 41' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.39 110.133 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 1.59 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 0.53 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 66' ' ' THR . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 0.38 110.065 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 0.47 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 0.97 109.745 -179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.68 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.84 110.307 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.121 0.486 . . . . 1.89 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 0.66 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 0.98 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 27' ' ' PHE . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 0.53 109.754 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 2.54 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 0.72 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 0.95 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 0.53 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.59 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.45 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 0.38 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.34 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52 108.815 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 16' ' ' VAL . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.5 109.223 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HB3' HD12 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.06 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.37 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 33' ' ' LEU . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 0.45 108.992 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 0.56 109.622 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.42 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.16 109.656 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 0.65 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.474 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 0.59 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.64 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 0.97 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 1.67 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 1.83 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.584 HG23 HD11 ' A' ' 70' ' ' LEU . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 0.52 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 0.58 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 51' ' ' LEU . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 0.5 110.059 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.25 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.19 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.01 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.99 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 0.67 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.69 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 0.52 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.26 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.88 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 0.49 109.492 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 0.67 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 HG21 ' A' ' 62' ' ' VAL . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 0.48 109.653 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.31 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.7 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.47 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 66' ' ' THR . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 0.54 108.325 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.42 110.462 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.58 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.96 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 62' ' ' VAL . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.54 109.517 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.95 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 0.65 109.433 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 42' ' ' ILE . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 0.59 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 0.97 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 0.7 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 1.4 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 1.62 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 0.4 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.86 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.41 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.15 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 0.53 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.66 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.07 111.341 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 1.83 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 0.55 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.55 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 0.47 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 2.93 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 0.84 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.13 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.45 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.42 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.7 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.41 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.47 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.4 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.53 109.402 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.17 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 2.85 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 0.38 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 0.47 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.37 111.386 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 0.83 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 0.51 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.442 ' OG1' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 0.47 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.18 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.57 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.3 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.05 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 70' ' ' LEU . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 0.45 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 0.4 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.82 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.67 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.628 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 1.96 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.74 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.06 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 0.53 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 46' ' ' LYS . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 0.47 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.19 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.2 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 0.71 109.325 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.86 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 0.58 109.549 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.8 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 0.62 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.95 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 0.43 109.273 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.1 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.19 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.626 HG22 HG12 ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.41 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.03 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' GLN . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 0.76 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.7 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.745 HD11 HG23 ' A' ' 42' ' ' ILE . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.4 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.09 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.8 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.23 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.39 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 0.44 109.76 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.37 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 0.46 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 0.41 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.51 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' HD23 ' A' ' 70' ' ' LEU . 21.7 t70 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46 109.368 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.572 -0.529 . . . . 1.26 109.572 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 35' ' ' ILE . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 0.6 109.65 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.492 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 1.88 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 0.35 109.758 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.15 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 0.61 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.05 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 0.4 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.59 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 0.6 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 0.39 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.44 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 0.79 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.49 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.35 109.283 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 0.54 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.33 110.736 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.82 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 0.55 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.43 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 0.39 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 1.88 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 1.44 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 0.81 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.637 HG23 HD11 ' A' ' 70' ' ' LEU . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 0.36 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 73' ' ' LEU . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 0.41 108.752 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.695 ' HB3' HD12 ' A' ' 51' ' ' LEU . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.86 109.865 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.02 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 0.82 109.442 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.76 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.04 109.235 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 0.61 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 44' ' ' LEU . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 0.44 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.15 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 0.82 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 0.49 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 0.67 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 62' ' ' VAL . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 0.44 109.47 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.83 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.72 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.55 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.15 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 57' ' ' LEU . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 0.57 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.11 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.96 109.616 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 0.94 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 0.45 109.341 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.06 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 0.84 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.58 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 42' ' ' ILE . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 0.41 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.67 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 0.79 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.23 109.729 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 1.68 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 0.58 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.73 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 0.44 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 0.47 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG12 ' CB ' ' A' ' 68' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.45 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.8 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67 110.092 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.232 0.539 . . . . 1.19 109.921 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.56 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.17 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.44 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.09 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 0.76 109.606 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.92 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.51 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 0.6 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 51' ' ' LEU . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 0.42 109.391 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.39 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.8 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.58 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.05 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.0 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 ' SG ' ' A' ' 18' ' ' CYS . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.4 109.333 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.69 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.4 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 0.68 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.13 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' OG1' ' A' ' 37' ' ' THR . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 0.54 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.49 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.646 ' OG1' HD12 ' A' ' 35' ' ' ILE . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 0.51 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.71 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.74 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.06 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB3' HG22 ' A' ' 37' ' ' THR . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 1.72 110.532 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 0.43 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 0.94 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.86 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.82 109.602 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.84 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.2 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 0.81 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 44' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 0.61 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.39 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.69 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.97 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.6 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 0.53 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 27' ' ' PHE . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 0.47 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.5 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 0.61 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.26 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.85 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 0.83 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 62' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.48 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.19 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 0.58 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.97 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.45 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.2 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.21 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.436 HD12 ' HE2' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.22 110.09 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 1.49 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.36 109.922 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' HG22 ' A' ' 66' ' ' THR . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 0.34 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 0.47 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HB2' ' A' ' 68' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 0.42 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.53 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.7 110.153 -179.329 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.103 0.478 . . . . 1.07 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 0.55 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 2.93 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 0.41 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.05 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.51 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 0.95 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 0.49 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.7 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.4 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 0.38 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.33 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.8 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.38 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 0.97 110.236 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.32 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 16' ' ' VAL . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.37 108.866 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 0.52 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.36 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 0.83 109.842 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.53 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 0.51 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.39 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 0.48 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 2.42 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.38 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.48 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.37 110.673 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 0.5 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 0.49 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 0.66 110.173 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.32 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.16 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.27 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 0.69 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 60' ' ' TYR . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 0.46 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.04 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.6 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 0.98 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 0.5 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 0.84 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 62' ' ' VAL . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 0.46 109.443 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.59 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.7 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' HD22 ' A' ' 51' ' ' LEU . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.63 109.976 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.19 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.564 HG21 HD22 ' A' ' 57' ' ' LEU . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 0.49 108.751 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.66 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54 109.289 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.83 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 HG22 ' CG1' ' A' ' 4' ' ' VAL . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 0.41 109.625 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.58 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.653 ' HB2' HG12 ' A' ' 6' ' ' VAL . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.08 109.748 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.592 HD11 HG23 ' A' ' 42' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.43 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.1 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.98 109.871 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.3 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 1.53 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 0.47 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 0.41 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 0.5 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 68' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.48 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.97 110.001 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.72 -0.474 . . . . 0.87 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 0.62 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 1.77 109.468 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 0.48 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 2.79 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 0.76 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 0.73 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 0.5 109.933 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 0.66 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.41 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.35 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.82 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' ' 44' ' ' LEU . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.4 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 0.91 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.47 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 0.47 109.285 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 0.68 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.41 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 0.82 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.7 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 0.44 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.4 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.654 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 0.37 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.24 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.67 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 1.71 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.78 110.991 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 0.37 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 0.45 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.49 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 0.97 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 1.78 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.95 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 0.65 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 0.56 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD11 HD21 ' A' ' 68' ' ' LEU . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 0.55 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.25 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.69 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.18 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 0.64 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.46 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' A' ' 27' ' ' PHE . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 0.6 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.72 109.437 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.37 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.56 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.35 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 0.48 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 1.51 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.61 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.71 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.743 HG22 HG12 ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 0.42 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.31 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.32 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 42' ' ' ILE . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 0.41 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.31 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG21 ' A' ' 37' ' ' THR . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.61 109.737 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.14 109.547 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 1.94 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 0.42 109.775 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 0.41 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HG2' ' A' ' 15' ' ' ARG . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 0.41 109.123 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 31' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.48 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.427 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.45 109.522 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.03 108.943 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG21 ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 0.76 109.94 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HG2' HG22 ' A' ' 5' ' ' VAL . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.13 110.141 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 0.4 109.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 1.97 110.235 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 0.75 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.09 109.784 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.46 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.83 109.902 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.71 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.58 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 0.49 108.969 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.33 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.98 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 4' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.5 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 0.81 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 1.94 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 0.4 109.124 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 6' ' ' VAL . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 0.51 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.37 111.222 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.07 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.56 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 0.44 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 0.41 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.32 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.73 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.43 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.33 110.513 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.45 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 0.53 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 0.77 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 0.91 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.46 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.8 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.12 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 0.64 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 0.54 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 2.76 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.14 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.476 HD13 ' OH ' ' A' ' 60' ' ' TYR . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 0.64 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 0.7 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 0.61 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 55' ' ' ILE . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.53 110.209 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.06 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 0.45 108.981 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.86 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.69 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.57 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 0.4 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.17 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 0.8 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.09 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 0.39 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.17 109.304 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.67 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 1.63 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.38 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 0.39 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.86 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 66' ' ' THR . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 0.34 110.357 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 15' ' ' ARG . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 0.44 109.544 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.46 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.63 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 121.04 0.448 . . . . 2.36 110.117 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 0.84 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.652 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 1.59 109.151 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 0.45 109.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 2.69 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 0.73 109.756 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 0.9 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 0.42 110.241 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.59 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.81 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.32 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.72 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.45 109.193 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 0.92 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 2.68 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 0.37 109.268 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 16' ' ' VAL . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 0.59 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.53 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 0.75 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 0.58 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.48 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 0.46 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.09 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.86 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.37 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 1.94 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 70' ' ' LEU . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 0.45 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 0.45 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 0.51 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 0.9 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HE2' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 0.92 109.367 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.9 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 0.51 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 0.48 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.46 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 2.7 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.07 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 0.51 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 0.52 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 62' ' ' VAL . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 0.43 109.35 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.7 109.58 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.71 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.42 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.19 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 57' ' ' LEU . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.52 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 0.99 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.82 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.83 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.584 HG22 HG12 ' A' ' 4' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 0.42 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.5 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.545 HD21 ' HE2' ' A' ' 46' ' ' LYS . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.63 109.719 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.15 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 42' ' ' ILE . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 0.45 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.13 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.91 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.33 109.417 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 1.48 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 0.43 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.69 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.556 ' CG1' HG22 ' A' ' 66' ' ' THR . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 0.37 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.54 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 0.89 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.84 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56 110.016 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.695 -0.483 . . . . 2.03 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.13 109.838 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 1.58 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 27' ' ' PHE . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 0.5 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 2.73 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 0.59 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 0.64 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 0.58 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.73 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 0.71 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 0.39 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.4 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.04 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.17 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 0.47 109.638 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 0.51 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.4 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 0.71 110.006 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.72 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 0.54 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 0.48 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.19 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79 111.502 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.05 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.25 110.546 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 70' ' ' LEU . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 0.56 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 0.69 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 51' ' ' LEU . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 0.89 109.938 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.19 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.768 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.0 109.225 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.02 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.84 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 0.72 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.78 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.768 HD21 ' HB2' ' A' ' 46' ' ' LYS . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 0.52 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 1.68 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 0.92 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 0.55 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 0.67 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 62' ' ' VAL . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 0.48 109.349 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.32 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.62 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 0.69 109.777 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.67 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 57' ' ' LEU . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 0.65 108.752 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.56 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 0.87 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.556 HG22 ' CG1' ' A' ' 4' ' ' VAL . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 0.43 109.775 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.06 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 0.98 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.86 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 0.43 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.09 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' A' ' 37' ' ' THR . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.24 109.451 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.46 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 0.45 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.84 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 0.46 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 0.55 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 0.6 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.27 109.518 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.22 141.34 35.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.58 109.697 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -33.8 76.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.707 -0.621 . . . . 1.42 109.789 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -46.3 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.6 -0.688 . . . . 1.56 109.243 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.56 64.8 0.01 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.01 -1.236 . . . . 0.73 110.01 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 101.08 3.27 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.639 -0.918 . . . . 2.78 109.646 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -101.36 100.48 10.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.91 109.211 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.55 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.36 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 0.41 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 2.9 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 0.48 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.06 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 0.43 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 57' ' ' LEU . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55 109.338 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 0.48 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 0.41 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.44 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.87 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.61 109.427 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 0.77 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.45 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 0.34 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 0.59 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.53 110.654 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 0.91 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.68 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' LEU . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 0.47 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 0.4 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' THR . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 2.34 109.797 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 0.96 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 1.81 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.38 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.662 HG23 HD11 ' A' ' 70' ' ' LEU . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 0.38 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 0.46 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 0.86 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.04 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CB ' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 0.93 109.529 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.05 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.14 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' VAL . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 0.83 110.367 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 60' ' ' TYR . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 0.61 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.23 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 0.98 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 0.53 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.64 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 0.45 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.86 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CG ' HD22 ' A' ' 51' ' ' LEU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.48 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.33 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 66' ' ' THR . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 0.48 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.23 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 0.95 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 HG13 ' A' ' 62' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.42 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.03 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.05 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.74 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.826 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.4 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.17 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 37' ' ' THR . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 0.93 109.925 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.27 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.36 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 0.39 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 66' ' ' THR . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 0.43 109.764 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 0.41 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD21 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 0.51 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.63 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 -76.89 142.45 40.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.59 109.685 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.31 -35.78 81.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 2.67 109.773 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -48.51 74.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.503 -0.748 . . . . 1.62 109.266 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.84 66.85 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.72 -1.352 . . . . 0.69 109.72 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.74 104.48 3.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.905 . . . . 1.56 109.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 114.53 27.76 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.76 109.4 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 0.54 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 1.86 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 0.52 109.699 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.31 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 0.9 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 0.9 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 0.63 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.573 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.57 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 0.64 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.744 HG12 ' HE3' ' A' ' 28' ' ' LYS . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 0.48 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.42 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.59 109.044 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.45 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.744 ' HE3' HG12 ' A' ' 24' ' ' VAL . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 1.6 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.599 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 2.5 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 26' ' ' ASP . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.55 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.47 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 0.72 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.74 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 0.67 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.61 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 0.61 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 1.86 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.99 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.57 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.38 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 0.51 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 0.55 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.08 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.08 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 1.65 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.0 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.75 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.13 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 0.84 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD12 ' HB3' ' A' ' 44' ' ' LEU . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 0.6 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.31 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.7 110.513 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.16 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.58 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.53 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 27' ' ' PHE . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 0.59 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.62 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.15 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CG ' HD22 ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.54 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.16 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 0.44 108.769 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.12 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.56 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.554 HG22 HG12 ' A' ' 4' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 0.48 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.28 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.04 109.726 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.86 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 HG23 ' A' ' 42' ' ' ILE . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.5 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.473 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 0.81 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 1.58 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.12 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 0.48 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.19 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.51 110.223 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 0.64 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 14' ' ' VAL . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 0.57 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.77 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -78.3 -77.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81 109.834 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.11 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 2.7 110.066 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -68.86 0.36 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.489 -0.757 . . . . 2.0 109.31 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.69 57.14 0.16 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.213 -1.555 . . . . 0.93 109.213 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.42 107.67 5.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.772 -0.84 . . . . 2.04 109.718 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -126.27 156.0 41.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.698 -0.626 . . . . 1.92 110.258 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.26 109.659 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.36 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 31' ' ' LEU . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.46 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.31 110.542 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 0.85 109.525 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.1 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.55 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.8 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 0.53 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 0.45 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.84 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 44' ' ' LEU . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.55 109.128 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 0.81 109.562 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 1.73 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 0.38 109.219 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 0.63 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.48 111.101 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 0.64 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.03 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 0.59 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.679 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 0.44 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.0 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.74 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 1.61 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.24 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 0.45 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 0.55 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 0.5 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 0.88 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.744 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 1.65 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.68 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.8 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.6 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 0.68 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 0.49 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 1.93 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.82 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 0.49 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.72 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 0.58 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.62 110.045 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 0.64 108.477 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 1.69 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.97 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.5 109.347 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.15 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.3 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.51 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.14 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.679 ' CD1' HG21 ' A' ' 37' ' ' THR . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.78 109.561 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.12 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.23 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 0.58 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 0.48 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 0.58 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 0.71 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.72 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 -76.72 143.67 39.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.6 109.398 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -37.79 85.41 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.693 -0.629 . . . . 3.9 110.276 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -48.85 76.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.448 -0.783 . . . . 1.88 109.56 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 64.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.394 -1.483 . . . . 0.81 109.394 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.13 113.18 8.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 2.26 109.832 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 112.67 25.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 1.48 109.293 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.47 110.06 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.15 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.44 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 0.94 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 0.83 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.25 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 0.55 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.82 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.73 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 0.48 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.35 108.64 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.99 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 0.7 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' HD12 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 0.85 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.02 109.702 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 0.42 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 0.48 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.51 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 0.79 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.72 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.53 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.49 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' TYR . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 0.47 110.633 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.5 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.02 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.57 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.29 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 70' ' ' LEU . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 0.49 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 73' ' ' LEU . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 0.55 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.99 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.06 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.11 109.842 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 0.98 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.8 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.22 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 0.74 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 0.46 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.24 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.74 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.32 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.52 109.392 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.79 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 62' ' ' VAL . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 0.73 109.646 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.31 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.58 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.74 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 46' ' ' LYS . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 1.83 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.82 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 0.89 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.805 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 0.55 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 0.92 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 0.57 109.304 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.865 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.45 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.37 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 37' ' ' THR . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.08 109.681 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 1.94 109.752 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 1.7 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 0.54 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 66' ' ' THR . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.41 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.45 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 0.43 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.65 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.92 148.88 29.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.9 110.439 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.8 ttm180 -62.29 -42.95 99.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.941 -0.474 . . . . 2.08 110.068 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -44.16 96.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.492 -0.755 . . . . 1.8 109.458 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.11 69.89 0.05 OUTLIER Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.214 -1.554 . . . . 0.92 109.214 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -145.16 116.66 8.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.718 -0.872 . . . . 2.19 109.95 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 113.89 27.68 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 35' ' ' ILE . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.52 109.888 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.21 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 0.46 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 1.39 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 0.82 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.12 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 0.47 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.97 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.7 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 0.47 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.43 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.71 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 57' ' ' LEU . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.5 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 1.79 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.38 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 0.42 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 0.63 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.42 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 0.65 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.68 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 14' ' ' VAL . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 0.52 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.45 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 35' ' ' ILE . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 0.48 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.25 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 1.62 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 2.52 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 70' ' ' LEU . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 0.47 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 0.5 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.45 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.22 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 1.66 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.84 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 0.63 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 0.75 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 46' ' ' LYS . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 0.54 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.31 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.71 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.09 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 0.59 109.668 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 0.63 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 0.48 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.24 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.7 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.6 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 57' ' ' LEU . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 0.55 108.878 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.33 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 0.92 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 4' ' ' VAL . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 0.42 109.746 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.35 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 0.87 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 42' ' ' ILE . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.46 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.04 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 1.27 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.36 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.04 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 0.39 109.813 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 0.34 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 0.5 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 0.54 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.73 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -76.67 -11.47 59.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.4 19.81 7.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.478 -0.764 . . . . 1.18 110.474 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.06 -57.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.69 -0.856 . . . . 1.12 108.69 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.79 47.22 0.15 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.501 -1.44 . . . . 0.69 109.501 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -157.57 137.78 12.66 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.635 -0.921 . . . . 2.55 109.985 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.614 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -140.21 117.48 11.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.557 -0.714 . . . . 1.62 109.805 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 0.6 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.06 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 0.49 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.13 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 0.92 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.12 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 0.46 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.24 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.69 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.49 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 0.49 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.34 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' LEU . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.63 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 0.96 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 1.69 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 0.39 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 0.56 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.454 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.39 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 0.87 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.77 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 42' ' ' ILE . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 0.53 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.48 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 72' ' ' TYR . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 0.38 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 1.95 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.59 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.32 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.53 110.174 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.73 HG21 HD11 ' A' ' 35' ' ' ILE . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.48 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 0.42 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 0.44 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.27 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.12 109.638 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.62 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 0.76 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' VAL . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 0.76 109.866 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.52 HD11 HD21 ' A' ' 68' ' ' LEU . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 0.48 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.21 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.7 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 1.91 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 0.65 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 0.75 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 27' ' ' PHE . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 0.6 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.16 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HD13 ' A' ' 55' ' ' ILE . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.52 109.897 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.84 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG22 ' HD3' ' A' ' 46' ' ' LYS . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 0.5 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.31 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.58 109.429 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.66 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 0.43 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.8 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 0.8 109.615 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.8 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.42 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 37' ' ' THR . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.55 109.998 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.54 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 1.51 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 0.49 109.92 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 66' ' ' THR . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.12 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 0.5 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 68' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 0.48 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 0.83 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.67 156.27 33.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -31.65 69.58 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 1.93 110.457 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -46.13 83.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.445 -0.784 . . . . 1.73 109.829 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.12 54.2 0.05 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.356 -1.498 . . . . 1.32 109.356 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.46 153.16 35.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.846 -0.796 . . . . 3.02 109.108 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt -121.31 146.34 46.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.097 -1.002 . . . . 2.64 110.353 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 0.58 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.12 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 0.44 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.31 109.569 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 0.65 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 0.74 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.42 110.108 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.72 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.41 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 0.42 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.32 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.9 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.46 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 0.67 109.766 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.37 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.35 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 0.47 109.545 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.37 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 0.79 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.73 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 0.48 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.42 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 1.6 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.5 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.01 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 2.95 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 0.46 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 0.43 107.956 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' A' ' 27' ' ' PHE . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 0.56 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 0.77 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.24 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.74 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.85 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.05 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 0.51 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 60' ' ' TYR . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 0.45 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HE2' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 0.89 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 1.89 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 0.48 109.588 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.62 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 62' ' ' VAL . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 0.51 109.8 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66 109.342 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' HD22 ' A' ' 51' ' ' LEU . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.54 110.12 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.33 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 57' ' ' LEU . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 0.57 108.671 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.47 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 0.89 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.922 HG22 HG12 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.43 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.52 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 6' ' ' VAL . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 0.56 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 42' ' ' ILE . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 0.42 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 0.99 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.68 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.31 109.579 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 1.71 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.51 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.73 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 68' ' ' LEU . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.42 109.921 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.89 108.678 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 0.57 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.05 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.08 152.01 33.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66 110.173 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -63.87 -36.93 85.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.771 -0.581 . . . . 2.05 109.85 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -47.38 78.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.506 -0.746 . . . . 1.69 109.046 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.55 69.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.319 -1.512 . . . . 0.75 109.319 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -147.97 109.64 4.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.723 -0.869 . . . . 1.61 109.682 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 125.68 43.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 1.18 109.708 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 35' ' ' ILE . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 0.8 109.688 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.23 109.21 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 30' ' ' VAL . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 0.56 110.162 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.21 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.73 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.1 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 0.69 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.9 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.5 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.637 HG12 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 0.43 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.4 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HE2' HG21 ' A' ' 4' ' ' VAL . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.49 109.393 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HD2' HG12 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.24 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 2.77 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.465 HG12 HG23 ' A' ' 16' ' ' VAL . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 0.36 108.605 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 0.73 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.69 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.84 109.897 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 0.83 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 14' ' ' VAL . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 0.55 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.59 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 41' ' ' LYS . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 0.56 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.4 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.01 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 1.9 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.722 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.2 111.183 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 70' ' ' LEU . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 0.53 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 0.49 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 0.78 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.03 109.45 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.95 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.9 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 0.68 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 0.57 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 44' ' ' LEU . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 0.55 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.09 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.85 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.25 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 0.66 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 0.68 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 0.53 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 51' ' ' LEU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.6 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 0.56 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.62 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.6 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.48 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.87 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD12 HG11 ' A' ' 4' ' ' VAL . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 0.61 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.18 109.57 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.693 ' HB2' HG12 ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 0.46 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.422 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.59 109.788 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.35 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 1.45 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 0.49 109.829 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.9 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 66' ' ' THR . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 0.37 110.15 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 0.55 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.73 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.449 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.74 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.45 147.64 39.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52 110.058 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -34.22 77.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.747 -0.596 . . . . 3.26 110.302 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -49.21 77.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 1.33 109.723 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.28 72.89 0.01 OUTLIER Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.231 -1.548 . . . . 0.74 109.231 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.9 ' HE3' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -152.22 151.0 30.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.746 -0.855 . . . . 2.15 109.865 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp -150.29 123.89 9.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.401 -0.812 . . . . 2.3 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 0.69 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.1 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 4' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 0.6 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.37 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.68 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 0.91 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 0.42 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.48 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HE3' ' A' ' 28' ' ' LYS . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 0.49 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.41 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.98 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HB2' HD11 ' A' ' 57' ' ' LEU . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.5 109.356 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 1.62 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.19 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 33' ' ' LEU . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 0.46 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 0.63 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.36 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 0.91 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.59 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.9 HG22 ' HE3' ' A' ' 12' ' ' LYS . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 0.51 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 0.48 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 1.97 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 1.68 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.15 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.61 HG23 HD11 ' A' ' 70' ' ' LEU . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 0.46 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 0.58 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 27' ' ' PHE . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 0.65 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 1.62 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 0.78 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.07 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 0.98 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.15 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.88 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.34 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 0.92 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.459 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 0.53 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.56 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 27' ' ' PHE . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 0.66 109.514 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.96 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.31 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.44 109.868 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 0.41 109.161 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.13 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.82 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.757 HG22 HG12 ' A' ' 4' ' ' VAL . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.47 109.62 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 1.6 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 0.84 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.38 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.48 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 0.93 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.01 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.4 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.06 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 0.38 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 66' ' ' THR . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 0.35 109.916 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.46 109.58 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 0.51 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.61 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 1.1 m-20 -82.49 -60.27 2.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.26 -64.46 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.557 -0.715 . . . . 1.35 109.855 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 130.07 22.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.643 -0.66 . . . . 1.64 109.462 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.58 39.36 96.36 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.003 -1.239 . . . . 0.87 110.003 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -145.62 113.25 6.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.608 -0.936 . . . . 2.23 109.903 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 117.78 8.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.642 -0.661 . . . . 1.78 109.732 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 0.52 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 1.97 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 31' ' ' LEU . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 0.52 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.16 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 0.5 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 0.65 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 0.48 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.51 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.41 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.49 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HG2' HD12 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 0.77 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 2.98 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 0.45 109.406 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 0.66 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.47 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 33' ' ' LEU . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 0.78 109.912 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.73 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 HD12 ' OG1' ' A' ' 37' ' ' THR . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 0.6 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.5 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.511 ' OG1' HD12 ' A' ' 35' ' ' ILE . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 0.45 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.36 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.76 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.08 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.04 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 70' ' ' LEU . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 0.43 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 0.47 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.624 HD12 ' HG2' ' A' ' 28' ' ' LYS . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 0.52 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.83 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 51' ' ' LEU . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 1.64 109.912 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.13 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 0.97 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.34 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.84 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 46' ' ' LYS . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 0.61 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 1.84 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.58 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 1.31 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 0.58 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 0.76 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 62' ' ' VAL . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 0.46 109.427 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.84 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.69 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 0.73 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.13 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.469 HG21 HD22 ' A' ' 57' ' ' LEU . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 0.51 109.072 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.23 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 0.87 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 4' ' ' VAL . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 0.44 109.5 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 0.98 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.32 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.43 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 42' ' ' ILE . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 0.4 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 0.7 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.64 109.883 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.46 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 1.61 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.65 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 27' ' ' PHE . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 0.42 109.566 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 0.47 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 68' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 0.4 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 -72.72 -61.74 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78 110.077 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.96 -66.66 0.47 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 1.27 109.587 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.54 109.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.619 -0.676 . . . . 1.57 109.297 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.65 -51.59 1.35 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.644 -1.383 . . . . 0.68 109.644 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -75.31 123.89 26.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.861 . . . . 2.03 109.896 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.7 154.21 41.16 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.649 -0.657 . . . . 1.79 109.753 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' CG2' ' A' ' 35' ' ' ILE . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 0.5 109.611 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 0.99 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 30' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 0.58 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.28 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 0.7 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.28 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 0.57 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.85 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.83 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 0.53 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.46 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.34 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.8 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 4' ' ' VAL . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.54 109.138 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 0.9 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 1.65 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 0.48 109.671 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 0.55 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.42 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 0.72 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.71 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD11 HG21 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 0.5 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.47 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 0.36 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.2 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 1.77 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.01 110.151 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 0.45 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 0.52 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.48 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.85 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.15 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.91 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.9 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.02 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 0.6 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 46' ' ' LYS . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 0.52 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.23 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.7 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.15 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.56 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.13 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 0.49 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.31 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.57 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG12 HD11 ' A' ' 2' ' ' ILE . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 0.49 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.28 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.7 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.74 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.45 ' CG2' HG13 ' A' ' 4' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.46 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.42 110.141 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 0.57 109.619 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 0.41 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.06 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.603 ' CD1' HG21 ' A' ' 37' ' ' THR . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.61 109.722 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' HE3' ' A' ' 41' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.39 110.133 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 1.59 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 0.53 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 66' ' ' THR . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 0.38 110.065 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 0.47 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 0.97 109.745 -179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.68 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -74.69 -63.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.84 110.307 -179.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.31 -66.63 0.54 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.738 . . . . 1.54 109.746 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.65 114.44 1.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.525 -0.734 . . . . 1.4 109.713 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.27 -26.54 23.26 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.38 -1.088 . . . . 1.48 110.38 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.98 121.86 42.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -1.019 . . . . 1.29 109.928 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 149.12 35.37 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.668 -0.645 . . . . 1.89 109.944 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 0.66 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 0.98 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 27' ' ' PHE . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 0.53 109.754 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 2.54 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 0.72 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 0.95 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 0.53 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.59 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.45 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 0.38 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.34 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52 108.815 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 16' ' ' VAL . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.5 109.223 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HB3' HD12 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.06 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.37 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 33' ' ' LEU . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 0.45 108.992 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 0.56 109.622 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.42 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.16 109.656 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 0.65 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.474 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 0.59 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.64 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 0.97 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 1.67 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 1.83 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.584 HG23 HD11 ' A' ' 70' ' ' LEU . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 0.52 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 0.58 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 51' ' ' LEU . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 0.5 110.059 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.25 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.19 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.01 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.99 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 0.67 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.69 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 0.52 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.26 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.88 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 0.49 109.492 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 0.67 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 HG21 ' A' ' 62' ' ' VAL . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 0.48 109.653 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.31 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.7 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.47 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 66' ' ' THR . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 0.54 108.325 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.42 110.462 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.58 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.96 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 62' ' ' VAL . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.54 109.517 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.95 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 0.65 109.433 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 42' ' ' ILE . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 0.59 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 0.97 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 0.7 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 1.4 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 1.62 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 0.4 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.86 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.41 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.15 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 0.53 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.66 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -8.36 59.26 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.07 111.341 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 64.6 34.66 9.72 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.31 -0.869 . . . . 1.32 110.039 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -60.64 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.781 . . . . 1.38 108.937 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.61 46.92 0.14 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.561 -1.415 . . . . 1.02 109.561 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -156.05 132.79 10.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.926 . . . . 1.5 109.909 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -134.92 109.88 8.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 1.83 109.105 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 0.55 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.55 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 0.47 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 2.93 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 0.84 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.13 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.45 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.42 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.7 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.41 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.47 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.4 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.53 109.402 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.17 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 2.85 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 0.38 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 0.47 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.37 111.386 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 0.83 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 0.51 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.442 ' OG1' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 0.47 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.18 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.57 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.3 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.05 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 70' ' ' LEU . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 0.45 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 0.4 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.82 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.67 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.628 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 1.96 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.74 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.06 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 0.53 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 46' ' ' LYS . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 0.47 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.19 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.2 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 0.71 109.325 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.86 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 0.58 109.549 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.8 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 0.62 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.95 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 0.43 109.273 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.1 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.19 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.626 HG22 HG12 ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.41 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.03 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' GLN . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 0.76 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.7 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.745 HD11 HG23 ' A' ' 42' ' ' ILE . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.4 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.09 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.8 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.23 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.39 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 0.44 109.76 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.37 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 0.46 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 0.41 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.51 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' HD23 ' A' ' 70' ' ' LEU . 21.7 t70 -75.53 -57.24 4.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46 109.368 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.55 -175.99 3.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.704 -0.623 . . . . 1.29 109.589 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 109.31 3.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 1.71 109.535 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 -38.45 3.25 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.918 -1.273 . . . . 0.8 109.918 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.33 128.43 34.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.635 -0.92 . . . . 1.16 110.192 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -141.63 133.59 27.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.796 -0.565 . . . . 1.26 109.572 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 35' ' ' ILE . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 0.6 109.65 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.492 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 1.88 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 0.35 109.758 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.15 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 0.61 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.05 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 0.4 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.59 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 0.6 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 0.39 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.44 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 0.79 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.49 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.35 109.283 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 0.54 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.33 110.736 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.82 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 0.55 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.43 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 0.39 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 1.88 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 1.44 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 0.81 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.637 HG23 HD11 ' A' ' 70' ' ' LEU . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 0.36 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 73' ' ' LEU . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 0.41 108.752 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.695 ' HB3' HD12 ' A' ' 51' ' ' LEU . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.86 109.865 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.02 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 0.82 109.442 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.76 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.04 109.235 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 0.61 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 44' ' ' LEU . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 0.44 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.15 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 0.82 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 0.49 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 0.67 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 62' ' ' VAL . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 0.44 109.47 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.83 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.72 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.55 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.15 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 57' ' ' LEU . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 0.57 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.11 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.96 109.616 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 0.94 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 0.45 109.341 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.06 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 0.84 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.58 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 42' ' ' ILE . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 0.41 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.67 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 0.79 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.23 109.729 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 1.68 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 0.58 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.73 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 0.44 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 0.47 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG12 ' CB ' ' A' ' 68' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.45 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.8 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 -82.68 173.2 12.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 10' ' ' LEU . 1.7 ptp85 -59.49 -35.86 74.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.634 -0.666 . . . . 1.22 110.203 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -82.96 -171.91 3.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.424 -0.798 . . . . 1.63 109.623 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.31 65.3 4.03 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.25 -1.14 . . . . 0.81 110.25 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -154.53 150.53 27.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.895 . . . . 3.36 109.893 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 153.41 50.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.598 -0.689 . . . . 1.19 109.921 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.56 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.17 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.44 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.09 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 0.76 109.606 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.92 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.51 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 0.6 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 51' ' ' LEU . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 0.42 109.391 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.39 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.8 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.58 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.05 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.0 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 ' SG ' ' A' ' 18' ' ' CYS . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.4 109.333 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.69 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.4 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 0.68 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.13 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' OG1' ' A' ' 37' ' ' THR . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 0.54 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.49 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.646 ' OG1' HD12 ' A' ' 35' ' ' ILE . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 0.51 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.71 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.74 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.06 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB3' HG22 ' A' ' 37' ' ' THR . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 1.72 110.532 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 0.43 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 0.94 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.86 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.82 109.602 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.84 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.2 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 0.81 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 44' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 0.61 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.39 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.69 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.97 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.6 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 0.53 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 27' ' ' PHE . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 0.47 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.5 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 0.61 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.26 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.85 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 0.83 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 62' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.48 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.19 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 0.58 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.97 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.45 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.2 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.21 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD12 ' HE2' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.22 110.09 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 1.49 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.36 109.922 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' HG22 ' A' ' 66' ' ' THR . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 0.34 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 0.47 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HB2' ' A' ' 68' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 0.42 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.53 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.34 -67.73 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.7 110.153 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.07 55.36 1.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.652 -0.655 . . . . 1.24 109.394 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.556 -0.715 . . . . 1.52 109.49 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.37 -56.85 0.35 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.514 -1.434 . . . . 0.77 109.514 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 111.12 16.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.812 -0.816 . . . . 1.99 109.512 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -112.5 125.44 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.749 -0.594 . . . . 1.07 109.927 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 0.55 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 2.93 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 0.41 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.05 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.51 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 0.95 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 0.49 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.7 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.4 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 0.38 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.33 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.8 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.38 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 0.97 110.236 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.32 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 16' ' ' VAL . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.37 108.866 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 0.52 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.36 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 0.83 109.842 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.53 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 0.51 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.39 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 0.48 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 2.42 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.38 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.48 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.37 110.673 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 0.5 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 0.49 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 0.66 110.173 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.32 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.16 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.27 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 0.69 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 60' ' ' TYR . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 0.46 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.04 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.6 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 0.98 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 0.5 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 0.84 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 62' ' ' VAL . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 0.46 109.443 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.59 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.7 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' HD22 ' A' ' 51' ' ' LEU . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.63 109.976 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.19 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.564 HG21 HD22 ' A' ' 57' ' ' LEU . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 0.49 108.751 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.66 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54 109.289 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.83 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 HG22 ' CG1' ' A' ' 4' ' ' VAL . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 0.41 109.625 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.58 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.653 ' HB2' HG12 ' A' ' 6' ' ' VAL . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.08 109.748 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.592 HD11 HG23 ' A' ' 42' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.43 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.1 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.98 109.871 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.3 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 1.53 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 0.47 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 0.41 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 0.5 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 68' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.48 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -79.27 -56.12 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.97 110.001 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -128.79 -63.06 0.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.684 -0.635 . . . . 1.48 109.664 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.36 -63.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.561 -0.712 . . . . 1.59 109.84 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.21 51.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.16 -1.176 . . . . 0.78 110.16 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 129.35 37.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -1.018 . . . . 2.58 110.074 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.33 124.44 8.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.87 109.72 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 0.62 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 1.77 109.468 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 0.48 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 2.79 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 0.76 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 0.73 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 0.5 109.933 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 0.66 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.41 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.35 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.82 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' ' 44' ' ' LEU . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.4 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 0.91 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.47 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 0.47 109.285 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 0.68 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.41 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 0.82 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.7 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 0.44 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.4 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.654 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 0.37 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.24 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.67 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 1.71 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.78 110.991 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 0.37 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 0.45 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.49 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 0.97 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 1.78 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.95 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 0.65 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 0.56 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD11 HD21 ' A' ' 68' ' ' LEU . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 0.55 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.25 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.69 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.18 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 0.64 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.46 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' A' ' 27' ' ' PHE . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 0.6 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.72 109.437 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.37 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.56 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.35 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 0.48 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 1.51 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.61 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.71 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.743 HG22 HG12 ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 0.42 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.31 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.32 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 42' ' ' ILE . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 0.41 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.31 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG21 ' A' ' 37' ' ' THR . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.61 109.737 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.14 109.547 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 1.94 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 0.42 109.775 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 0.41 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HG2' ' A' ' 15' ' ' ARG . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 0.41 109.123 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 31' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.48 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.427 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.45 109.522 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -87.85 147.84 24.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 71' ' ' TYR . 8.1 mmt-85 -65.97 -37.63 86.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.713 -0.617 . . . . 1.24 110.039 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -48.35 81.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.581 -0.7 . . . . 1.21 109.416 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.99 61.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.011 -1.236 . . . . 0.62 110.011 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.52 100.56 3.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.966 . . . . 0.9 109.525 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -104.28 118.62 37.07 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.03 108.943 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG21 ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 0.76 109.94 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HG2' HG22 ' A' ' 5' ' ' VAL . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.13 110.141 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 0.4 109.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 1.97 110.235 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 0.75 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.09 109.784 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.46 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.83 109.902 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.71 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.58 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 0.49 108.969 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.33 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.98 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 4' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.5 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 0.81 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 1.94 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 0.4 109.124 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 6' ' ' VAL . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 0.51 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.37 111.222 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.07 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.56 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 0.44 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 0.41 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.32 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.73 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.43 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.33 110.513 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.45 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 0.53 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 0.77 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 0.91 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.46 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.8 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.12 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 0.64 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 0.54 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 2.76 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.14 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.476 HD13 ' OH ' ' A' ' 60' ' ' TYR . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 0.64 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 0.7 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 0.61 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 55' ' ' ILE . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.53 110.209 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.06 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 0.45 108.981 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.86 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.69 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.57 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 0.4 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.17 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 0.8 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.09 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 0.39 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 9' ' ' ARG . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.17 109.304 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.67 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 1.63 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.38 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 0.39 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.86 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 66' ' ' THR . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 0.34 110.357 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 15' ' ' ARG . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 0.44 109.544 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.46 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.63 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.89 -43.05 72.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.29 -63.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.658 -0.651 . . . . 2.05 109.417 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.46 113.93 0.87 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 1.23 109.353 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -60.03 0.36 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.837 -1.305 . . . . 0.8 109.837 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 125.47 29.16 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.591 -0.946 . . . . 0.8 109.792 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.2 154.52 43.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.636 -0.665 . . . . 2.36 110.117 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 0.84 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.652 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 1.59 109.151 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 0.45 109.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 2.69 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 0.73 109.756 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 0.9 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 0.42 110.241 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.59 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.81 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.32 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.72 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.45 109.193 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 0.92 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 2.68 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 0.37 109.268 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 16' ' ' VAL . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 0.59 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.53 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 0.75 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 0.58 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.48 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 0.46 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.09 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.86 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.37 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 1.94 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 70' ' ' LEU . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 0.45 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 0.45 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 0.51 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 0.9 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HE2' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 0.92 109.367 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.9 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 0.51 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 0.48 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.46 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 2.7 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.07 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 0.51 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 0.52 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 62' ' ' VAL . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 0.43 109.35 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.7 109.58 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.71 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.42 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.19 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 57' ' ' LEU . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.52 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 0.99 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.82 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.83 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.584 HG22 HG12 ' A' ' 4' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 0.42 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.5 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.545 HD21 ' HE2' ' A' ' 46' ' ' LYS . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.63 109.719 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.15 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 42' ' ' ILE . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 0.45 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.13 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.91 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.33 109.417 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 1.48 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 0.43 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.69 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.556 ' CG1' HG22 ' A' ' 66' ' ' THR . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 0.37 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.54 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 0.89 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.84 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 -78.14 -80.79 0.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56 110.016 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -55.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.547 -0.72 . . . . 1.72 110.145 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -62.11 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.69 . . . . 1.65 109.622 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.92 55.11 0.14 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.729 -1.349 . . . . 1.0 109.729 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.76 107.42 10.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.755 -0.85 . . . . 1.81 109.406 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.81 117.44 28.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.576 -0.703 . . . . 2.03 109.695 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.13 109.838 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 1.58 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 27' ' ' PHE . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 0.5 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 2.73 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 0.59 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 0.64 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 0.58 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.73 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 0.71 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 0.39 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.4 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.04 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.17 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 0.47 109.638 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 0.51 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.4 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 0.71 110.006 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.72 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 0.54 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 0.48 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.19 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79 111.502 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.05 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.25 110.546 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 70' ' ' LEU . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 0.56 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 0.69 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 51' ' ' LEU . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 0.89 109.938 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.19 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.768 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.0 109.225 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.02 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.84 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 0.72 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.78 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.768 HD21 ' HB2' ' A' ' 46' ' ' LYS . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 0.52 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 1.68 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 0.92 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 0.55 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 0.67 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 62' ' ' VAL . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 0.48 109.349 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.32 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.62 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 0.69 109.777 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.67 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 57' ' ' LEU . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 0.65 108.752 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.56 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 0.87 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.556 HG22 ' CG1' ' A' ' 4' ' ' VAL . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 0.43 109.775 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.06 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 0.98 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.86 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 0.43 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.09 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' A' ' 37' ' ' THR . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.24 109.451 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.46 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 0.45000000000000001 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.83999999999999997 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 0.46000000000000002 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 0.55000000000000004 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 0.59999999999999998 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.27 109.518 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.57999999999999996 109.697 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.211 -0.662 . . . . 0.91000000000000003 109.211 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.55000000000000004 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.3600000000000001 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 0.40999999999999998 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 2.8999999999999999 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 0.47999999999999998 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.0600000000000001 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 0.42999999999999999 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 57' ' ' LEU . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55000000000000004 109.338 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 0.47999999999999998 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 0.40999999999999998 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.44 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.8700000000000001 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.60999999999999999 109.427 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 0.77000000000000002 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.45 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 0.34000000000000002 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 0.58999999999999997 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.53000000000000003 110.654 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 0.91000000000000003 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.68000000000000005 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' LEU . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 0.46999999999999997 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52000000000000002 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 0.40000000000000002 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' THR . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 2.3399999999999999 109.797 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 0.95999999999999996 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 1.8100000000000001 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.3799999999999999 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.662 HG23 HD11 ' A' ' 70' ' ' LEU . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 0.38 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 0.46000000000000002 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 0.85999999999999999 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.04 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CB ' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 0.93000000000000005 109.529 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.05 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.1399999999999999 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' VAL . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 0.82999999999999996 110.367 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 60' ' ' TYR . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 0.60999999999999999 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.23 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79000000000000004 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 0.97999999999999998 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.64000000000000001 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 0.45000000000000001 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.85999999999999999 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67000000000000004 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CG ' HD22 ' A' ' 51' ' ' LEU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.47999999999999998 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 66' ' ' THR . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 0.47999999999999998 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.23 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65000000000000002 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 0.94999999999999996 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 HG13 ' A' ' 62' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.41999999999999998 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.03 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.05 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.73999999999999999 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.826 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.40000000000000002 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.1699999999999999 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 37' ' ' THR . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 0.93000000000000005 109.925 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.27 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.3600000000000001 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 0.39000000000000001 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 66' ' ' THR . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 0.42999999999999999 109.764 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 0.40999999999999998 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD21 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 0.51000000000000001 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.63 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.685 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.593 . . . . 0.76000000000000001 109.4 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 0.54000000000000004 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 1.8600000000000001 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 0.52000000000000002 109.699 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.3100000000000001 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 0.90000000000000002 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 0.90000000000000002 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 0.63 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.573 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.56999999999999995 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 0.64000000000000001 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.744 HG12 ' HE3' ' A' ' 28' ' ' LYS . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.5900000000000001 109.044 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.45000000000000001 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.744 ' HE3' HG12 ' A' ' 24' ' ' VAL . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 1.6000000000000001 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.599 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 2.5 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 26' ' ' ASP . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.46999999999999997 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 0.71999999999999997 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.73999999999999999 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.60999999999999999 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 0.60999999999999999 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 1.8600000000000001 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.98999999999999999 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.5700000000000001 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.3799999999999999 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 0.51000000000000001 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 0.55000000000000004 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.0800000000000001 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.0800000000000001 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 1.6499999999999999 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.0 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.75 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.1299999999999999 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 0.83999999999999997 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD12 ' HB3' ' A' ' 44' ' ' LEU . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 0.59999999999999998 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.3100000000000001 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.69999999999999996 110.513 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.1599999999999999 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.57999999999999996 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.53000000000000003 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 27' ' ' PHE . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 0.58999999999999997 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.6200000000000001 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.1499999999999999 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CG ' HD22 ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.54000000000000004 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.1599999999999999 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 0.44 108.769 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.1200000000000001 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78000000000000003 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.56000000000000005 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.554 HG22 HG12 ' A' ' 4' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 0.47999999999999998 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.28 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.04 109.726 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.85999999999999999 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 HG23 ' A' ' 42' ' ' ILE . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.5 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.473 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 0.81000000000000005 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 1.5800000000000001 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.1200000000000001 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 0.47999999999999998 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.1899999999999999 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.51000000000000001 110.223 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 0.64000000000000001 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 14' ' ' VAL . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 0.56999999999999995 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.77000000000000002 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81000000000000005 109.834 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 121.221 0.534 . . . . 1.9199999999999999 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.26 109.659 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.3599999999999999 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 31' ' ' LEU . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.46000000000000002 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.3100000000000001 110.542 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 0.84999999999999998 109.525 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.1000000000000001 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.55000000000000004 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.80000000000000004 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67000000000000004 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 0.53000000000000003 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 0.45000000000000001 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34000000000000002 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.83999999999999997 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 44' ' ' LEU . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.55000000000000004 109.128 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 0.81000000000000005 109.562 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 1.73 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 0.38 109.219 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 0.63 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.47999999999999998 111.101 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 0.64000000000000001 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.03 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 0.58999999999999997 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52000000000000002 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.679 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 0.44 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.0 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.73999999999999999 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 1.6100000000000001 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.2400000000000002 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 0.45000000000000001 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 0.55000000000000004 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 0.5 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 0.88 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.744 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 1.6499999999999999 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.68000000000000005 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.80000000000000004 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.59999999999999998 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 0.68000000000000005 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 0.48999999999999999 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 1.9299999999999999 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66000000000000003 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.81999999999999995 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 0.48999999999999999 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.71999999999999997 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 0.57999999999999996 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.62 110.045 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 0.64000000000000001 108.477 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 1.6899999999999999 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67000000000000004 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.96999999999999997 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.5 109.347 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.1499999999999999 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.3 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.51000000000000001 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.1399999999999999 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.679 ' CD1' HG21 ' A' ' 37' ' ' THR . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.78000000000000003 109.561 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.1200000000000001 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.23 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 0.57999999999999996 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92000000000000004 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 0.47999999999999998 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 0.57999999999999996 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.71999999999999997 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.59999999999999998 109.398 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.293 -0.632 . . . . 1.48 109.293 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.46999999999999997 110.06 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.1499999999999999 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.44 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 0.93999999999999995 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.25 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 0.55000000000000004 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.81999999999999995 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.72999999999999998 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 0.47999999999999998 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.34999999999999998 108.64 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.98999999999999999 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 0.69999999999999996 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' HD12 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 0.84999999999999998 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.02 109.702 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 0.41999999999999998 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 0.47999999999999998 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.51000000000000001 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 0.79000000000000004 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.71999999999999997 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.53000000000000003 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.48999999999999999 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' TYR . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 0.46999999999999997 110.633 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.5 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.02 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.5700000000000001 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.29 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 70' ' ' LEU . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 0.48999999999999999 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 73' ' ' LEU . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 0.55000000000000004 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.98999999999999999 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.0600000000000001 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.1100000000000001 109.842 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 0.97999999999999998 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.80000000000000004 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.22 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 0.73999999999999999 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 0.46000000000000002 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.2400000000000002 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.73999999999999999 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.3200000000000001 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.52000000000000002 109.392 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.79000000000000004 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 62' ' ' VAL . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 0.72999999999999998 109.646 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.3100000000000001 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76000000000000001 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.57999999999999996 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.7400000000000002 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 46' ' ' LYS . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 0.69999999999999996 108.549 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 1.8300000000000001 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.81999999999999995 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 0.89000000000000001 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.805 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 0.55000000000000004 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 0.92000000000000004 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 0.56999999999999995 109.304 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54000000000000004 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.865 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.45000000000000001 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.3700000000000001 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 37' ' ' THR . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.0800000000000001 109.681 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 1.9399999999999999 109.752 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 1.7 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 0.54000000000000004 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 66' ' ' THR . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.40999999999999998 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.45000000000000001 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 0.42999999999999999 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.6499999999999999 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.90000000000000002 110.439 -179.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 35' ' ' ILE . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.52000000000000002 109.888 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.21 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 0.46000000000000002 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 1.3899999999999999 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 0.81999999999999995 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.1200000000000001 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 0.46999999999999997 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.96999999999999997 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76000000000000001 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.69999999999999996 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 0.46999999999999997 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.42999999999999999 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.70999999999999996 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 57' ' ' LEU . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.5 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 1.79 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.3799999999999999 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 0.41999999999999998 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 0.63 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.41999999999999998 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 0.65000000000000002 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.68000000000000005 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 14' ' ' VAL . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 0.52000000000000002 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.45000000000000001 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 35' ' ' ILE . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 0.47999999999999998 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.25 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89000000000000001 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 1.6200000000000001 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 2.52 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 70' ' ' LEU . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 0.46999999999999997 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 0.5 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.45000000000000001 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.22 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 1.6599999999999999 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89000000000000001 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.83999999999999997 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 0.63 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 0.75 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 46' ' ' LYS . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 0.54000000000000004 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.3100000000000001 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.70999999999999996 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 0.58999999999999997 109.668 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 0.63 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 0.47999999999999998 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.2400000000000002 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.69999999999999996 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.59999999999999998 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 57' ' ' LEU . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 0.55000000000000004 108.878 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.3300000000000001 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91000000000000003 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 0.92000000000000004 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 4' ' ' VAL . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 0.41999999999999998 109.746 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 0.87 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 42' ' ' ILE . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.46000000000000002 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.04 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 1.27 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.3600000000000001 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.04 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 0.39000000000000001 109.813 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 0.34000000000000002 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 0.5 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 0.54000000000000004 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.72999999999999998 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.614 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.27 0.557 . . . . 1.6200000000000001 109.805 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 0.59999999999999998 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.0600000000000001 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 0.48999999999999999 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.1299999999999999 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 0.92000000000000004 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.1200000000000001 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 0.46000000000000002 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.68999999999999995 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.48999999999999999 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 0.48999999999999999 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.34000000000000002 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' LEU . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.63 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 0.95999999999999996 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 1.6899999999999999 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 0.39000000000000001 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 0.56000000000000005 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.454 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.39000000000000001 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 0.87 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 42' ' ' ILE . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 0.53000000000000003 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.47999999999999998 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 72' ' ' TYR . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 0.38 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 1.95 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.58999999999999997 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.3200000000000001 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.5299999999999998 110.174 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.73 HG21 HD11 ' A' ' 35' ' ' ILE . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.47999999999999998 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 0.41999999999999998 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 0.44 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.27 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.1200000000000001 109.638 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.62 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 0.76000000000000001 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' VAL . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.866 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.52 HD11 HD21 ' A' ' 68' ' ' LEU . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 0.47999999999999998 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.21 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.69999999999999996 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 1.9099999999999999 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 0.65000000000000002 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 0.75 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 27' ' ' PHE . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 0.59999999999999998 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77000000000000002 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.1599999999999999 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HD13 ' A' ' 55' ' ' ILE . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.52000000000000002 109.897 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.83999999999999997 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG22 ' HD3' ' A' ' 46' ' ' LYS . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 0.5 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.3100000000000001 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.57999999999999996 109.429 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.66000000000000003 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 0.42999999999999999 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.80000000000000004 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 0.80000000000000004 109.615 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.80000000000000004 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.41999999999999998 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 37' ' ' THR . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.55000000000000004 109.998 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.54 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 1.51 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 0.48999999999999999 109.92 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93000000000000005 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 66' ' ' THR . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 0.5 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 68' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 0.82999999999999996 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.349 0.595 . . . . 2.6400000000000001 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 0.57999999999999996 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.1200000000000001 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 0.44 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.3100000000000001 109.569 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 0.73999999999999999 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.41999999999999998 110.108 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.71999999999999997 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51000000000000001 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.40999999999999998 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 0.41999999999999998 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.32000000000000001 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.90000000000000002 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.46000000000000002 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 0.67000000000000004 109.766 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.3700000000000001 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.34999999999999998 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 0.46999999999999997 109.545 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.37 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 0.79000000000000004 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.72999999999999998 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 0.47999999999999998 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.41999999999999998 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 1.6000000000000001 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.5 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.01 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 2.9500000000000002 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 0.46000000000000002 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 0.42999999999999999 107.956 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' A' ' 27' ' ' PHE . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 0.56000000000000005 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 0.77000000000000002 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.24 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.73999999999999999 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.84999999999999998 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.05 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 0.51000000000000001 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 60' ' ' TYR . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 0.45000000000000001 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HE2' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 0.89000000000000001 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56000000000000005 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 1.8899999999999999 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 0.47999999999999998 109.588 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.62 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 62' ' ' VAL . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 0.51000000000000001 109.8 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66000000000000003 109.342 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' HD22 ' A' ' 51' ' ' LEU . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.54000000000000004 110.12 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.3300000000000001 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 57' ' ' LEU . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 0.56999999999999995 108.671 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.47 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 0.89000000000000001 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.922 HG22 HG12 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.42999999999999999 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.52 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 6' ' ' VAL . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 0.56000000000000005 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52000000000000002 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 42' ' ' ILE . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 0.41999999999999998 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 0.98999999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.3100000000000001 109.579 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 1.71 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.51000000000000001 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.72999999999999998 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 68' ' ' LEU . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.41999999999999998 109.921 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.89000000000000001 108.678 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 0.56999999999999995 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.05 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66000000000000003 110.173 -179.622 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.193 0.521 . . . . 1.1799999999999999 109.708 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 35' ' ' ILE . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 0.80000000000000004 109.688 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.23 109.21 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 30' ' ' VAL . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 0.56000000000000005 110.162 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.21 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.72999999999999998 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.1000000000000001 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 0.68999999999999995 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.5 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.637 HG12 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 0.42999999999999999 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.40000000000000002 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HE2' HG21 ' A' ' 4' ' ' VAL . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.48999999999999999 109.393 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HD2' HG12 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.24 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 2.77 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.465 HG12 HG23 ' A' ' 16' ' ' VAL . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 0.35999999999999999 108.605 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 0.72999999999999998 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.68999999999999995 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.83999999999999997 109.897 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 0.82999999999999996 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 14' ' ' VAL . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 0.55000000000000004 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.58999999999999997 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 41' ' ' LYS . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 0.56000000000000005 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.3999999999999999 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.01 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 1.8999999999999999 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.722 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.2000000000000002 111.183 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 70' ' ' LEU . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 0.53000000000000003 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 0.48999999999999999 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 0.78000000000000003 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.03 109.45 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.94999999999999996 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.90000000000000002 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1000000000000001 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 0.68000000000000005 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 0.56999999999999995 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 44' ' ' LEU . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 0.55000000000000004 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.0899999999999999 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.84999999999999998 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.25 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 0.66000000000000003 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 0.68000000000000005 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 0.53000000000000003 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79000000000000004 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 51' ' ' LEU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.59999999999999998 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 0.56000000000000005 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.6200000000000001 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.59999999999999998 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.47999999999999998 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.87 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD12 HG11 ' A' ' 4' ' ' VAL . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 0.60999999999999999 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 109.57 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.693 ' HB2' HG12 ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 0.46000000000000002 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 0.78000000000000003 109.21 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.58999999999999997 109.788 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.3500000000000001 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 1.45 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 0.48999999999999999 109.829 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.90000000000000002 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 66' ' ' THR . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 0.37 110.15 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 0.55000000000000004 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.72999999999999998 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.449 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.73999999999999999 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52000000000000002 110.058 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.409 0.623 . . . . 2.2999999999999998 110.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 0.68999999999999995 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.1000000000000001 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 4' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 0.59999999999999998 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.3700000000000001 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.68000000000000005 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 0.91000000000000003 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 0.41999999999999998 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76000000000000001 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.47999999999999998 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HE3' ' A' ' 28' ' ' LYS . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 0.48999999999999999 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.40999999999999998 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.97999999999999998 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HB2' HD11 ' A' ' 57' ' ' LEU . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.5 109.356 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 1.6200000000000001 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.1899999999999999 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 33' ' ' LEU . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 0.46000000000000002 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 0.63 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.35999999999999999 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 0.91000000000000003 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.58999999999999997 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 0.51000000000000001 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54000000000000004 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 0.47999999999999998 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 1.97 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79000000000000004 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 1.6799999999999999 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.1499999999999999 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.61 HG23 HD11 ' A' ' 70' ' ' LEU . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 0.46000000000000002 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 0.57999999999999996 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 27' ' ' PHE . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 0.65000000000000002 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 1.6200000000000001 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.0700000000000001 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 0.97999999999999998 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.1499999999999999 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.88 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.3400000000000001 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65000000000000002 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 0.92000000000000004 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.459 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 0.53000000000000003 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.56000000000000005 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 27' ' ' PHE . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 0.66000000000000003 109.514 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.95999999999999996 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.3100000000000001 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.44 109.868 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 0.40999999999999998 109.161 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.1299999999999999 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78000000000000003 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.81999999999999995 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.757 HG22 HG12 ' A' ' 4' ' ' VAL . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.46999999999999997 109.62 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 1.6000000000000001 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 0.83999999999999997 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.3799999999999999 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.47999999999999998 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 0.93000000000000005 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.01 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.3999999999999999 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.0600000000000001 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 0.38 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 66' ' ' THR . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 0.34999999999999998 109.916 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.46000000000000002 109.58 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 0.51000000000000001 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.60999999999999999 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.221 0.534 . . . . 1.78 109.732 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 0.52000000000000002 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 1.97 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 31' ' ' LEU . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 0.52000000000000002 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.1600000000000001 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 0.5 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 0.65000000000000002 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 0.47999999999999998 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79000000000000004 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.51000000000000001 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.40999999999999998 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93000000000000005 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.48999999999999999 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HG2' HD12 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 0.77000000000000002 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 2.98 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 0.45000000000000001 109.406 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 0.66000000000000003 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.46999999999999997 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 0.78000000000000003 109.912 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.72999999999999998 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 HD12 ' OG1' ' A' ' 37' ' ' THR . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 0.59999999999999998 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.5 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.511 ' OG1' HD12 ' A' ' 35' ' ' ILE . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 0.45000000000000001 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.3600000000000001 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.76000000000000001 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.0800000000000001 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.04 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 70' ' ' LEU . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 0.42999999999999999 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 0.46999999999999997 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.624 HD12 ' HG2' ' A' ' 28' ' ' LYS . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 0.52000000000000002 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.82999999999999996 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 51' ' ' LEU . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 1.6399999999999999 109.912 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.1299999999999999 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 0.96999999999999997 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.3400000000000001 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.83999999999999997 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 46' ' ' LYS . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 0.60999999999999999 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 1.8400000000000001 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.57999999999999996 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 1.3100000000000001 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 0.57999999999999996 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 0.76000000000000001 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 62' ' ' VAL . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 0.46000000000000002 109.427 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.8400000000000001 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.68999999999999995 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 0.72999999999999998 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.1299999999999999 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.469 HG21 HD22 ' A' ' 57' ' ' LEU . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 0.51000000000000001 109.072 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.23 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66000000000000003 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 0.87 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 4' ' ' VAL . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 0.44 109.5 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 0.97999999999999998 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.3200000000000001 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.4299999999999999 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 42' ' ' ILE . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 0.40000000000000002 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 0.69999999999999996 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.64000000000000001 109.883 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.46 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 1.6100000000000001 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.65000000000000002 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 27' ' ' PHE . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 0.41999999999999998 109.566 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 0.46999999999999997 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 68' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 0.40000000000000002 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78000000000000003 110.077 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.172 0.511 . . . . 1.79 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' CG2' ' A' ' 35' ' ' ILE . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 0.5 109.611 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 0.98999999999999999 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 30' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 0.57999999999999996 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.28 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 0.69999999999999996 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.28 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 0.56999999999999995 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.84999999999999998 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.82999999999999996 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 0.53000000000000003 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.46000000000000002 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.34000000000000002 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.80000000000000004 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 4' ' ' VAL . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.54000000000000004 109.138 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 0.90000000000000002 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 1.6499999999999999 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 0.47999999999999998 109.671 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 0.55000000000000004 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.41999999999999998 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 0.71999999999999997 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.70999999999999996 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.649 HD11 HG21 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 0.5 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.46999999999999997 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 0.35999999999999999 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.2000000000000002 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68000000000000005 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 1.77 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.01 110.151 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 0.45000000000000001 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 0.52000000000000002 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.47999999999999998 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.84999999999999998 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.1499999999999999 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.91000000000000003 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.90000000000000002 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.02 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 0.59999999999999998 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 46' ' ' LYS . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 0.52000000000000002 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.23 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.69999999999999996 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.1499999999999999 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.56000000000000005 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.1299999999999999 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 0.48999999999999999 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.3100000000000001 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.56999999999999995 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG12 HD11 ' A' ' 2' ' ' ILE . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 0.48999999999999999 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.28 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.69999999999999996 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.73999999999999999 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.45 ' CG2' HG13 ' A' ' 4' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.46000000000000002 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.4199999999999999 110.141 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 0.56999999999999995 109.619 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 0.40999999999999998 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.0600000000000001 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.603 ' CD1' HG21 ' A' ' 37' ' ' THR . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 109.722 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' HE3' ' A' ' 41' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.3899999999999999 110.133 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 1.5900000000000001 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 0.53000000000000003 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65000000000000002 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 66' ' ' THR . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 0.38 110.065 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 0.46999999999999997 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 0.96999999999999997 109.745 -179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.68000000000000005 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.83999999999999997 110.307 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.121 0.486 . . . . 1.8899999999999999 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 0.66000000000000003 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 0.97999999999999998 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 27' ' ' PHE . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 0.53000000000000003 109.754 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 2.54 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 0.71999999999999997 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 0.94999999999999996 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 0.53000000000000003 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79000000000000004 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.58999999999999997 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.45000000000000001 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 0.38 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.34000000000000002 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52000000000000002 108.815 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 16' ' ' VAL . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.5 109.223 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HB3' HD12 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.0600000000000001 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.3700000000000001 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 33' ' ' LEU . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 0.45000000000000001 108.992 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 0.56000000000000005 109.622 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.41999999999999998 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.1599999999999999 109.656 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 0.65000000000000002 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55000000000000004 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.474 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 0.58999999999999997 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.6399999999999999 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 0.96999999999999997 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 1.6699999999999999 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 1.8300000000000001 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.584 HG23 HD11 ' A' ' 70' ' ' LEU . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 0.52000000000000002 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 0.57999999999999996 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 51' ' ' LEU . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 0.5 110.059 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.25 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.1899999999999999 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.01 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.98999999999999999 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 0.67000000000000004 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.68999999999999995 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 0.52000000000000002 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.2599999999999998 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67000000000000004 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.88 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 0.48999999999999999 109.492 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 0.67000000000000004 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 HG21 ' A' ' 62' ' ' VAL . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 0.47999999999999998 109.653 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.3100000000000001 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.69999999999999996 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.46999999999999997 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' CE1' ' A' ' 63' ' ' HIS . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 66' ' ' THR . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 0.54000000000000004 108.325 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 61' ' ' GLU . 46.5 m80 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.4199999999999999 110.462 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.57999999999999996 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.95999999999999996 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 62' ' ' VAL . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.54000000000000004 109.517 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.94999999999999996 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 0.65000000000000002 109.433 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 42' ' ' ILE . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 0.58999999999999997 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 0.96999999999999997 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 0.69999999999999996 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 1.3999999999999999 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 1.6200000000000001 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 0.40000000000000002 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.85999999999999999 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.40999999999999998 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.1499999999999999 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 0.53000000000000003 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.66000000000000003 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.0700000000000001 111.341 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 1.8300000000000001 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 0.55000000000000004 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.55 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 0.46999999999999997 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 2.9300000000000002 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 0.83999999999999997 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.1299999999999999 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.45000000000000001 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.4199999999999999 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.69999999999999996 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.40999999999999998 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.46999999999999997 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.40000000000000002 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.53000000000000003 109.402 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.1699999999999999 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 2.8500000000000001 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 0.38 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 0.46999999999999997 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.37 111.386 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 0.82999999999999996 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 0.51000000000000001 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45000000000000001 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.442 ' OG1' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 0.46999999999999997 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.1799999999999999 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.56999999999999995 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.3 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.0499999999999998 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 70' ' ' LEU . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 0.45000000000000001 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 0.40000000000000002 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.81999999999999995 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.67000000000000004 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.628 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 1.96 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.73999999999999999 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.0600000000000001 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 0.53000000000000003 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 46' ' ' LYS . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 0.46999999999999997 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.1899999999999999 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.2 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 0.70999999999999996 109.325 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.85999999999999999 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 0.57999999999999996 109.549 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.80000000000000004 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 0.62 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.94999999999999996 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 0.42999999999999999 109.273 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.1000000000000001 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64000000000000001 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.1899999999999999 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.626 HG22 HG12 ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.40999999999999998 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.03 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' GLN . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 0.76000000000000001 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.69999999999999996 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.745 HD11 HG23 ' A' ' 42' ' ' ILE . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.40000000000000002 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.0900000000000001 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.80000000000000004 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.23 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.3899999999999999 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 0.44 109.76 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.37 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 0.46000000000000002 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 0.40999999999999998 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.51000000000000001 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' HD23 ' A' ' 70' ' ' LEU . 21.7 t70 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46000000000000002 109.368 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.572 -0.529 . . . . 1.26 109.572 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 35' ' ' ILE . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 0.59999999999999998 109.65 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.492 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 1.8799999999999999 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 0.34999999999999998 109.758 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.1499999999999999 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 0.60999999999999999 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.05 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 0.40000000000000002 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.58999999999999997 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 0.59999999999999998 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 0.39000000000000001 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28000000000000003 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66000000000000003 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.44 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 0.79000000000000004 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.49 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.34999999999999998 109.283 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 0.54000000000000004 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.33000000000000002 110.736 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.81999999999999995 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52000000000000002 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.42999999999999999 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 0.39000000000000001 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 1.8799999999999999 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46000000000000002 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 1.4399999999999999 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 0.81000000000000005 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.637 HG23 HD11 ' A' ' 70' ' ' LEU . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 0.35999999999999999 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 73' ' ' LEU . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 0.40999999999999998 108.752 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.695 ' HB3' HD12 ' A' ' 51' ' ' LEU . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.85999999999999999 109.865 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.02 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 0.81999999999999995 109.442 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.76000000000000001 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64000000000000001 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.04 109.235 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 0.60999999999999999 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 44' ' ' LEU . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 0.44 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.1499999999999999 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53000000000000003 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 0.81999999999999995 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 0.48999999999999999 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 0.67000000000000004 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 62' ' ' VAL . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 0.44 109.47 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.82999999999999996 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.55000000000000004 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.1499999999999999 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 57' ' ' LEU . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 0.56999999999999995 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.1099999999999999 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.95999999999999996 109.616 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 0.93999999999999995 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 0.45000000000000001 109.341 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.0600000000000001 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.57999999999999996 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 42' ' ' ILE . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 0.40999999999999998 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.67000000000000004 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 0.79000000000000004 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.23 109.729 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 1.6799999999999999 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 0.57999999999999996 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.72999999999999998 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 0.44 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 0.46999999999999997 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG12 ' CB ' ' A' ' 68' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.45000000000000001 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.80000000000000004 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67000000000000004 110.092 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.232 0.539 . . . . 1.1899999999999999 109.921 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.56000000000000005 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.1699999999999999 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.44 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.0900000000000001 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 0.76000000000000001 109.606 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.92000000000000004 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.51000000000000001 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68000000000000005 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64000000000000001 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 0.59999999999999998 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 51' ' ' LEU . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 0.41999999999999998 109.391 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.39000000000000001 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.80000000000000004 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.57999999999999996 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.05 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.0 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 ' SG ' ' A' ' 18' ' ' CYS . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.40000000000000002 109.333 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.68999999999999995 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.40000000000000002 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 0.68000000000000005 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.1299999999999999 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' OG1' ' A' ' 37' ' ' THR . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 0.54000000000000004 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.48999999999999999 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.646 ' OG1' HD12 ' A' ' 35' ' ' ILE . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 0.51000000000000001 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.71 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.73999999999999999 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.0600000000000001 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB3' HG22 ' A' ' 37' ' ' THR . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 1.72 110.532 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 0.42999999999999999 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 0.57999999999999996 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 0.93999999999999995 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.85999999999999999 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.81999999999999995 109.602 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.83999999999999997 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89000000000000001 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.2 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 0.81000000000000005 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 44' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 0.60999999999999999 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.3900000000000001 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.68999999999999995 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.96999999999999997 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.59999999999999998 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 0.53000000000000003 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 27' ' ' PHE . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 0.46999999999999997 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.5 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 0.60999999999999999 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.26 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.84999999999999998 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 0.82999999999999996 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 62' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.47999999999999998 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.1899999999999999 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 0.57999999999999996 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.45000000000000001 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.2 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.21 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.436 HD12 ' HE2' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.22 110.09 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 1.49 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.35999999999999999 109.922 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92000000000000004 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' HG22 ' A' ' 66' ' ' THR . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 0.34000000000000002 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 0.46999999999999997 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HB2' ' A' ' 68' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 0.41999999999999998 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.53000000000000003 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.69999999999999996 110.153 -179.329 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.103 0.478 . . . . 1.0700000000000001 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 2.9300000000000002 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 0.40999999999999998 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.0499999999999998 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.51000000000000001 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 0.94999999999999996 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 0.48999999999999999 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92000000000000004 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.69999999999999996 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.3999999999999999 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 0.38 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.80000000000000004 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.38 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 0.96999999999999997 110.236 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.3199999999999998 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 16' ' ' VAL . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.37 108.866 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 0.52000000000000002 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.35999999999999999 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 0.82999999999999996 109.842 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.53000000000000003 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 0.51000000000000001 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.39000000000000001 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 0.47999999999999998 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 2.4199999999999999 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.3799999999999999 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.48 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.3700000000000001 110.673 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 0.5 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 0.48999999999999999 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 0.66000000000000003 110.173 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.3200000000000001 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.1599999999999999 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.27 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 0.68999999999999995 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 60' ' ' TYR . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 0.46000000000000002 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.04 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.59999999999999998 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 0.5 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 0.83999999999999997 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 62' ' ' VAL . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 0.46000000000000002 109.443 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.5900000000000001 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.69999999999999996 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' HD22 ' A' ' 51' ' ' LEU . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.63 109.976 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.1899999999999999 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.564 HG21 HD22 ' A' ' 57' ' ' LEU . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 0.48999999999999999 108.751 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.6599999999999999 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54000000000000004 109.289 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.82999999999999996 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 HG22 ' CG1' ' A' ' 4' ' ' VAL . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 0.40999999999999998 109.625 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.57999999999999996 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.653 ' HB2' HG12 ' A' ' 6' ' ' VAL . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.0800000000000001 109.748 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65000000000000002 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.592 HD11 HG23 ' A' ' 42' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.42999999999999999 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.1000000000000001 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.97999999999999998 109.871 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.3 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 1.53 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 0.46999999999999997 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91000000000000003 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 0.40999999999999998 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 0.5 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 68' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.47999999999999998 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.96999999999999997 110.001 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.72 -0.474 . . . . 0.87 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 0.62 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 1.77 109.468 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 0.47999999999999998 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 2.79 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 0.76000000000000001 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 0.5 109.933 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78000000000000003 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 0.66000000000000003 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.40999999999999998 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.34999999999999998 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.81999999999999995 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' ' 44' ' ' LEU . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.40000000000000002 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 0.91000000000000003 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.4700000000000002 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 0.46999999999999997 109.285 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 0.68000000000000005 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.40999999999999998 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 0.81999999999999995 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.69999999999999996 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 0.44 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.40000000000000002 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.654 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 0.37 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.24 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.67000000000000004 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 1.71 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.991 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 0.37 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 0.45000000000000001 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.48999999999999999 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 0.96999999999999997 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 1.78 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78000000000000003 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.94999999999999996 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 0.65000000000000002 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 0.56000000000000005 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD11 HD21 ' A' ' 68' ' ' LEU . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 0.55000000000000004 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.25 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.68999999999999995 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.1799999999999999 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 0.64000000000000001 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.46000000000000002 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' A' ' 27' ' ' PHE . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 0.59999999999999998 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.437 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.3700000000000001 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.56000000000000005 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.3500000000000001 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 0.47999999999999998 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 1.51 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.70999999999999996 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.743 HG22 HG12 ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 0.41999999999999998 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.3100000000000001 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.3200000000000001 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 42' ' ' ILE . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 0.40999999999999998 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.3100000000000001 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG21 ' A' ' 37' ' ' THR . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.60999999999999999 109.737 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.1399999999999999 109.547 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 1.9399999999999999 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 0.41999999999999998 109.775 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 0.40999999999999998 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HG2' ' A' ' 15' ' ' ARG . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 0.40999999999999998 109.123 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 31' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.47999999999999998 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.427 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.45000000000000001 109.522 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.03 108.943 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG21 ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 0.76000000000000001 109.94 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HG2' HG22 ' A' ' 5' ' ' VAL . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.1299999999999999 110.141 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 0.40000000000000002 109.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 1.97 110.235 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 0.75 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.0900000000000001 109.784 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.46000000000000002 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.82999999999999996 109.902 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.57999999999999996 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 0.48999999999999999 108.969 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.33000000000000002 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.97999999999999998 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 4' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.5 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 0.81000000000000005 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 1.9399999999999999 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 109.124 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 6' ' ' VAL . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 0.51000000000000001 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.37 111.222 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.0700000000000001 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.56000000000000005 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 0.44 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39000000000000001 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 0.40999999999999998 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.72999999999999998 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.4299999999999999 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.3300000000000001 110.513 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.45000000000000001 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 0.53000000000000003 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 0.77000000000000002 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 0.91000000000000003 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.46 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.80000000000000004 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.1200000000000001 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 0.64000000000000001 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 0.54000000000000004 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 2.7599999999999998 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66000000000000003 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.1399999999999999 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.476 HD13 ' OH ' ' A' ' 60' ' ' TYR . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 0.64000000000000001 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 0.69999999999999996 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 0.60999999999999999 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68000000000000005 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 55' ' ' ILE . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.53000000000000003 110.209 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.0600000000000001 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 0.45000000000000001 108.981 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.85999999999999999 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.68999999999999995 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.56999999999999995 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 0.40000000000000002 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.1699999999999999 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 0.80000000000000004 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.0900000000000001 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 0.39000000000000001 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.1699999999999999 109.304 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.67000000000000004 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 1.6299999999999999 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.3799999999999999 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 0.39000000000000001 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.85999999999999999 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 66' ' ' THR . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 0.34000000000000002 110.357 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 15' ' ' ARG . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 0.44 109.544 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.46000000000000002 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.63 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 121.04 0.448 . . . . 2.3599999999999999 110.117 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 0.83999999999999997 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.652 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 1.5900000000000001 109.151 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 0.45000000000000001 109.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 2.6899999999999999 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 0.72999999999999998 109.756 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 0.90000000000000002 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 0.41999999999999998 110.241 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.58999999999999997 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.81000000000000005 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.32000000000000001 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.71999999999999997 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.45000000000000001 109.193 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 0.92000000000000004 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 2.6800000000000002 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 0.37 109.268 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 16' ' ' VAL . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 0.58999999999999997 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.53000000000000003 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 0.75 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67000000000000004 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 0.57999999999999996 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.47999999999999998 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 0.46000000000000002 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.0899999999999999 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.85999999999999999 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.3700000000000001 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 1.9399999999999999 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 70' ' ' LEU . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 0.45000000000000001 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 0.45000000000000001 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 0.51000000000000001 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 0.90000000000000002 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HE2' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 0.92000000000000004 109.367 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.90000000000000002 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 0.51000000000000001 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 0.47999999999999998 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.46000000000000002 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 2.7000000000000002 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65000000000000002 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.0699999999999998 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 0.51000000000000001 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 0.52000000000000002 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 62' ' ' VAL . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 0.42999999999999999 109.35 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.69999999999999996 109.58 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.70999999999999996 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.41999999999999998 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 57' ' ' LEU . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.52000000000000002 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 0.98999999999999999 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.81999999999999995 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.82999999999999996 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.584 HG22 HG12 ' A' ' 4' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 0.41999999999999998 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.5 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.545 HD21 ' HE2' ' A' ' 46' ' ' LYS . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.63 109.719 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 42' ' ' ILE . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 0.45000000000000001 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.1299999999999999 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.91000000000000003 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.3300000000000001 109.417 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 1.48 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 0.42999999999999999 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.68999999999999995 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.556 ' CG1' HG22 ' A' ' 66' ' ' THR . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 0.37 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.54000000000000004 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 0.89000000000000001 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.83999999999999997 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56000000000000005 110.016 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.695 -0.483 . . . . 2.0299999999999998 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.1299999999999999 109.838 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 1.5800000000000001 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 27' ' ' PHE . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 0.5 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 2.73 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 0.58999999999999997 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 0.64000000000000001 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 0.57999999999999996 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.72999999999999998 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55000000000000004 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 0.70999999999999996 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 0.39000000000000001 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33000000000000002 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51000000000000001 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.40000000000000002 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.04 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.1699999999999999 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.638 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 0.51000000000000001 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.40000000000000002 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 0.70999999999999996 110.006 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.71999999999999997 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 0.54000000000000004 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 0.47999999999999998 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.1899999999999999 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79000000000000004 111.502 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.05 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.25 110.546 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 70' ' ' LEU . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 0.56000000000000005 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 0.68999999999999995 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 51' ' ' LEU . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 0.89000000000000001 109.938 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.1899999999999999 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.768 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.0 109.225 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.02 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 0.71999999999999997 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.78000000000000003 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.768 HD21 ' HB2' ' A' ' 46' ' ' LYS . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 0.52000000000000002 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 1.6799999999999999 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54000000000000004 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 0.92000000000000004 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 0.55000000000000004 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 0.67000000000000004 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 62' ' ' VAL . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 0.47999999999999998 109.349 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.3200000000000001 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.6200000000000001 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 0.68999999999999995 109.777 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.6699999999999999 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 57' ' ' LEU . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 0.65000000000000002 108.752 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.5600000000000001 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66000000000000003 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 0.87 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.556 HG22 ' CG1' ' A' ' 4' ' ' VAL . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 0.42999999999999999 109.775 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.0600000000000001 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 0.97999999999999998 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.85999999999999999 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 0.42999999999999999 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.0900000000000001 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' A' ' 37' ' ' THR . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.2400000000000002 109.451 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.203 0.525 . . . . 1.46 109.754 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.0 pt -126.25 161.33 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.617 -0.677 . . . . 0.45000000000000001 109.915 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.82 114.19 22.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.138 -0.69 . . . . 0.83999999999999997 109.138 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 66' ' ' THR . 3.2 m -114.18 151.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.621 -0.674 . . . . 0.46000000000000002 109.615 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.53 140.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.705 . . . . 0.55000000000000004 109.425 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.3 t -121.44 126.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.52 -0.738 . . . . 0.59999999999999998 109.15 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -119.66 117.87 29.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.675 -0.641 . . . . 1.27 109.518 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.22 141.34 35.7 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.757 -0.589 . . . . 0.57999999999999996 109.697 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -33.8 76.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.707 -0.621 . . . . 1.4199999999999999 109.789 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -46.3 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.6 -0.688 . . . . 1.5600000000000001 109.243 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.56 64.8 0.01 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.01 -1.236 . . . . 0.72999999999999998 110.01 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 101.08 3.27 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.639 -0.918 . . . . 2.7799999999999998 109.646 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -101.36 100.48 10.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.91000000000000003 109.211 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 35' ' ' ILE . 25.0 t -121.6 140.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.55000000000000004 109.633 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 148.25 25.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.558 -0.714 . . . . 1.3600000000000001 109.449 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -152.33 141.37 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.491 -0.755 . . . . 0.40999999999999998 109.779 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -100.31 152.8 19.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.519 -0.738 . . . . 2.8999999999999999 110.213 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.1 -153.51 0.25 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.087 -0.709 . . . . 0.47999999999999998 109.087 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.67 150.68 49.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.176 -0.952 . . . . 1.0600000000000001 109.382 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.69 -32.64 71.85 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.478 -0.764 . . . . 0.42999999999999999 109.348 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.77 -18.54 47.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.656 -0.652 . . . . 0.87 109.787 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 57' ' ' LEU . 28.4 t70 -60.29 146.33 44.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.575 -0.703 . . . . 0.55000000000000004 109.338 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 1.2 t -89.2 160.7 16.83 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.761 . . . . 0.47999999999999998 110.494 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 89.2 t -62.12 -32.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.717 -0.614 . . . . 0.40999999999999998 109.487 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -60.36 -50.82 63.4 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.44 109.203 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -34.54 78.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.848 -0.795 . . . . 1.8700000000000001 109.178 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.56 -44.71 95.66 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.427 -0.583 . . . . 0.60999999999999999 109.427 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -66.85 -29.94 69.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.744 -0.597 . . . . 0.77000000000000002 109.954 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -69.03 -42.63 76.11 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.45 109.562 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -42.17 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.619 -0.675 . . . . 0.34000000000000002 109.248 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . 31.6 tp -67.46 -39.97 85.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.621 -0.674 . . . . 0.58999999999999997 109.642 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.1 t -54.08 -29.17 43.38 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.945 -0.472 . . . . 0.53000000000000003 110.654 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.92 -36.21 81.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 0.91000000000000003 110.12 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.52 -50.65 8.59 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.503 -0.748 . . . . 0.68000000000000005 110.735 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 31' ' ' LEU . 22.4 pt -77.01 -26.83 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.387 -0.82 . . . . 0.46999999999999997 110.962 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.86 49.45 54.63 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.218 -1.953 . . . . 0.52000000000000002 108.218 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.9 m -117.63 3.06 12.38 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.038 -0.684 . . . . 0.40000000000000002 110.484 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' THR . 2.4 mt-30 66.31 152.29 0.12 Allowed Pre-proline 0 N--CA 1.503 2.221 0 O-C-N 121.415 -0.803 . . . . 2.3399999999999999 109.797 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.92 -9.84 22.59 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.452 2.101 . . . . 0.95999999999999996 111.279 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -97.8 -12.19 22.5 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.419 -0.801 . . . . 1.8100000000000001 110.512 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 17.28 16.18 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.127 -0.983 . . . . 1.3799999999999999 110.71 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.662 HG23 HD11 ' A' ' 70' ' ' LEU . 95.1 mt -110.08 133.69 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.005 . . . . 0.38 109.65 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.61 117.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.399 -0.963 . . . . 0.46000000000000002 108.399 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD12 ' A' ' 51' ' ' LEU . 5.8 mt -98.79 146.87 25.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.786 . . . . 0.85999999999999999 110.066 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 69' ' ' GLU . 2.0 mm100 -127.32 140.63 52.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.628 -0.67 . . . . 1.04 109.732 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CB ' HD21 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -128.9 92.87 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.614 -0.679 . . . . 0.93000000000000005 109.529 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.35 51.5 51.99 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.928 -1.269 . . . . 1.05 109.928 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.31 63.86 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.957 -1.257 . . . . 1.03 109.957 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -149.32 131.8 15.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 1.1399999999999999 109.024 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 50' ' ' VAL . 13.2 p -79.73 129.49 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.726 . . . . 0.82999999999999996 110.367 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 60' ' ' TYR . 15.4 mt -93.1 138.85 31.17 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.528 -0.916 . . . . 0.60999999999999999 108.528 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 mttt -122.06 149.81 43.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 3.23 110.415 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.1 p-10 -60.79 -31.12 70.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.936 -0.478 . . . . 0.79000000000000004 110.409 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -64.53 -21.59 66.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.518 -0.739 . . . . 0.97999999999999998 110.746 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.19 142.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 109.595 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -80.48 156.85 26.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.64000000000000001 110.325 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 62' ' ' VAL . 38.7 mt -60.77 -35.01 75.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.752 -0.593 . . . . 0.45000000000000001 109.898 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.78 -35.74 71.21 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.633 -0.667 . . . . 0.85999999999999999 110.018 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.54 -45.62 89.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 0.67000000000000004 109.227 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CG ' HD22 ' A' ' 51' ' ' LEU . 57.5 m-85 -74.28 -16.23 60.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.75 -0.594 . . . . 0.47999999999999998 109.906 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 2.1 tp10 78.52 67.07 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 109.83 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 66' ' ' THR . 59.0 t -109.21 115.55 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.701 -0.852 . . . . 0.47999999999999998 108.701 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -121.01 -173.68 2.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.641 -0.662 . . . . 1.23 110.255 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.0 p-10 -67.74 146.27 53.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.65000000000000002 110.422 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 58.61 38.78 25.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.075 0.464 . . . . 0.94999999999999996 110.467 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 HG13 ' A' ' 62' ' ' VAL . 6.4 t -101.03 158.28 16.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.347 -0.845 . . . . 0.41999999999999998 109.441 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -101.25 131.42 47.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 1.03 110.081 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.51 50.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.468 -0.567 . . . . 1.05 109.468 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.68 153.28 20.28 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.479 -0.763 . . . . 0.73999999999999999 109.572 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.826 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -122.46 148.72 44.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.567 -0.708 . . . . 0.40000000000000002 110.053 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.19 148.31 30.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.009 -0.737 . . . . 1.1699999999999999 109.009 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 37' ' ' THR . 25.2 m-85 -107.15 109.31 21.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 0.93000000000000005 109.925 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.359 -0.829 . . . . 1.27 109.71 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.057 0.456 . . . . 1.3600000000000001 109.775 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 26.1 pt -121.25 161.73 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.724 -0.61 . . . . 0.39000000000000001 109.87 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -111.52 108.0 17.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.574 -0.704 . . . . 0.63 109.2 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 66' ' ' THR . 25.2 m -112.84 158.67 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.587 -0.696 . . . . 0.42999999999999999 109.764 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.18 143.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.624 -0.673 . . . . 0.40999999999999998 109.689 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD21 ' A' ' 44' ' ' LEU . 29.9 m -117.65 130.27 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.602 -0.686 . . . . 0.51000000000000001 109.472 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -111.55 116.25 30.53 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.638 -0.664 . . . . 0.63 109.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.2 t70 -76.89 142.45 40.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.694 . . . . 0.58999999999999997 109.685 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.31 -35.78 81.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 2.6699999999999999 109.773 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -48.51 74.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.503 -0.748 . . . . 1.6200000000000001 109.266 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.84 66.85 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.72 -1.352 . . . . 0.68999999999999995 109.72 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.74 104.48 3.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.905 . . . . 1.5600000000000001 109.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 114.53 27.76 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.76000000000000001 109.4 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.4 t -126.58 144.31 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.639 -0.663 . . . . 0.54000000000000004 109.662 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 136.53 47.94 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 1.8600000000000001 109.344 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.55 138.98 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.512 -0.742 . . . . 0.52000000000000002 109.699 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -110.42 138.45 46.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.432 -0.792 . . . . 2.3100000000000001 110.372 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 163.44 40.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.626 -0.671 . . . . 0.90000000000000002 109.67 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.18 145.65 30.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.282 -0.886 . . . . 0.90000000000000002 109.177 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.64 67.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.511 -0.743 . . . . 0.63 109.987 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.573 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.61 -21.73 38.11 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 1.01 109.887 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.09 151.2 40.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.525 -0.734 . . . . 0.56999999999999995 109.911 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.9 p -81.74 164.04 22.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.687 -0.633 . . . . 0.64000000000000001 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.744 HG12 ' HE3' ' A' ' 28' ' ' LYS . 88.4 t -61.22 -34.41 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.89 -44.17 96.23 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.5 t70 -67.87 -37.22 81.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 1.5900000000000001 109.044 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.481 ' HB2' HD11 ' A' ' 57' ' ' LEU . 72.8 t80 -62.1 -45.0 95.41 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.011 -0.737 . . . . 0.45000000000000001 109.011 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.744 ' HE3' HG12 ' A' ' 24' ' ' VAL . 11.1 mttt -67.99 -33.92 75.55 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.401 -0.592 . . . . 1.6000000000000001 109.401 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.599 ' HE2' ' HG3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -61.37 -44.15 97.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.716 -0.615 . . . . 2.5 109.6 179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 26' ' ' ASP . 22.1 t -64.45 -40.12 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -66.25 -36.47 83.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.55000000000000004 109.529 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.3 m -62.42 -34.32 76.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.746 -0.596 . . . . 0.46999999999999997 110.228 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.82 -27.47 65.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.337 -0.852 . . . . 0.71999999999999997 109.9 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -82.66 -45.6 14.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.73999999999999999 111.029 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 36' ' ' GLY . 28.9 pt -107.66 -44.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 111.063 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 106.56 54.31 0.69 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.114 -1.194 . . . . 0.60999999999999999 110.114 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -109.13 -15.03 14.41 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.646 -0.914 . . . . 0.60999999999999999 110.343 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER 67.69 155.95 0.14 Allowed Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.712 -0.618 . . . . 1.8600000000000001 110.416 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 35.4 Cg_endo -76.49 64.34 7.3 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.793 2.329 . . . . 0.98999999999999999 109.649 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -166.61 -43.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.694 -0.629 . . . . 1.5700000000000001 109.329 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.67 5.97 49.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 2.3799999999999999 110.288 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 28' ' ' LYS . 63.3 mt -98.67 128.51 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.285 -0.884 . . . . 0.51000000000000001 109.619 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 73' ' ' LEU . 58.2 t -121.18 108.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.474 -0.935 . . . . 0.55000000000000004 108.474 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.97 141.55 31.59 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 1.0800000000000001 109.987 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.7 mm100 -124.59 128.64 49.2 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.342 -0.614 . . . . 1.0800000000000001 109.342 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -120.76 95.75 4.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.571 -0.705 . . . . 1.6499999999999999 109.504 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.31 49.93 48.5 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.277 -1.129 . . . . 1.0 110.277 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.28 48.34 64.88 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.843 -1.303 . . . . 0.75 109.843 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -152.59 132.32 13.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.65 -0.912 . . . . 1.1299999999999999 109.162 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.86 138.33 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 0.83999999999999997 109.59 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD12 ' HB3' ' A' ' 44' ' ' LEU . 20.6 mt -99.19 119.84 38.53 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.194 -0.669 . . . . 0.59999999999999998 109.194 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 3.9 mmpt? -104.17 147.55 27.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 2.3100000000000001 109.94 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.4 p-10 -59.76 -27.59 66.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.837 -0.539 . . . . 0.69999999999999996 110.513 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -66.83 -17.75 65.04 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.547 -0.72 . . . . 1.1599999999999999 110.658 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 52' ' ' LYS . 4.8 mp -106.73 148.65 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.57999999999999996 109.361 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 88.1 p -86.83 155.76 20.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.53000000000000003 110.493 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 27' ' ' PHE . 43.7 mt -60.38 -34.39 73.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.309 -0.626 . . . . 0.58999999999999997 109.309 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.41 82.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.749 -0.594 . . . . 1.6200000000000001 109.667 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -44.55 93.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.627 . . . . 1.1499999999999999 109.41 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CG ' HD22 ' A' ' 51' ' ' LEU . 38.1 m-85 -73.06 -16.91 61.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.749 -0.594 . . . . 0.54000000000000004 109.981 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.04 75.95 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.546 0.688 . . . . 1.1599999999999999 109.354 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.8 t -103.86 119.84 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.769 -0.826 . . . . 0.44 108.769 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.39 167.26 11.28 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.411 0.624 . . . . 2.1200000000000001 110.336 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.7 p-10 -72.57 142.29 48.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.78000000000000003 109.385 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.94 31.15 18.19 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.715 -0.616 . . . . 0.56000000000000005 109.962 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.554 HG22 HG12 ' A' ' 4' ' ' VAL . 7.8 t -89.87 155.37 19.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.372 -0.83 . . . . 0.47999999999999998 109.624 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.54 122.97 42.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.475 -0.765 . . . . 1.28 109.688 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -113.84 161.61 17.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.699 -0.626 . . . . 1.04 109.726 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.5 OUTLIER -102.56 138.0 40.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.85999999999999999 109.317 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 HG23 ' A' ' 42' ' ' ILE . 31.0 tp -113.65 144.2 43.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.5 109.925 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.473 ' CB ' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.6 149.41 33.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.705 . . . . 0.81000000000000005 109.095 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 37' ' ' THR . 40.0 m-85 -107.02 130.13 54.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.481 -0.762 . . . . 1.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.443 -0.789 . . . . 1.5800000000000001 109.926 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.755 -0.461 . . . . 1.1200000000000001 109.755 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.5 161.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.644 -0.66 . . . . 0.47999999999999998 110.084 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 131.47 55.64 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.207 -0.664 . . . . 1.1899999999999999 109.207 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -129.93 158.13 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.51000000000000001 110.223 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.4 m -115.19 137.43 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.681 -0.637 . . . . 0.64000000000000001 109.483 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 14' ' ' VAL . 30.7 m -121.8 121.69 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.463 -0.773 . . . . 0.56999999999999995 109.775 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -108.85 142.6 39.21 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.69 -0.631 . . . . 0.77000000000000002 109.731 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -78.3 -77.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.547 -0.721 . . . . 0.81000000000000005 109.834 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.11 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 2.7000000000000002 110.066 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -68.86 0.36 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.489 -0.757 . . . . 2.0 109.31 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.69 57.14 0.16 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.213 -1.555 . . . . 0.93000000000000005 109.213 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.42 107.67 5.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.772 -0.84 . . . . 2.04 109.718 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -126.27 156.0 41.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.698 -0.626 . . . . 1.9199999999999999 110.258 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.97 158.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.706 -0.621 . . . . 1.26 109.659 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.53 133.93 52.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.628 -0.67 . . . . 2.3599999999999999 109.469 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 31' ' ' LEU . 14.9 p -144.42 138.99 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.46000000000000002 109.268 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -114.55 136.57 52.88 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.522 -0.736 . . . . 2.3100000000000001 110.542 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.64 156.97 41.49 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.525 -0.546 . . . . 0.84999999999999998 109.525 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.89 143.58 37.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.312 -0.867 . . . . 1.1000000000000001 109.372 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.69 65.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.64 -0.662 . . . . 0.55000000000000004 110.124 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.49 -22.81 40.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.512 -0.743 . . . . 0.80000000000000004 109.902 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.32 154.01 36.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.716 . . . . 0.67000000000000004 109.866 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 78.1 p -87.32 167.2 14.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.533 -0.729 . . . . 0.53000000000000003 110.36 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.64 -34.57 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.933 -0.766 . . . . 0.45000000000000001 108.933 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.17 -45.82 92.22 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 108.977 -1.649 . . . . 0.34000000000000002 108.977 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.15 -37.69 84.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.793 -0.828 . . . . 0.83999999999999997 108.901 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 44' ' ' LEU . 33.4 t80 -60.81 -40.82 94.17 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.128 -0.693 . . . . 0.55000000000000004 109.128 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -71.46 -33.09 69.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.821 -0.55 . . . . 0.81000000000000005 109.562 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.31 -41.71 93.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.573 -0.704 . . . . 1.73 109.862 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.07 -36.01 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.458 -0.776 . . . . 0.38 109.219 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.545 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -71.02 -49.09 48.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.657 -0.652 . . . . 0.63 109.649 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.8 p -53.56 -20.84 5.52 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.72 -0.613 . . . . 0.47999999999999998 111.101 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -41.16 59.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.145 -0.972 . . . . 0.64000000000000001 110.155 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 11.7 pt20 -82.62 -35.46 26.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.391 -0.818 . . . . 1.03 111.239 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 31' ' ' LEU . 3.0 pt -92.3 -24.97 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 O-C-N 121.144 -0.973 . . . . 0.58999999999999997 110.493 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.66 45.35 59.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.78 -1.728 . . . . 0.52000000000000002 108.78 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.679 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.2 m -116.75 2.51 12.91 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.923 -0.751 . . . . 0.44 110.081 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mt-30 66.0 152.1 0.12 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.606 -0.684 . . . . 2.0 110.058 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.01 -17.03 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.434 2.089 . . . . 0.73999999999999999 110.718 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -86.37 -17.71 33.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.593 -0.692 . . . . 1.6100000000000001 110.283 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -108.28 3.0 23.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.281 -0.887 . . . . 2.2400000000000002 110.775 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 70' ' ' LEU . 64.2 mt -100.97 122.21 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.075 -1.015 . . . . 0.45000000000000001 109.873 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.45 104.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.178 -1.045 . . . . 0.55000000000000004 108.178 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -98.99 147.51 24.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.375 -0.828 . . . . 0.5 110.418 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 2.2 mt-30 -133.8 132.83 40.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.771 -0.58 . . . . 0.88 109.58 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.744 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.4 96.86 7.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 1.6499999999999999 109.521 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.04 -87.96 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.875 -1.29 . . . . 0.68000000000000005 109.875 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.58 49.22 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.42 -1.472 . . . . 0.80000000000000004 109.42 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.2 p -153.87 138.88 17.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.682 -0.893 . . . . 0.59999999999999998 109.772 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.14 130.24 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.967 -0.753 . . . . 0.68000000000000005 108.967 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 46' ' ' LYS . 45.8 mt -86.05 126.97 34.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.633 -0.667 . . . . 0.48999999999999999 109.709 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.09 144.14 44.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.815 -0.553 . . . . 1.9299999999999999 109.646 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -57.83 -26.55 62.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.851 -0.531 . . . . 0.66000000000000003 110.439 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.43 -16.91 64.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.81999999999999995 110.804 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.5 mp -109.6 150.43 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.266 -0.896 . . . . 0.48999999999999999 109.32 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.42 158.04 18.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.71999999999999997 110.293 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.7 -37.35 83.81 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.662 -0.649 . . . . 0.57999999999999996 109.687 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' ' HB3' ' A' ' 56' ' ' SER . 10.9 pt-20 -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.687 -0.633 . . . . 1.97 110.079 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.49 -44.34 78.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 109.301 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 47.4 m-85 -71.6 -16.8 62.3 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.719 -0.613 . . . . 0.62 110.045 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 75.85 55.97 0.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.496 0.665 . . . . 1.49 110.177 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 59.2 t -84.55 115.5 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.477 -0.935 . . . . 0.64000000000000001 108.477 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -100.46 173.94 6.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.605 -0.685 . . . . 1.6899999999999999 110.469 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.7 138.67 55.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.67000000000000004 109.784 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 58.84 40.29 22.99 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.329 0.585 . . . . 0.96999999999999997 110.052 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -90.81 157.71 17.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.5 109.347 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -98.03 129.05 44.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.816 . . . . 1.1499999999999999 109.591 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -125.67 162.6 24.65 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.303 0.573 . . . . 1.3 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -105.54 146.51 29.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.085 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 42' ' ' ILE . 51.6 tp -125.67 128.94 48.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.51000000000000001 109.513 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 150.64 49.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.688 -0.633 . . . . 1.1399999999999999 109.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.679 ' CD1' HG21 ' A' ' 37' ' ' THR . 29.6 m-85 -109.1 122.12 46.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.78000000000000003 109.561 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 41' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 117.721 -1.133 . . . . 2.1200000000000001 109.944 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.18 0.514 . . . . 1.23 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 pt -123.7 161.68 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.564 -0.71 . . . . 0.57999999999999996 109.71 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -113.99 131.75 56.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.224 -0.658 . . . . 0.92000000000000004 109.224 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 66' ' ' THR . 34.1 m -130.25 155.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.381 -0.824 . . . . 0.47999999999999998 110.452 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.09 122.82 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.064 -0.717 . . . . 0.57999999999999996 109.064 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.2 t -102.27 119.76 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.456 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -110.62 114.88 28.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.668 -0.645 . . . . 0.71999999999999997 109.802 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . 10.8 t70 -76.72 143.67 39.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.603 -0.685 . . . . 0.59999999999999998 109.398 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -37.79 85.41 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.693 -0.629 . . . . 3.8999999999999999 110.276 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -48.85 76.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.448 -0.783 . . . . 1.8799999999999999 109.56 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 64.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.394 -1.483 . . . . 0.81000000000000005 109.394 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.13 113.18 8.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 2.2599999999999998 109.832 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 112.67 25.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 1.48 109.293 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.89 146.43 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.657 -0.652 . . . . 0.46999999999999997 110.06 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -105.67 129.32 53.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.462 -0.57 . . . . 2.1499999999999999 109.462 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.2 139.57 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.44 109.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 142.8 43.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.563 -0.71 . . . . 0.93999999999999995 110.213 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.86 164.59 38.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 109.646 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -86.29 151.16 23.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.352 -0.842 . . . . 1.25 109.765 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -22.81 65.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.685 -0.634 . . . . 0.55000000000000004 109.482 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.79 -21.37 44.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 1.0 109.771 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.19 152.09 46.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.585 -0.697 . . . . 0.81999999999999995 109.621 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.0 p -87.17 165.95 15.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.72999999999999998 110.46 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 97.9 t -59.96 -32.16 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.963 -0.755 . . . . 0.47999999999999998 108.963 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -59.95 -48.77 84.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.64 -1.784 . . . . 0.34999999999999998 108.64 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.96 -38.53 88.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.906 -0.761 . . . . 0.98999999999999999 109.059 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 4' ' ' VAL . 38.6 t80 -60.47 -45.08 95.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.008 -0.738 . . . . 0.69999999999999996 109.008 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' HD12 ' A' ' 44' ' ' LEU . 79.4 mttt -67.77 -28.72 67.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.854 -0.529 . . . . 0.84999999999999998 109.592 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -69.23 -45.99 68.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 3.02 109.702 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.68 -40.39 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.667 -0.646 . . . . 0.41999999999999998 109.357 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 35' ' ' ILE . 36.5 tp -68.83 -42.15 77.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.712 -0.618 . . . . 0.47999999999999998 109.797 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.8 t -53.05 -30.55 36.42 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.89 -0.506 . . . . 0.51000000000000001 110.721 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.21 -35.16 79.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.301 -0.874 . . . . 0.79000000000000004 110.221 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.47 -52.42 6.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.71999999999999997 110.43 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.2 pt -73.96 -25.32 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.53000000000000003 110.69 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.1 48.75 67.15 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.286 -1.925 . . . . 0.48999999999999999 108.286 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' TYR . 6.2 m -116.74 5.69 13.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.033 -0.686 . . . . 0.46999999999999997 110.633 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.18 149.71 0.12 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.404 -0.81 . . . . 1.5 109.937 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.7 -8.13 20.09 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 122.579 2.186 . . . . 1.02 111.214 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -102.04 -3.11 28.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.422 -0.799 . . . . 1.5700000000000001 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.43 19.78 9.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.069 -1.019 . . . . 2.29 110.544 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 70' ' ' LEU . 81.7 mt -114.0 131.67 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.968 . . . . 0.48999999999999999 109.835 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 73' ' ' LEU . 72.7 t -123.58 111.52 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.171 -1.048 . . . . 0.55000000000000004 108.171 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -98.94 141.51 31.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.462 -0.774 . . . . 0.98999999999999999 110.293 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.56 150.7 50.08 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.727 -0.608 . . . . 1.0600000000000001 109.499 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.97 104.25 6.46 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.521 -0.737 . . . . 1.1100000000000001 109.842 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.04 48.64 81.91 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.0 -1.24 . . . . 0.97999999999999998 110.0 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.48 45.48 85.02 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.016 -1.234 . . . . 0.80000000000000004 110.016 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 136.41 27.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.727 -0.866 . . . . 1.22 109.056 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.47 125.51 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.487 -0.758 . . . . 0.73999999999999999 110.291 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -94.44 129.33 41.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.754 -0.832 . . . . 0.46000000000000002 108.754 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 3.5 mttm -115.27 148.38 39.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.682 . . . . 3.2400000000000002 110.619 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -60.98 -29.68 69.82 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.986 -0.446 . . . . 0.73999999999999999 110.573 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -65.0 -16.83 63.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.516 -0.74 . . . . 1.3200000000000001 110.913 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.1 mp -108.45 145.97 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.992 . . . . 0.52000000000000002 109.392 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.7 OUTLIER -83.83 157.16 22.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.79000000000000004 110.187 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 62' ' ' VAL . 30.2 mt -62.7 -34.21 76.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.707 -0.621 . . . . 0.72999999999999998 109.646 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -30.67 71.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.776 -0.577 . . . . 1.3100000000000001 110.045 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.4 -42.08 72.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.57 -0.706 . . . . 0.76000000000000001 109.141 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -72.35 -16.66 61.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.722 -0.611 . . . . 0.57999999999999996 109.965 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.46 56.01 0.06 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.467 0.651 . . . . 2.7400000000000002 110.117 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 46' ' ' LYS . 54.5 t -84.18 118.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.549 -0.908 . . . . 0.69999999999999996 108.549 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -100.61 172.01 7.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.545 -0.722 . . . . 1.8300000000000001 110.44 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.71 138.79 50.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.752 -0.593 . . . . 0.81999999999999995 109.557 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.96 34.87 16.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.145 0.497 . . . . 0.89000000000000001 110.155 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.805 HG22 HG12 ' A' ' 4' ' ' VAL . 11.7 t -89.1 168.02 12.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.366 -0.834 . . . . 0.55000000000000004 109.469 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -98.7 123.15 42.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.425 -0.797 . . . . 0.92000000000000004 109.927 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.2 mm? -112.68 146.91 37.85 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.304 -0.628 . . . . 0.56999999999999995 109.304 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -102.79 149.87 24.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.529 -0.732 . . . . 0.54000000000000004 109.595 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.865 ' HB2' HG12 ' A' ' 6' ' ' VAL . 25.7 tp -125.4 138.93 54.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.45000000000000001 109.624 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 9.9 m-85 -140.06 145.35 37.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.169 -0.678 . . . . 1.3700000000000001 109.169 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 37' ' ' THR . 22.5 m-85 -104.08 128.23 51.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.792 . . . . 1.0800000000000001 109.681 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.798 -1.096 . . . . 1.9399999999999999 109.752 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 1.7 109.999 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 13.3 pt -121.87 162.54 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.646 -0.659 . . . . 0.54000000000000004 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -115.35 123.46 48.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.938 -0.764 . . . . 0.87 108.938 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 66' ' ' THR . 26.9 m -120.5 147.79 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.40999999999999998 109.86 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 15' ' ' ARG . 27.1 m -104.82 138.8 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.45000000000000001 109.362 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 29.7 m -115.82 124.88 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.315 -0.865 . . . . 0.42999999999999999 109.472 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.82 117.37 34.18 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.997 -0.742 . . . . 1.6499999999999999 108.997 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.92 148.88 29.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.609 -0.682 . . . . 0.90000000000000002 110.439 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.8 ttm180 -62.29 -42.95 99.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.941 -0.474 . . . . 2.0800000000000001 110.068 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -44.16 96.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.492 -0.755 . . . . 1.8 109.458 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.11 69.89 0.05 OUTLIER Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.214 -1.554 . . . . 0.92000000000000004 109.214 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -145.16 116.66 8.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.718 -0.872 . . . . 2.1899999999999999 109.95 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 113.89 27.68 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 35' ' ' ILE . 23.8 t -118.41 149.1 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.52000000000000002 109.888 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HD3' HG12 ' A' ' 5' ' ' VAL . 6.1 mmt180 -108.06 127.6 53.93 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.063 -0.718 . . . . 3.21 109.063 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.28 136.01 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.705 -0.622 . . . . 0.46000000000000002 109.49 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 136.48 52.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.5 -0.75 . . . . 1.3899999999999999 110.198 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.97 161.49 42.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.798 -0.564 . . . . 0.81999999999999995 109.585 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -82.14 148.6 28.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 1.1200000000000001 109.757 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.32 66.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.685 -0.635 . . . . 0.46999999999999997 109.856 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.51 -22.83 43.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.96999999999999997 109.706 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 150.16 49.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.59 -0.694 . . . . 0.76000000000000001 109.458 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.59 167.97 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.69999999999999996 110.383 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 96.9 t -60.01 -30.79 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.038 -0.727 . . . . 0.46999999999999997 109.038 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.81 -45.53 94.81 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 108.861 -1.695 . . . . 0.42999999999999999 108.861 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t70 -70.68 -36.65 73.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.812 -0.817 . . . . 0.70999999999999996 109.001 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 57' ' ' LEU . 43.5 t80 -63.26 -33.83 76.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.803 -0.561 . . . . 0.5 109.748 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 44' ' ' LEU . 10.1 mttt -78.7 -39.23 37.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 1.79 110.318 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 9.1 pttt -65.16 -28.01 69.11 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.438 -0.789 . . . . 1.3799999999999999 109.639 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 88.2 t -79.35 -39.87 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.605 -0.887 . . . . 0.41999999999999998 108.605 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.14 -42.5 80.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.742 -0.599 . . . . 0.63 109.713 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -52.95 -25.85 13.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.868 -0.52 . . . . 0.41999999999999998 111.158 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.7 mm? -71.67 -35.56 70.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.942 . . . . 0.65000000000000002 109.878 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.4 -52.51 6.82 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 0.68000000000000005 110.3 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 14' ' ' VAL . 14.3 pt -76.48 -20.15 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.476 -0.765 . . . . 0.52000000000000002 110.848 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.11 47.18 87.84 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.429 -1.868 . . . . 0.45000000000000001 108.429 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 35' ' ' ILE . 7.8 m -115.91 -14.09 11.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.944 -0.739 . . . . 0.47999999999999998 110.738 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 29.1 mm-40 70.81 150.86 0.13 Allowed Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.541 -0.724 . . . . 1.25 109.691 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.98 63.4 6.79 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.668 2.246 . . . . 0.89000000000000001 110.013 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -152.31 -45.75 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.434 -0.58 . . . . 1.6200000000000001 109.434 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.48 15.67 28.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.651 -0.656 . . . . 2.52 110.062 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 70' ' ' LEU . 82.7 mt -98.96 130.38 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.289 -0.882 . . . . 0.46999999999999997 109.679 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 59.5 t -125.29 104.29 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.391 -0.966 . . . . 0.5 108.391 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.9 mt -99.11 139.06 35.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.45000000000000001 110.042 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 3.0 mt-30 -130.7 128.75 41.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.73 -0.606 . . . . 1.22 109.605 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.47 99.48 11.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.577 -0.702 . . . . 1.6599999999999999 109.774 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.07 -86.84 0.38 Allowed Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.962 -1.255 . . . . 0.89000000000000001 109.962 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.13 46.0 0.99 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.577 -1.409 . . . . 0.83999999999999997 109.577 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -151.81 139.03 19.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.741 -0.858 . . . . 0.63 109.749 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -80.55 131.69 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.548 -0.72 . . . . 0.75 109.276 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 46' ' ' LYS . 53.4 mt -87.16 120.8 28.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.598 -0.689 . . . . 0.54000000000000004 109.513 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 143.23 33.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 1.3100000000000001 109.772 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 12.8 m-20 -62.72 -23.0 66.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.809 -0.557 . . . . 0.70999999999999996 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -74.23 -12.01 60.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 110.898 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.21 144.02 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.166 -0.959 . . . . 0.58999999999999997 109.668 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -79.48 153.37 29.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.694 -0.629 . . . . 0.63 110.504 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 27' ' ' PHE . 51.3 mt -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.76 -0.588 . . . . 0.47999999999999998 109.57 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -37.84 79.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.843 -0.536 . . . . 2.2400000000000002 109.736 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.38 -43.32 97.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.696 -0.628 . . . . 0.69999999999999996 109.423 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.99 -18.45 62.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.603 . . . . 0.59999999999999998 110.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 71.93 64.84 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.617 0.722 . . . . 1.47 109.529 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 57' ' ' LEU . 62.4 t -90.62 124.11 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.878 -0.786 . . . . 0.55000000000000004 108.878 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.58 162.24 13.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.716 -0.615 . . . . 1.3300000000000001 110.163 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 4.8 p-10 -70.34 145.18 51.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.91000000000000003 109.358 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 59.34 35.19 23.13 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.741 -0.6 . . . . 0.92000000000000004 109.668 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 4' ' ' VAL . 8.4 t -94.18 163.61 13.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.803 . . . . 0.41999999999999998 109.746 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.68 130.46 45.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.722 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.01 158.86 31.13 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.163 0.506 . . . . 0.87 109.702 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.8 mp0 -105.36 152.78 22.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.559 -0.713 . . . . 1.22 109.614 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 42' ' ' ILE . 53.9 tp -134.59 133.55 40.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.46000000000000002 109.35 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 87.3 m-85 -137.04 148.22 46.66 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 1.04 109.441 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -100.48 110.52 22.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.576 -0.703 . . . . 1.27 109.503 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.846 -1.073 . . . . 1.3600000000000001 109.595 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.139 0.495 . . . . 1.04 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.6 pt -118.49 162.33 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.715 -0.616 . . . . 0.39000000000000001 109.813 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.0 106.01 14.56 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.999 -0.741 . . . . 0.87 108.999 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 66' ' ' THR . 21.3 m -100.4 157.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.632 -0.668 . . . . 0.34000000000000002 110.127 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG13 ' HE2' ' A' ' 13' ' ' LYS . 23.3 t -104.41 138.6 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.613 -0.679 . . . . 0.5 109.203 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -129.17 115.25 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.523 -0.736 . . . . 0.54000000000000004 109.256 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.63 143.54 46.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.526 -0.734 . . . . 0.72999999999999998 109.756 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -76.67 -11.47 59.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.588 -0.695 . . . . 1.03 110.545 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.4 19.81 7.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.478 -0.764 . . . . 1.1799999999999999 110.474 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.06 -57.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.69 -0.856 . . . . 1.1200000000000001 108.69 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.79 47.22 0.15 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.501 -1.44 . . . . 0.68999999999999995 109.501 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -157.57 137.78 12.66 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.635 -0.921 . . . . 2.5499999999999998 109.985 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.614 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -140.21 117.48 11.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.557 -0.714 . . . . 1.6200000000000001 109.805 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.81 144.34 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 0.59999999999999998 109.512 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 140.69 44.91 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.903 -0.777 . . . . 1.0600000000000001 108.903 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.94 141.98 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.788 . . . . 0.48999999999999999 109.793 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -108.65 145.17 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 2.1299999999999999 109.92 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 158.17 20.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.628 . . . . 0.92000000000000004 109.41 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -80.29 145.83 31.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.49 -0.756 . . . . 1.1200000000000001 109.336 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -22.2 66.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.786 . . . . 0.46000000000000002 109.551 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 12.4 pt-20 -83.64 -19.07 36.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.495 -0.753 . . . . 2.2400000000000002 110.025 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 154.38 28.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.416 -0.802 . . . . 0.68999999999999995 109.712 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 86.4 p -82.87 160.57 22.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.507 -0.746 . . . . 0.48999999999999999 110.218 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 79.2 t -60.28 -35.94 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.679 -0.86 . . . . 0.48999999999999999 108.679 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.05 -45.92 91.96 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.1 -1.6 . . . . 0.34000000000000002 109.1 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.13 -39.25 89.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.786 -0.832 . . . . 1.03 109.007 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' LEU . 77.2 t80 -60.95 -41.92 97.25 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.362 -0.607 . . . . 0.63 109.362 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 44' ' ' LEU . 26.4 mttt -70.51 -29.15 65.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.789 -0.569 . . . . 0.95999999999999996 109.838 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -69.54 -41.69 75.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.602 -0.686 . . . . 1.6899999999999999 109.823 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.5 t -71.9 -39.36 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.56 -0.713 . . . . 0.39000000000000001 109.355 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.3 tp -69.5 -46.35 66.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.643 -0.661 . . . . 0.56000000000000005 109.571 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.454 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 89.9 p -58.28 -25.19 61.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.84 -0.538 . . . . 0.39000000000000001 110.794 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 mt -67.64 -35.82 79.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.385 -0.822 . . . . 0.87 109.902 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -81.54 -48.07 12.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 110.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 42' ' ' ILE . 20.8 pt -75.17 -23.4 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.471 -0.768 . . . . 0.53000000000000003 110.813 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.59 90.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 108.211 -1.956 . . . . 0.47999999999999998 108.211 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 72' ' ' TYR . 2.6 m -122.64 9.66 9.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.086 -0.655 . . . . 0.38 110.27 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 15.2 mt-30 65.35 154.09 0.12 Allowed Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.488 -0.758 . . . . 1.95 110.272 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 -11.41 17.41 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.777 2.318 . . . . 0.58999999999999997 111.069 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.02 -3.43 24.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.383 -0.823 . . . . 1.3200000000000001 110.561 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -115.77 22.66 12.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.149 -0.97 . . . . 2.5299999999999998 110.174 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.73 HG21 HD11 ' A' ' 35' ' ' ILE . 14.1 pt -130.25 136.22 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.47999999999999998 110.06 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.4 t -112.46 112.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.32 -0.993 . . . . 0.41999999999999998 108.32 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 28' ' ' LYS . 8.0 mt -99.83 132.82 44.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.669 -0.644 . . . . 0.44 110.086 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' SER . 3.8 mt-30 -125.2 121.52 34.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 1.27 109.459 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -97.25 93.18 6.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.522 -0.736 . . . . 1.1200000000000001 109.638 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.34 48.03 78.4 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.187 -1.165 . . . . 0.62 110.187 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.73 44.75 30.69 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.883 -1.287 . . . . 0.63 109.883 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 6.7 t -140.93 123.73 16.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.549 -0.971 . . . . 0.76000000000000001 108.77 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' VAL . 28.3 m -78.08 122.82 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 109.866 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.52 HD11 HD21 ' A' ' 68' ' ' LEU . 19.1 mt -95.09 125.6 39.85 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.14 -0.689 . . . . 0.47999999999999998 109.14 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -106.47 143.08 35.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.21 109.638 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -59.01 -28.32 66.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.851 -0.531 . . . . 0.69999999999999996 110.132 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -66.34 -23.36 66.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.608 -0.683 . . . . 1.9099999999999999 110.761 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 59' ' ' ASP . 3.7 mp -102.22 154.21 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.392 -0.817 . . . . 0.65000000000000002 109.631 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.9 OUTLIER -90.53 157.18 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.644 -0.66 . . . . 0.75 110.324 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 27' ' ' PHE . 30.0 mt -60.59 -38.85 86.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.595 . . . . 0.59999999999999998 109.481 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.33 -34.12 71.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.804 -0.56 . . . . 0.77000000000000002 109.862 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 8.6 t70 -64.3 -44.93 90.11 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.173 -0.677 . . . . 1.1599999999999999 109.173 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HD13 ' A' ' 55' ' ' ILE . 54.8 m-85 -73.79 -16.88 61.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.52000000000000002 109.897 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.3 68.5 0.14 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.655 0.74 . . . . 0.83999999999999997 109.274 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG22 ' HD3' ' A' ' 46' ' ' LYS . 92.8 t -90.17 123.57 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.996 -0.742 . . . . 0.5 108.996 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -98.57 162.65 13.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.713 -0.617 . . . . 1.3100000000000001 110.121 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.33 144.01 53.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.59 -0.694 . . . . 0.57999999999999996 109.429 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 60.21 33.63 21.03 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.819 -0.551 . . . . 0.66000000000000003 109.99 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 4' ' ' VAL . 15.1 t -84.53 161.59 20.16 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.416 -0.802 . . . . 0.42999999999999999 109.548 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.33 119.81 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.776 . . . . 0.80000000000000004 109.642 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -116.57 150.05 38.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.313 0.578 . . . . 0.80000000000000004 109.615 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 2.3 mp0 -105.72 142.9 34.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.80000000000000004 109.236 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 6' ' ' VAL . 41.0 tp -120.2 130.84 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.258 -0.645 . . . . 0.41999999999999998 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -136.82 143.59 43.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 37' ' ' THR . 24.6 m-85 -104.85 125.74 51.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.55000000000000004 109.998 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.829 -1.082 . . . . 1.54 109.692 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 16.3 mtt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.09 0.471 . . . . 1.51 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 11.1 pt -121.29 159.42 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.637 -0.665 . . . . 0.48999999999999999 109.92 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 133.76 44.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.977 -0.749 . . . . 0.93000000000000005 108.977 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 66' ' ' THR . 2.4 m -134.13 146.81 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 109.539 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 15' ' ' ARG . 27.5 m -112.96 133.76 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.665 . . . . 0.5 109.568 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 68' ' ' LEU . 24.3 m -114.64 137.69 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 109.625 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.42 111.07 23.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.575 -0.703 . . . . 0.82999999999999996 109.869 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.67 156.27 33.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.845 -0.534 . . . . 0.75 109.997 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -31.65 69.58 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 1.9299999999999999 110.457 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -46.13 83.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.445 -0.784 . . . . 1.73 109.829 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.12 54.2 0.05 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.356 -1.498 . . . . 1.3200000000000001 109.356 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.46 153.16 35.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.846 -0.796 . . . . 3.02 109.108 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.1 pttt -121.31 146.34 46.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.097 -1.002 . . . . 2.6400000000000001 110.353 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.62 144.57 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.345 0.593 . . . . 0.57999999999999996 109.49 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.97 121.89 45.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.752 -0.832 . . . . 2.1200000000000001 108.752 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 4' ' ' VAL . 13.5 p -130.29 140.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.703 -0.623 . . . . 0.44 109.647 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HG2' ' HB3' ' A' ' 1' ' ' MET . 7.7 tttt -108.82 125.55 52.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.73 . . . . 1.3100000000000001 109.569 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -151.91 154.56 36.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.76 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.02 150.11 32.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.63 -0.669 . . . . 0.73999999999999999 109.303 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -19.56 65.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.41999999999999998 110.108 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.97 -16.12 57.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.417 -0.802 . . . . 0.71999999999999997 110.132 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.83 147.26 51.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.48 -0.763 . . . . 0.51000000000000001 110.014 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 85.9 p -78.22 164.84 24.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.675 -0.641 . . . . 0.40999999999999998 110.042 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 51' ' ' LEU . 70.4 t -61.57 -36.4 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.582 -0.699 . . . . 0.41999999999999998 109.134 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.45 93.31 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 108.994 -1.642 . . . . 0.32000000000000001 108.994 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.88 -40.84 95.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.844 -0.798 . . . . 0.90000000000000002 108.937 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 4' ' ' VAL . 56.1 t80 -59.46 -41.5 89.85 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.539 -0.541 . . . . 0.46000000000000002 109.539 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -71.01 -33.94 70.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.633 . . . . 0.67000000000000004 109.766 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -64.23 -43.71 94.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.622 -0.674 . . . . 1.3700000000000001 109.936 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.77 -41.78 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.34999999999999998 109.165 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.92 -39.92 87.5 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 0.46999999999999997 109.545 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -62.98 -32.21 73.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.872 -0.517 . . . . 0.37 110.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.4 -0.813 . . . . 0.79000000000000004 110.015 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -82.51 -46.75 13.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.72999999999999998 110.87 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.0 pt -100.24 -38.29 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.366 -0.834 . . . . 0.47999999999999998 110.9 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.97 54.81 1.09 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.555 -1.418 . . . . 0.37 109.555 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -112.6 -23.86 10.0 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.747 -0.855 . . . . 0.41999999999999998 110.277 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' THR . 12.2 mm-40 71.5 153.55 0.15 Allowed Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 109.24 -0.652 . . . . 1.6000000000000001 109.24 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.14 76.58 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.196 1.931 . . . . 0.5 109.634 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -173.9 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.469 -0.567 . . . . 1.01 109.469 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -5.86 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 2.9500000000000002 110.417 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' A' ' 70' ' ' LEU . 2.2 pt -105.64 119.78 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.177 -0.952 . . . . 0.46000000000000002 110.198 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.24 115.8 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.956 -1.127 . . . . 0.42999999999999999 107.956 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' A' ' 27' ' ' PHE . 7.4 mt -97.66 134.11 41.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.425 -0.797 . . . . 0.56000000000000005 109.589 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 23.8 mt-30 -132.22 131.12 41.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.633 -0.667 . . . . 0.77000000000000002 109.623 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -67.1 0.81 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.704 -0.623 . . . . 1.24 109.604 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.95 71.56 0.38 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.489 -1.444 . . . . 0.73999999999999999 109.489 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.93 28.05 51.44 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.645 -1.382 . . . . 0.84999999999999998 109.645 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.32 133.92 14.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.55 -0.971 . . . . 1.05 109.218 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HE2' ' A' ' 52' ' ' LYS . 27.8 m -79.48 152.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.643 -0.66 . . . . 0.51000000000000001 109.947 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 60' ' ' TYR . 13.5 mt -100.79 133.35 45.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.676 -0.64 . . . . 0.45000000000000001 109.291 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HE2' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.05 152.97 28.87 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.626 -0.671 . . . . 0.89000000000000001 110.184 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.35 -28.56 68.26 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.694 -0.628 . . . . 0.56000000000000005 109.972 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -62.54 -13.42 30.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.599 -0.688 . . . . 1.8899999999999999 110.58 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 4.5 mp -117.83 143.95 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.269 -0.894 . . . . 0.47999999999999998 109.588 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -88.39 159.52 17.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.62 110.141 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 62' ' ' VAL . 35.5 mt -60.92 -31.91 71.41 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.751 -0.593 . . . . 0.51000000000000001 109.8 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.57 -36.14 82.81 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.609 -0.682 . . . . 1.05 109.615 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.2 m-20 -66.93 -42.89 84.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.705 -0.622 . . . . 0.66000000000000003 109.342 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' HD22 ' A' ' 51' ' ' LEU . 33.4 m-85 -71.54 -16.5 62.32 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.829 -0.545 . . . . 0.54000000000000004 110.12 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.33 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.577 0.704 . . . . 2.3300000000000001 109.869 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 57' ' ' LEU . 61.9 t -94.78 115.02 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.671 -0.862 . . . . 0.56999999999999995 108.671 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -99.79 171.59 7.78 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.645 -0.659 . . . . 1.47 110.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 t70 -70.01 138.63 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.668 . . . . 0.63 109.817 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.54 33.28 13.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.88 -0.512 . . . . 0.89000000000000001 110.223 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.922 HG22 HG12 ' A' ' 4' ' ' VAL . 7.6 t -90.34 161.61 15.53 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.42999999999999999 109.591 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.33 127.68 47.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.52 110.233 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 6' ' ' VAL . 1.2 mm? -116.3 149.93 38.46 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.361 -0.607 . . . . 0.56000000000000005 109.361 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -99.28 136.79 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.423 -0.798 . . . . 0.52000000000000002 109.484 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 42' ' ' ILE . 45.2 tp -125.33 116.85 22.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.618 -0.676 . . . . 0.41999999999999998 109.247 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.65 160.48 17.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.699 -0.626 . . . . 0.98999999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.75 113.55 26.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.985 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.436 -0.792 . . . . 1.3100000000000001 109.579 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.174 0.512 . . . . 1.71 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 5.9 pt -121.19 160.6 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.51000000000000001 110.069 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.97 136.15 39.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.08 -0.711 . . . . 0.72999999999999998 109.08 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 68' ' ' LEU . 3.2 t -128.38 157.27 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.41999999999999998 109.921 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 110.55 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.89000000000000001 108.678 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 70' ' ' LEU . 2.1 t -103.53 126.19 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.709 -0.619 . . . . 0.56999999999999995 109.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.13 126.66 55.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.633 . . . . 1.05 109.534 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.08 152.01 33.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.788 -0.57 . . . . 0.66000000000000003 110.173 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -63.87 -36.93 85.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.771 -0.581 . . . . 2.0499999999999998 109.85 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -47.38 78.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.506 -0.746 . . . . 1.6899999999999999 109.046 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.55 69.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.319 -1.512 . . . . 0.75 109.319 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -147.97 109.64 4.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.723 -0.869 . . . . 1.6100000000000001 109.682 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 125.68 43.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 1.1799999999999999 109.708 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 35' ' ' ILE . 9.2 t -124.85 143.09 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.643 -0.66 . . . . 0.80000000000000004 109.688 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -108.48 137.59 46.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.635 -0.665 . . . . 1.23 109.21 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.465 HG23 HG12 ' A' ' 30' ' ' VAL . 10.3 p -144.26 140.11 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.58 -0.7 . . . . 0.56000000000000005 110.162 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -108.12 125.93 52.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.715 . . . . 1.21 109.62 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 p -159.34 155.21 26.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.72999999999999998 109.629 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -74.37 146.98 42.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.1000000000000001 109.664 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -17.8 65.04 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.658 -0.651 . . . . 0.68999999999999995 110.103 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.59 -15.74 58.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 110.005 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.19 154.61 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.472 -0.768 . . . . 0.62 109.869 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 69.0 p -80.64 166.67 20.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.5 110.177 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.637 HG12 ' HD2' ' A' ' 28' ' ' LYS . 97.1 t -62.14 -34.77 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.95 -0.759 . . . . 0.42999999999999999 108.95 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.73 -42.21 99.32 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.827 -1.709 . . . . 0.40000000000000002 108.827 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.61 -36.07 82.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.816 . . . . 1.73 109.015 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HE2' HG21 ' A' ' 4' ' ' VAL . 26.0 t80 -62.86 -46.1 89.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.393 -0.595 . . . . 0.48999999999999999 109.393 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HD2' HG12 ' A' ' 24' ' ' VAL . 8.3 mtpt -67.79 -28.42 67.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.688 -0.633 . . . . 1.24 110.052 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -69.36 -49.96 50.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 2.77 109.563 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.465 HG12 HG23 ' A' ' 16' ' ' VAL . 39.3 t -65.64 -39.08 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.605 -0.887 . . . . 0.35999999999999999 108.605 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 35' ' ' ILE . 14.9 tp -65.5 -40.05 92.6 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.498 -0.556 . . . . 0.72999999999999998 109.498 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 t -54.67 -27.56 40.96 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.779 -0.576 . . . . 0.68999999999999995 110.735 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.8 mm? -70.71 -33.85 71.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.83999999999999997 109.897 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.59 -47.11 12.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.536 -0.728 . . . . 0.82999999999999996 110.673 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 14' ' ' VAL . 16.7 pt -85.74 -26.22 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -0.804 . . . . 0.55000000000000004 111.209 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.97 45.16 75.01 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.238 -1.945 . . . . 0.58999999999999997 108.238 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 41' ' ' LYS . 10.2 m -112.93 -5.12 13.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.018 -0.695 . . . . 0.56000000000000005 110.696 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.69 156.32 0.13 Allowed Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.546 -0.721 . . . . 1.3999999999999999 109.987 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.47 -11.0 24.33 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.592 2.195 . . . . 1.01 111.192 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.42 -18.42 28.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.449 -0.782 . . . . 1.8999999999999999 110.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.722 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.7 OUTLIER -116.21 10.61 14.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.155 -0.965 . . . . 2.2000000000000002 111.183 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 70' ' ' LEU . 88.5 mt -106.28 129.82 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.948 -1.095 . . . . 0.53000000000000003 109.446 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.76 113.89 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.477 -0.934 . . . . 0.48999999999999999 108.477 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -98.24 143.72 28.44 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.35 -0.844 . . . . 0.78000000000000003 110.002 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 1.1 mt-30 -132.25 135.39 46.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.671 -0.643 . . . . 1.03 109.45 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 1.4 mmtt -86.0 -67.94 0.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.94999999999999996 109.459 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 72.58 0.3 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.929 -1.669 . . . . 0.90000000000000002 108.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.27 31.56 37.72 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.208 -1.557 . . . . 1.1000000000000001 109.208 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.8 p -155.27 135.41 13.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.911 . . . . 0.68000000000000005 109.449 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.13 140.56 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.593 -0.692 . . . . 0.56999999999999995 110.017 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 44' ' ' LEU . 21.7 mt -89.05 148.48 23.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.677 -0.86 . . . . 0.55000000000000004 108.677 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -127.77 150.14 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.509 -0.744 . . . . 3.0899999999999999 110.281 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.8 -26.41 68.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.575 -0.528 . . . . 0.84999999999999998 109.575 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.8 -13.29 42.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 2.25 110.001 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.49 142.75 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.376 -0.827 . . . . 0.66000000000000003 109.655 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -83.25 155.83 23.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.696 -0.628 . . . . 0.68000000000000005 109.919 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.11 -32.03 71.72 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 0.53000000000000003 109.573 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.36 -36.01 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.681 -0.637 . . . . 1.77 109.571 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -66.05 -44.21 85.22 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.296 -0.631 . . . . 0.79000000000000004 109.296 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 51' ' ' LEU . 24.4 m-85 -71.66 -16.19 62.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.697 -0.627 . . . . 0.59999999999999998 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER 83.04 71.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.74 0.781 . . . . 1.45 109.451 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 66' ' ' THR . 72.3 t -113.02 104.29 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.361 -0.978 . . . . 0.56000000000000005 108.361 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -104.85 -179.67 4.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.678 -0.639 . . . . 1.6200000000000001 110.483 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 3.6 t70 -65.75 137.9 57.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.643 -0.66 . . . . 0.59999999999999998 109.763 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.63 36.36 13.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.213 0.53 . . . . 1.0 110.113 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 62' ' ' VAL . 13.7 t -92.48 147.44 22.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.325 -0.859 . . . . 0.47999999999999998 109.362 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.79 137.35 36.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.87 110.096 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD12 HG11 ' A' ' 4' ' ' VAL . 3.7 mt -131.84 163.66 27.79 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.26 0.552 . . . . 0.60999999999999999 109.657 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -101.84 142.81 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 109.57 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.693 ' HB2' HG12 ' A' ' 6' ' ' VAL . 38.0 tp -118.03 144.22 45.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.635 -0.665 . . . . 0.46000000000000002 109.7 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.422 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -144.19 145.05 31.84 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.21 -0.663 . . . . 0.78000000000000003 109.21 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.0 m-85 -102.56 105.62 16.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 0.58999999999999997 109.788 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.845 -1.074 . . . . 1.3500000000000001 109.537 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.164 0.507 . . . . 1.45 110.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.0 pt -124.84 163.27 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.736 -0.603 . . . . 0.48999999999999999 109.829 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -112.87 121.41 44.6 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.051 -0.722 . . . . 0.90000000000000002 109.051 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 66' ' ' THR . 28.8 m -115.17 151.88 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.541 -0.724 . . . . 0.37 110.15 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.47 120.28 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.842 -0.799 . . . . 0.55000000000000004 108.842 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 70' ' ' LEU . 39.1 t -109.35 124.91 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.72999999999999998 109.36 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.449 ' HB3' ' HG3' ' A' ' 13' ' ' LYS . 2.3 p30 -129.36 128.52 43.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.471 -0.768 . . . . 0.73999999999999999 110.039 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.45 147.64 39.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.636 -0.665 . . . . 0.52000000000000002 110.058 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -34.22 77.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.747 -0.596 . . . . 3.2599999999999998 110.302 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -49.21 77.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 1.3300000000000001 109.723 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.28 72.89 0.01 OUTLIER Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.231 -1.548 . . . . 0.73999999999999999 109.231 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.9 ' HE3' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -152.22 151.0 30.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.746 -0.855 . . . . 2.1499999999999999 109.865 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG3' ' HB3' ' A' ' 7' ' ' ASN . 3.0 tttp -150.29 123.89 9.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.401 -0.812 . . . . 2.2999999999999998 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.49 159.53 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.747 -0.596 . . . . 0.68999999999999995 109.649 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -118.38 134.64 54.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 3.1000000000000001 109.1 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 4' ' ' VAL . 8.3 p -138.2 138.37 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.836 -0.801 . . . . 0.59999999999999998 108.836 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 140.94 40.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.497 -0.752 . . . . 2.3700000000000001 110.218 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.96 165.75 35.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.774 -0.579 . . . . 0.68000000000000005 109.764 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.39 144.7 26.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.318 -0.864 . . . . 0.91000000000000003 109.195 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -23.6 67.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.447 -0.783 . . . . 0.41999999999999998 109.776 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.22 -19.76 35.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.462 -0.774 . . . . 0.76000000000000001 110.056 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.58 152.79 41.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 109.974 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 79.7 p -82.51 162.58 21.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.579 -0.7 . . . . 0.47999999999999998 110.284 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HE3' ' A' ' 28' ' ' LYS . 89.4 t -62.05 -33.06 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.073 -0.714 . . . . 0.48999999999999999 109.073 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.38 86.8 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 108.962 -1.655 . . . . 0.40999999999999998 108.962 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.42 -37.59 83.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.814 -0.815 . . . . 0.97999999999999998 108.882 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HB2' HD11 ' A' ' 57' ' ' LEU . 22.1 t80 -59.85 -40.89 90.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.356 -0.609 . . . . 0.5 109.356 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HE3' HG12 ' A' ' 24' ' ' VAL . 15.7 mttt -72.6 -31.88 65.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 1.6200000000000001 109.488 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HG2' ' HG3' ' A' ' 39' ' ' PRO . 23.1 mttt -63.12 -44.93 94.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.681 . . . . 1.1899999999999999 109.338 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 33' ' ' LEU . 26.5 t -67.18 -36.86 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.027 -0.731 . . . . 0.46000000000000002 109.027 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -66.8 -42.91 85.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 0.63 109.333 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -49.52 -23.31 1.55 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.35999999999999999 111.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.6 mt -69.91 -45.37 67.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.966 -1.084 . . . . 0.91000000000000003 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -82.94 -32.23 27.29 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.433 -0.792 . . . . 0.58999999999999997 111.664 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.9 HG22 ' HE3' ' A' ' 12' ' ' LYS . 10.1 pt -96.03 -31.58 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 121.055 -1.028 . . . . 0.51000000000000001 110.863 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 44.26 49.49 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.42 -1.872 . . . . 0.54000000000000004 108.42 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 9.4 m -113.25 -6.7 13.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.928 -0.748 . . . . 0.47999999999999998 110.719 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.7 mt-30 67.85 150.15 0.12 Allowed Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.603 -0.686 . . . . 1.97 110.614 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 34.1 Cg_endo -75.75 61.82 6.32 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.747 2.298 . . . . 0.79000000000000004 109.84 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.82 -42.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.339 -0.615 . . . . 1.6799999999999999 109.339 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -98.95 12.96 34.34 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.629 -0.67 . . . . 1.1499999999999999 110.126 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.61 HG23 HD11 ' A' ' 70' ' ' LEU . 71.6 mt -98.56 128.79 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 0.46000000000000002 109.604 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.28 109.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.43 -0.952 . . . . 0.57999999999999996 108.43 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 27' ' ' PHE . 4.3 mt -98.52 137.34 37.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.288 -0.883 . . . . 0.65000000000000002 110.003 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.1 mt-30 -122.11 119.89 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.741 -0.599 . . . . 1.6200000000000001 109.419 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -107.15 90.08 3.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 109.513 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.76 50.5 60.96 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.1 -1.2 . . . . 1.0700000000000001 110.1 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.9 43.62 40.66 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.924 -1.27 . . . . 0.97999999999999998 109.924 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -144.51 122.01 11.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.645 -0.915 . . . . 1.1499999999999999 109.095 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.99 128.99 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.525 -0.734 . . . . 0.88 109.599 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 68' ' ' LEU . 21.5 mt -96.03 117.69 31.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 147.42 30.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.7 -0.625 . . . . 1.3400000000000001 109.834 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.8 -27.6 63.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.897 -0.502 . . . . 0.65000000000000002 110.368 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.96 -18.25 65.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.56 -0.712 . . . . 0.92000000000000004 110.608 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.459 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -109.66 148.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.381 -0.824 . . . . 0.53000000000000003 109.385 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 77.9 p -87.04 157.5 19.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.59 -0.693 . . . . 0.56000000000000005 110.496 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 27' ' ' PHE . 22.5 mt -61.29 -38.42 86.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.742 -0.598 . . . . 0.66000000000000003 109.514 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -58.11 -34.03 69.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.767 -0.583 . . . . 0.95999999999999996 109.779 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.96 -45.43 89.16 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.225 -0.657 . . . . 1.3100000000000001 109.225 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 55' ' ' ILE . 64.2 m-85 -74.71 -16.81 60.73 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.806 -0.559 . . . . 0.44 109.868 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 72.37 76.29 0.16 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.5 0.667 . . . . 1.78 109.751 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.42 143.5 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.161 -0.681 . . . . 0.40999999999999998 109.161 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -125.37 165.93 17.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.437 -0.79 . . . . 1.1299999999999999 110.39 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.55 141.94 53.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.751 -0.593 . . . . 0.78000000000000003 109.631 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 58.6 38.18 25.27 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.264 0.554 . . . . 0.81999999999999995 109.808 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.757 HG22 HG12 ' A' ' 4' ' ' VAL . 13.0 t -88.79 154.82 19.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.413 -0.804 . . . . 0.46999999999999997 109.62 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 119.26 36.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 1.6000000000000001 109.302 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.63 158.57 22.52 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.338 0.589 . . . . 0.83999999999999997 110.018 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.59 145.18 35.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 2.3799999999999999 109.884 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' A' ' 6' ' ' VAL . 21.8 tp -114.27 140.85 48.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.47999999999999998 109.757 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.35 150.52 36.75 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.126 -0.694 . . . . 0.93000000000000005 109.126 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.48 134.28 50.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.407 -0.808 . . . . 1.01 109.865 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.461 -0.78 . . . . 1.3999999999999999 109.655 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.158 0.504 . . . . 2.0600000000000001 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 28.4 pt -124.87 162.62 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.665 -0.647 . . . . 0.38 109.56 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.77 111.59 21.48 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.9 -0.778 . . . . 1.02 108.9 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 66' ' ' THR . 33.3 m -112.82 157.78 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.646 -0.659 . . . . 0.34999999999999998 109.916 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.57 144.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.46000000000000002 109.58 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 26.7 m -122.12 135.16 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.563 -0.711 . . . . 0.51000000000000001 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -113.58 137.2 51.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.60999999999999999 109.242 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 12' ' ' LYS . 1.1 m-20 -82.49 -60.27 2.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.544 -0.722 . . . . 1.03 110.125 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.26 -64.46 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.557 -0.715 . . . . 1.3500000000000001 109.855 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 130.07 22.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.643 -0.66 . . . . 1.6399999999999999 109.462 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.58 39.36 96.36 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.003 -1.239 . . . . 0.87 110.003 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -145.62 113.25 6.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.608 -0.936 . . . . 2.23 109.903 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 117.78 8.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.642 -0.661 . . . . 1.78 109.732 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 t -116.11 146.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.652 -0.655 . . . . 0.52000000000000002 109.555 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.9 141.58 37.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.537 -0.727 . . . . 1.97 109.263 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 31' ' ' LEU . 5.3 p -150.94 134.92 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.765 . . . . 0.52000000000000002 109.682 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -102.41 147.67 26.44 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.789 . . . . 2.1600000000000001 110.214 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 p -164.75 157.05 16.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.642 -0.661 . . . . 0.5 109.666 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -88.67 148.71 23.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.405 -0.809 . . . . 0.65000000000000002 109.343 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.68 -24.28 67.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.546 -0.721 . . . . 0.47999999999999998 109.931 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.6 -21.49 41.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.497 -0.752 . . . . 0.79000000000000004 109.725 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.6 150.52 46.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 109.496 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 81.2 p -88.87 173.29 8.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.532 -0.73 . . . . 0.51000000000000001 110.434 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 57.9 t -62.2 -27.36 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.9 -47.1 92.27 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.55 -1.82 . . . . 0.40999999999999998 108.55 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.88 -34.62 73.81 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.815 -0.809 . . . . 0.93000000000000005 108.815 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 44' ' ' LEU . 13.2 t80 -60.64 -45.54 93.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.974 -0.75 . . . . 0.48999999999999999 108.974 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HG2' HD12 ' A' ' 44' ' ' LEU . 44.8 mttt -71.6 -28.98 64.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.379 -0.6 . . . . 0.77000000000000002 109.379 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -41.65 95.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.561 -0.712 . . . . 2.98 109.616 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -73.55 -37.66 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.533 -0.729 . . . . 0.45000000000000001 109.406 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -66.9 -45.46 77.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.624 -0.672 . . . . 0.66000000000000003 110.104 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.7 p -55.49 -23.48 26.11 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.768 -0.582 . . . . 0.46999999999999997 110.938 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.1 mm? -74.81 -34.45 62.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.179 -0.95 . . . . 0.78000000000000003 109.912 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.39 -50.86 8.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.517 -0.74 . . . . 0.72999999999999998 110.458 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 HD12 ' OG1' ' A' ' 37' ' ' THR . 8.7 pt -81.4 -24.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 121.567 -0.708 . . . . 0.59999999999999998 110.908 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.61 40.54 77.37 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.739 -1.745 . . . . 0.5 108.739 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.511 ' OG1' HD12 ' A' ' 35' ' ' ILE . 4.0 m -111.37 -5.53 14.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.895 -0.768 . . . . 0.45000000000000001 110.442 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 67.36 156.02 0.14 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.479 -0.763 . . . . 1.3600000000000001 109.968 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.19 -7.76 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.707 2.272 . . . . 0.76000000000000001 111.534 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.05 -29.5 20.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 1.0800000000000001 109.929 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -106.35 8.97 31.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 2.04 110.918 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 70' ' ' LEU . 47.7 mt -100.33 127.34 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.975 -1.078 . . . . 0.42999999999999999 109.47 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.85 104.09 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.541 -0.911 . . . . 0.46999999999999997 108.541 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.624 HD12 ' HG2' ' A' ' 28' ' ' LYS . 6.5 mt -100.4 141.95 32.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 0.52000000000000002 110.51 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 2.2 pt20 -145.45 158.64 43.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.871 -0.518 . . . . 0.82999999999999996 109.708 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 51' ' ' LEU . 11.4 mttt -98.66 23.69 8.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 1.6399999999999999 109.912 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.71 61.61 1.1 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.675 -1.37 . . . . 1.1299999999999999 109.675 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.35 5.84 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 110.363 -1.095 . . . . 0.96999999999999997 110.363 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.93 122.34 46.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.443 -1.033 . . . . 1.3400000000000001 109.755 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.73 130.98 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.83999999999999997 109.336 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 46' ' ' LYS . 16.0 mt -81.95 123.29 28.74 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.331 -0.618 . . . . 0.60999999999999999 109.331 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -95.14 148.48 22.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.73 -0.606 . . . . 1.8400000000000001 110.349 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 17.7 m-20 -69.39 -21.71 63.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.857 -0.527 . . . . 0.57999999999999996 110.513 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -76.43 -9.02 58.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.416 -0.803 . . . . 1.3100000000000001 110.763 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.26 143.06 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.135 -0.978 . . . . 0.57999999999999996 109.655 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -75.04 151.9 38.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.729 -0.607 . . . . 0.76000000000000001 110.277 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 62' ' ' VAL . 42.7 mt -61.53 -32.01 72.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.588 -0.695 . . . . 0.46000000000000002 109.427 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -37.02 77.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.808 -0.557 . . . . 1.8400000000000001 109.628 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.2 -43.96 97.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.322 -0.622 . . . . 0.68999999999999995 109.322 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -71.82 -16.6 62.17 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.763 -0.586 . . . . 0.72999999999999998 109.908 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 72.48 54.21 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.484 0.659 . . . . 1.1299999999999999 110.043 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.469 HG21 HD22 ' A' ' 57' ' ' LEU . 96.0 t -82.83 117.63 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.311 -0.868 . . . . 0.51000000000000001 109.072 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -95.77 168.31 10.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 1.23 110.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -71.45 142.51 50.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.479 -0.763 . . . . 0.66000000000000003 109.664 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.82 34.17 19.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.731 -0.605 . . . . 0.87 110.112 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 4' ' ' VAL . 13.2 t -90.25 156.01 18.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.331 -0.856 . . . . 0.44 109.5 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.11 122.1 40.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.463 -0.773 . . . . 0.97999999999999998 109.481 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -117.73 165.54 13.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.771 -0.58 . . . . 1.3200000000000001 109.767 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 45' ' ' GLN . 1.0 OUTLIER -104.93 145.78 29.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.052 -0.722 . . . . 1.4299999999999999 109.052 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 42' ' ' ILE . 59.7 tp -129.99 140.93 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.654 -0.654 . . . . 0.40000000000000002 109.636 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -142.18 147.59 36.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.655 . . . . 0.69999999999999996 109.398 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 37' ' ' THR . 27.3 m-85 -101.34 112.3 24.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.411 -0.806 . . . . 0.64000000000000001 109.883 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.899 -1.048 . . . . 1.46 109.467 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.196 0.522 . . . . 1.6100000000000001 109.879 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 2.8 pt -128.06 161.81 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.65000000000000002 109.969 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.75 136.2 43.0 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.167 -0.679 . . . . 0.5 109.167 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 27' ' ' PHE . 3.3 t -124.05 155.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.456 -0.778 . . . . 0.41999999999999998 109.566 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.65 112.48 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.987 -0.745 . . . . 0.46999999999999997 108.987 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 68' ' ' LEU . 26.9 m -99.49 137.04 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.566 -0.709 . . . . 0.40000000000000002 109.822 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.74 125.24 50.62 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.042 -0.725 . . . . 0.63 109.042 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 2.8 m-20 -72.72 -61.74 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.713 . . . . 0.78000000000000003 110.077 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.96 -66.66 0.47 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 1.27 109.587 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.54 109.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.619 -0.676 . . . . 1.5700000000000001 109.297 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.65 -51.59 1.35 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.644 -1.383 . . . . 0.68000000000000005 109.644 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -75.31 123.89 26.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.861 . . . . 2.0299999999999998 109.896 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.7 154.21 41.16 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.649 -0.657 . . . . 1.79 109.753 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' CG2' ' A' ' 35' ' ' ILE . 11.1 t -121.16 145.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.427 -0.796 . . . . 0.5 109.611 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.66 139.09 40.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 0.98999999999999999 109.234 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 30' ' ' VAL . 7.1 p -148.39 132.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.416 -0.802 . . . . 0.57999999999999996 109.537 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 136.96 43.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.532 -0.73 . . . . 1.28 110.406 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 p -158.83 172.32 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.751 -0.593 . . . . 0.69999999999999996 109.595 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -90.54 144.72 25.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 1.28 109.685 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.99 66.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.606 -0.684 . . . . 0.56999999999999995 109.843 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.13 -24.33 47.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.485 -0.759 . . . . 0.84999999999999998 109.636 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.25 155.18 35.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.662 . . . . 0.82999999999999996 109.888 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 88.5 p -88.33 174.47 8.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.61 -0.681 . . . . 0.53000000000000003 110.341 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 49.1 t -63.01 -28.98 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.644 -0.66 . . . . 0.46000000000000002 109.363 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.72 94.99 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.849 -1.7 . . . . 0.34000000000000002 108.849 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.24 -38.17 89.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.822 -0.81 . . . . 0.80000000000000004 108.843 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 4' ' ' VAL . 17.9 t80 -60.81 -45.01 96.08 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.138 -0.69 . . . . 0.54000000000000004 109.138 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HD3' HG13 ' A' ' 42' ' ' ILE . 11.9 mttp -67.97 -32.93 73.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.813 -0.555 . . . . 0.90000000000000002 110.137 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -67.78 -46.3 72.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.619 -0.676 . . . . 1.6499999999999999 110.141 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 16' ' ' VAL . 39.5 t -71.56 -38.7 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.546 -0.721 . . . . 0.47999999999999998 109.671 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -68.45 -49.1 62.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.721 -0.612 . . . . 0.55000000000000004 109.859 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.9 p -57.1 -26.79 61.05 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.74 -0.6 . . . . 0.41999999999999998 111.048 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 mt -66.63 -35.4 80.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.242 -0.911 . . . . 0.71999999999999997 110.125 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.65 -48.62 10.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.70999999999999996 110.435 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD11 HG21 ' A' ' 42' ' ' ILE . 17.9 pt -74.35 -24.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.52 -0.738 . . . . 0.5 110.69 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.71 39.99 76.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.533 -1.827 . . . . 0.46999999999999997 108.533 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.7 m -116.51 4.81 13.29 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.883 -0.775 . . . . 0.35999999999999999 110.243 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' THR . 38.1 mt-30 65.44 154.9 0.12 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.543 -0.723 . . . . 2.2000000000000002 109.892 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.87 -15.77 18.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.598 2.198 . . . . 0.68000000000000005 111.464 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -95.94 -5.89 40.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 1.77 110.964 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -116.03 23.99 11.79 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 1.01 110.151 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 35' ' ' ILE . 16.6 pt -131.02 128.56 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.251 -0.905 . . . . 0.45000000000000001 110.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -107.57 113.59 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.686 -0.857 . . . . 0.52000000000000002 108.686 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.5 144.47 27.8 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.47999999999999998 109.62 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.3 mt-30 -134.92 143.51 46.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.84999999999999998 109.661 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -92.46 -59.0 2.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 1.1499999999999999 109.532 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.93 72.69 0.26 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.255 -1.538 . . . . 0.91000000000000003 109.255 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 25.12 55.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.894 -1.283 . . . . 0.90000000000000002 109.894 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.35 139.03 17.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.967 . . . . 1.02 109.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.75 146.45 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.528 -0.733 . . . . 0.59999999999999998 110.558 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 46' ' ' LYS . 16.4 mt -94.9 139.59 31.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.131 -0.692 . . . . 0.52000000000000002 109.131 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -113.62 147.51 37.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 3.23 110.076 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 p-10 -62.47 -26.66 68.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 0.69999999999999996 110.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -68.71 -11.1 59.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 1.1499999999999999 111.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 52' ' ' LYS . 4.6 mp -110.89 144.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.56000000000000005 109.552 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 86.9 p -76.7 151.51 36.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.605 -0.684 . . . . 1.1299999999999999 110.204 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.55 -34.55 75.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.722 -0.611 . . . . 0.48999999999999999 109.607 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.89 -34.16 76.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.76 -0.588 . . . . 1.3100000000000001 109.517 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.4 -42.1 92.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.601 -0.687 . . . . 1.25 109.188 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.3 m-85 -74.44 -15.91 60.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.836 -0.54 . . . . 0.56999999999999995 110.25 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 82.12 75.52 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.701 0.762 . . . . 1.53 109.106 -179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG12 HD11 ' A' ' 2' ' ' ILE . 57.3 t -119.31 104.76 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.262 -1.014 . . . . 0.48999999999999999 108.262 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.94 -176.44 3.06 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.393 0.616 . . . . 1.28 110.657 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.9 t70 -67.5 137.47 55.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.665 -0.647 . . . . 0.69999999999999996 110.102 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.51 39.4 27.91 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.35 0.595 . . . . 0.73999999999999999 110.147 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.45 ' CG2' HG13 ' A' ' 4' ' ' VAL . 13.5 t -92.0 158.53 16.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.393 -0.817 . . . . 0.46000000000000002 109.315 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.66 142.31 30.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.459 -0.775 . . . . 1.4199999999999999 110.141 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.23 171.08 14.55 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.765 -0.584 . . . . 0.56999999999999995 109.619 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.6 mp0 -115.03 145.43 42.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -0.769 . . . . 0.5 109.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 57.2 tp -132.35 134.39 45.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.637 -0.664 . . . . 0.40999999999999998 109.775 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -137.6 159.37 42.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.202 -0.666 . . . . 1.0600000000000001 109.202 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.603 ' CD1' HG21 ' A' ' 37' ' ' THR . 23.0 m-85 -112.65 115.47 28.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 109.722 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' HE3' ' A' ' 41' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 117.695 -1.145 . . . . 1.3899999999999999 110.133 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.79 -0.448 . . . . 1.5900000000000001 109.79 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 3.1 pt -123.76 162.14 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.611 -0.681 . . . . 0.53000000000000003 110.132 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.5 147.51 26.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.109 -0.7 . . . . 0.65000000000000002 109.109 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 66' ' ' THR . 2.9 t -136.13 155.17 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.4 -0.813 . . . . 0.38 110.065 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.0 114.94 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.334 -0.987 . . . . 0.46999999999999997 108.334 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.81 112.09 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 0.96999999999999997 109.745 -179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -98.09 127.54 44.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.239 -0.652 . . . . 0.68000000000000005 109.239 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -74.69 -63.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.712 -0.618 . . . . 0.83999999999999997 110.307 -179.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.31 -66.63 0.54 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.738 . . . . 1.54 109.746 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.65 114.44 1.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.525 -0.734 . . . . 1.3999999999999999 109.713 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.27 -26.54 23.26 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.38 -1.088 . . . . 1.48 110.38 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.98 121.86 42.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -1.019 . . . . 1.29 109.928 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 149.12 35.37 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.668 -0.645 . . . . 1.8899999999999999 109.944 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.41 144.94 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.545 -0.722 . . . . 0.66000000000000003 109.747 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -100.44 130.24 46.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.862 -0.792 . . . . 0.97999999999999998 108.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 27' ' ' PHE . 9.3 p -141.41 131.67 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.707 -0.621 . . . . 0.53000000000000003 109.754 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 136.07 47.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.545 -0.722 . . . . 2.54 110.112 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.27 165.89 33.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.631 -0.668 . . . . 0.71999999999999997 109.629 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -87.83 146.76 25.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.263 -0.898 . . . . 0.94999999999999996 109.597 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.35 -22.73 67.05 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.606 -0.684 . . . . 0.53000000000000003 110.067 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.12 -21.49 54.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.79000000000000004 109.683 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.57 157.46 36.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.58999999999999997 109.691 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 90.2 p -94.71 175.83 6.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.45000000000000001 110.3 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.9 t -62.28 -29.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.247 -0.649 . . . . 0.38 109.247 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.16 95.37 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.986 -1.646 . . . . 0.34000000000000002 108.986 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.6 m-20 -66.18 -38.1 87.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.82 -0.812 . . . . 0.52000000000000002 108.815 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 16' ' ' VAL . 9.0 t80 -57.71 -43.05 84.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.223 -0.658 . . . . 0.5 109.223 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HB3' HD12 ' A' ' 42' ' ' ILE . 71.9 mttt -69.77 -37.4 76.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.774 -0.579 . . . . 1.0600000000000001 109.76 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -61.48 -46.65 89.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.736 -0.602 . . . . 1.3700000000000001 109.607 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 33' ' ' LEU . 19.5 t -67.12 -37.36 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.992 -0.744 . . . . 0.45000000000000001 108.992 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.33 -41.96 90.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.753 -0.592 . . . . 0.56000000000000005 109.622 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -57.48 -30.54 65.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.935 -0.478 . . . . 0.41999999999999998 110.614 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -67.84 -32.02 72.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 1.1599999999999999 109.656 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -43.17 16.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.646 -0.659 . . . . 0.63 110.91 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 36' ' ' GLY . 24.4 pt -112.51 -45.87 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.29 -0.881 . . . . 0.65000000000000002 111.15 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 103.67 55.54 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.939 -1.264 . . . . 0.55000000000000004 109.939 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.474 ' HB ' ' CG1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -110.66 -20.51 12.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.907 . . . . 0.58999999999999997 109.953 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 3.5 mm100 70.78 156.07 0.16 Allowed Pre-proline 0 N--CA 1.504 2.259 0 O-C-N 121.82 -0.55 . . . . 1.6399999999999999 110.599 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 38' ' ' GLN . 32.8 Cg_endo -75.43 69.32 5.9 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.765 2.31 . . . . 0.96999999999999997 109.861 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.66 -46.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.149 -0.685 . . . . 1.6699999999999999 109.149 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.74 10.5 41.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.501 -0.75 . . . . 1.8300000000000001 110.159 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.584 HG23 HD11 ' A' ' 70' ' ' LEU . 84.1 mt -98.47 132.91 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -0.969 . . . . 0.52000000000000002 109.881 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.67 108.13 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.16 -1.052 . . . . 0.57999999999999996 108.16 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 51' ' ' LEU . 19.2 mt -98.38 135.75 39.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.357 -0.839 . . . . 0.5 110.059 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.3 mt-30 -125.29 143.65 50.86 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.694 -0.628 . . . . 1.25 109.478 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -124.89 85.75 2.46 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.476 -0.765 . . . . 1.1899999999999999 109.685 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.09 51.62 13.61 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.564 -1.014 . . . . 1.01 110.564 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.16 44.13 54.43 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.367 -1.093 . . . . 0.98999999999999999 110.367 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 98.1 p -146.63 132.45 19.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.675 -0.897 . . . . 0.67000000000000004 109.296 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.74 123.34 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.68999999999999995 109.455 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 46' ' ' LYS . 38.6 mt -89.54 126.3 35.54 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.199 -0.667 . . . . 0.52000000000000002 109.199 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.39 146.37 33.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.623 -0.673 . . . . 2.2599999999999998 110.308 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.8 p-10 -61.29 -25.1 66.88 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.903 -0.498 . . . . 0.67000000000000004 110.352 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -70.3 -11.37 60.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.88 110.817 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD13 ' OH ' ' A' ' 60' ' ' TYR . 5.1 mp -110.61 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.224 -0.923 . . . . 0.48999999999999999 109.492 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -76.75 153.37 35.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.737 -0.602 . . . . 0.67000000000000004 110.16 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 HG21 ' A' ' 62' ' ' VAL . 46.8 mt -62.74 -31.84 72.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.763 -0.586 . . . . 0.47999999999999998 109.653 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.9 -34.3 74.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.59 -0.694 . . . . 1.3100000000000001 109.69 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.06 -45.38 85.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.571 -0.705 . . . . 0.69999999999999996 109.2 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 45.6 m-85 -72.48 -16.59 61.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.788 -0.57 . . . . 0.46999999999999997 109.938 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' CE1' ' A' ' 63' ' ' HIS . 2.0 tp10 77.22 68.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.641 0.734 . . . . 1.25 110.139 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 66' ' ' THR . 48.8 t -104.83 113.31 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.325 -0.991 . . . . 0.54000000000000004 108.325 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 61' ' ' GLU . 46.5 m80 -110.75 -178.38 3.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.663 -0.648 . . . . 1.4199999999999999 110.462 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.4 t70 -67.93 138.15 55.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.683 -0.636 . . . . 0.57999999999999996 109.828 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.36 36.98 20.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.882 -0.511 . . . . 0.95999999999999996 110.172 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 62' ' ' VAL . 12.8 t -92.02 159.82 15.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.54000000000000004 109.517 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -98.45 141.65 31.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.427 -0.796 . . . . 0.94999999999999996 110.293 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -141.87 164.27 30.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.433 -0.58 . . . . 0.65000000000000002 109.433 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.3 mp0 -110.71 147.85 33.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.46 -0.775 . . . . 1.0 109.681 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 42' ' ' ILE . 31.9 tp -126.07 129.55 49.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.644 -0.66 . . . . 0.58999999999999997 109.707 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -135.88 151.72 50.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.269 -0.641 . . . . 0.96999999999999997 109.269 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.29 120.47 42.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.443 -0.786 . . . . 0.69999999999999996 109.518 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.117 0 CA-C-O 118.658 -0.687 . . . . 1.3999999999999999 110.049 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.747 -0.464 . . . . 1.6200000000000001 109.747 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.9 pt -123.02 161.97 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.795 -0.566 . . . . 0.40000000000000002 109.835 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.05 113.13 25.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.021 -0.733 . . . . 0.85999999999999999 109.021 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 HG22 ' A' ' 66' ' ' THR . 30.3 m -112.54 154.56 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.509 -0.744 . . . . 0.40999999999999998 110.135 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.5 136.13 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.674 -0.641 . . . . 1.1499999999999999 109.353 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.728 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.1 t -120.18 122.84 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.677 -0.639 . . . . 0.53000000000000003 109.534 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -109.24 139.99 43.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.642 -0.661 . . . . 0.66000000000000003 109.41 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -8.36 59.26 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.596 -0.69 . . . . 1.0700000000000001 111.341 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 64.6 34.66 9.72 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.31 -0.869 . . . . 1.3200000000000001 110.039 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -60.64 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.781 . . . . 1.3799999999999999 108.937 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.61 46.92 0.14 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.561 -1.415 . . . . 1.02 109.561 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -156.05 132.79 10.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.926 . . . . 1.5 109.909 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -134.92 109.88 8.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.105 -0.702 . . . . 1.8300000000000001 109.105 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.74 132.07 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.645 -0.659 . . . . 0.55000000000000004 109.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.08 24.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.91 -0.774 . . . . 1.55 108.91 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 31' ' ' LEU . 8.9 p -153.82 151.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.352 -0.843 . . . . 0.46999999999999997 110.171 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 141.85 44.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.654 -0.654 . . . . 2.9300000000000002 109.942 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 155.68 26.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.59 -0.694 . . . . 0.83999999999999997 109.547 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -79.3 147.04 32.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.828 . . . . 1.1299999999999999 109.326 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.94 -22.97 67.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.45000000000000001 109.852 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 19' ' ' LEU . 4.0 pt-20 -87.54 -15.06 38.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 1.4199999999999999 110.231 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.54 150.69 35.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.349 -0.844 . . . . 0.69999999999999996 109.892 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 84.2 p -78.63 158.64 28.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.705 -0.622 . . . . 0.40999999999999998 110.18 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 65.5 t -61.88 -37.06 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.46999999999999997 108.972 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 53' ' ' ASP . . . -57.95 -41.28 94.22 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.912 -1.675 . . . . 0.40000000000000002 108.912 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -40.09 93.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.813 -0.816 . . . . 1.53 108.903 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.28 -44.12 95.64 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.402 -0.592 . . . . 0.53000000000000003 109.402 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -65.3 -32.85 74.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.58 -0.526 . . . . 1.1699999999999999 109.58 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -67.25 -40.68 86.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 2.8500000000000001 109.742 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.47 -31.86 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.413 -0.804 . . . . 0.38 108.949 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.03 -47.81 34.38 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.644 -0.66 . . . . 0.46999999999999997 109.679 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.8 p -51.26 -27.54 9.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.962 -0.461 . . . . 0.37 111.386 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.12 -38.49 82.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.238 -0.914 . . . . 0.82999999999999996 109.915 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -82.49 -53.64 5.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.608 -0.683 . . . . 0.87 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 31' ' ' LEU . 20.5 pt -73.25 -22.94 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.413 -0.805 . . . . 0.51000000000000001 111.085 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.15 41.79 92.02 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.515 -1.834 . . . . 0.45000000000000001 108.515 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.442 ' OG1' HD12 ' A' ' 35' ' ' ILE . 8.2 m -110.25 -9.13 14.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.988 -0.713 . . . . 0.46999999999999997 110.277 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 149.78 0.13 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.6 -0.687 . . . . 1.1799999999999999 109.943 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.1 71.26 5.75 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.602 2.201 . . . . 0.56999999999999995 109.806 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -167.48 -43.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.722 -0.611 . . . . 1.3 109.524 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.07 14.86 29.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.652 -0.655 . . . . 2.0499999999999998 110.009 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 70' ' ' LEU . 86.5 mt -98.5 123.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.855 . . . . 0.45000000000000001 109.272 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.08 103.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.469 -0.938 . . . . 0.40000000000000002 108.469 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -98.46 148.59 23.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.81999999999999995 109.685 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 12.0 mt-30 -134.99 143.0 46.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.673 -0.642 . . . . 0.67000000000000004 109.824 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.628 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.02 -56.01 4.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.095 -0.706 . . . . 1.96 109.095 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.31 59.19 0.21 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.919 -1.672 . . . . 0.73999999999999999 108.919 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.35 -18.03 18.45 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.94 -1.264 . . . . 0.88 109.94 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.17 142.84 47.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.529 -0.983 . . . . 1.0600000000000001 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.44 151.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.551 -0.718 . . . . 0.53000000000000003 110.252 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 46' ' ' LYS . 11.8 mt -102.39 130.4 49.14 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.902 -0.777 . . . . 0.46999999999999997 108.902 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -104.7 143.89 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.623 -0.673 . . . . 2.1899999999999999 110.231 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 6.4 p-10 -58.76 -31.36 68.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.801 -0.562 . . . . 0.62 110.691 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.9 -22.54 66.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 1.2 110.676 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 59' ' ' ASP . 3.5 mp -105.15 148.69 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.39 -0.819 . . . . 0.70999999999999996 109.325 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -89.59 158.33 17.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.85999999999999999 110.319 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.3 mt -58.69 -39.46 80.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.744 -0.597 . . . . 0.57999999999999996 109.549 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -56.46 -37.48 70.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.789 -0.569 . . . . 0.80000000000000004 109.908 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 12.4 m-20 -65.56 -45.49 83.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.588 -0.695 . . . . 0.75 109.243 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -71.82 -16.79 62.17 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.795 -0.565 . . . . 0.62 110.007 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.15 76.59 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.523 0.677 . . . . 0.94999999999999996 109.283 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.72 139.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 109.273 -0.64 . . . . 0.42999999999999999 109.273 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -115.13 153.91 29.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 1.1000000000000001 109.763 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.78 140.92 56.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.608 -0.683 . . . . 0.64000000000000001 109.389 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.06 34.42 21.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.704 -0.622 . . . . 1.1899999999999999 109.822 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.626 HG22 HG12 ' A' ' 4' ' ' VAL . 13.7 t -88.71 156.17 19.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.378 -0.826 . . . . 0.40999999999999998 109.647 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.62 122.06 41.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 1.03 109.777 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' GLN . 1.3 mt -111.39 160.56 16.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.773 -0.579 . . . . 0.76000000000000001 109.84 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.2 mp0 -105.33 137.78 42.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.02 -0.733 . . . . 0.69999999999999996 109.02 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.745 HD11 HG23 ' A' ' 42' ' ' ILE . 33.9 tp -117.94 132.69 56.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.40000000000000002 109.546 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -142.47 149.09 38.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.121 -0.696 . . . . 1.0900000000000001 109.121 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -104.06 125.16 50.19 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 0.80000000000000004 109.816 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.662 -1.161 . . . . 1.23 110.118 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.304 0.573 . . . . 1.3899999999999999 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.5 pt -114.61 161.98 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.627 -0.67 . . . . 0.44 109.76 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 118.95 38.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 27' ' ' PHE . 33.7 m -121.32 160.78 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.37 109.945 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 15' ' ' ARG . 18.6 m -117.53 127.85 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.577 -0.702 . . . . 0.46000000000000002 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' A' ' 70' ' ' LEU . 3.4 t -112.16 124.85 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.006 -0.739 . . . . 0.40999999999999998 109.006 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -103.9 118.74 37.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.63 -0.669 . . . . 0.51000000000000001 109.759 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' HD23 ' A' ' 70' ' ' LEU . 21.7 t70 -75.53 -57.24 4.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.73 -0.606 . . . . 0.46000000000000002 109.368 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.55 -175.99 3.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.704 -0.623 . . . . 1.29 109.589 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 109.31 3.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 1.71 109.535 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 -38.45 3.25 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.918 -1.273 . . . . 0.80000000000000004 109.918 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.33 128.43 34.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.635 -0.92 . . . . 1.1599999999999999 110.192 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -141.63 133.59 27.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.796 -0.565 . . . . 1.26 109.572 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 35' ' ' ILE . 17.4 t -128.72 148.11 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.656 -0.652 . . . . 0.59999999999999998 109.65 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.492 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -109.16 138.73 45.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.556 -0.715 . . . . 1.8799999999999999 109.635 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.7 132.16 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.638 . . . . 0.34999999999999998 109.758 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 130.21 51.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.556 -0.715 . . . . 1.1499999999999999 110.32 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.29 152.04 33.88 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.558 -0.714 . . . . 0.60999999999999999 109.614 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.55 147.84 31.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.413 -0.805 . . . . 1.05 109.737 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -22.38 66.92 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.634 -0.666 . . . . 0.40000000000000002 109.925 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.42 -21.69 38.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.551 -0.718 . . . . 1.01 109.877 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.29 158.8 30.63 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.487 -0.758 . . . . 0.58999999999999997 109.829 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -93.39 172.47 8.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.579 -0.701 . . . . 0.59999999999999998 110.337 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 79.8 t -61.93 -30.68 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.317 -0.624 . . . . 0.39000000000000001 109.317 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.34 -45.44 95.44 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.977 -1.649 . . . . 0.28000000000000003 108.977 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -66.23 -35.57 80.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.79 -0.83 . . . . 0.66000000000000003 108.902 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' A' ' 4' ' ' VAL . 20.4 t80 -60.87 -42.82 98.63 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.065 -0.717 . . . . 0.44 109.065 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 24' ' ' VAL . 12.1 mttm -71.44 -29.8 65.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.665 . . . . 0.79000000000000004 109.844 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.78 -40.46 88.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.455 -0.778 . . . . 1.49 109.859 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -38.46 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.34999999999999998 109.283 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 35' ' ' ILE . 28.7 tp -67.32 -39.03 85.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.709 -0.619 . . . . 0.54000000000000004 109.856 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -57.45 -24.61 56.69 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.658 -0.651 . . . . 0.33000000000000002 110.736 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.2 -32.84 65.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.175 -0.953 . . . . 0.81999999999999995 109.785 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 -45.77 14.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.56 -0.713 . . . . 0.52000000000000002 110.75 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.0 pt -89.87 -44.06 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.348 -0.845 . . . . 0.55000000000000004 110.697 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.42 59.44 1.09 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.207 -1.157 . . . . 0.42999999999999999 110.207 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.53 3.58 4.22 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.683 -0.893 . . . . 0.39000000000000001 110.39 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.0 OUTLIER 63.67 155.88 0.12 Allowed Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.479 -0.763 . . . . 1.8799999999999999 110.444 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.35 64.32 7.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.68 2.253 . . . . 0.46000000000000002 109.921 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -169.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.63 . . . . 1.4399999999999999 109.49 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.51 8.27 39.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.591 -0.693 . . . . 0.81000000000000005 110.156 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.637 HG23 HD11 ' A' ' 70' ' ' LEU . 96.5 mt -97.59 136.49 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.297 -0.877 . . . . 0.35999999999999999 109.366 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 73' ' ' LEU . 48.9 t -122.58 116.09 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.752 -0.832 . . . . 0.40999999999999998 108.752 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.695 ' HB3' HD12 ' A' ' 51' ' ' LEU . 4.8 mt -98.65 134.25 41.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.85999999999999999 109.865 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -123.06 125.75 45.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.669 -0.645 . . . . 1.02 109.324 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.3 tttp -120.06 98.66 6.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.669 -0.644 . . . . 0.81999999999999995 109.442 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.19 46.97 89.53 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.91 -1.276 . . . . 0.76000000000000001 109.91 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.43 47.25 64.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.866 -1.293 . . . . 0.64000000000000001 109.866 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -145.42 130.28 18.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.658 -0.907 . . . . 1.04 109.235 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.73 119.85 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.49 -0.756 . . . . 0.60999999999999999 109.689 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 44' ' ' LEU . 27.8 mt -85.59 123.84 31.46 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.098 -0.705 . . . . 0.44 109.098 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.39 149.66 25.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.668 -0.645 . . . . 2.1499999999999999 110.037 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.8 p-10 -63.05 -27.75 69.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.855 -0.528 . . . . 0.53000000000000003 110.464 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.13 -14.03 61.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.588 -0.695 . . . . 0.81999999999999995 110.852 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -108.46 142.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.885 . . . . 0.48999999999999999 109.601 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -79.03 152.7 30.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.699 -0.626 . . . . 0.67000000000000004 110.189 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 62' ' ' VAL . 58.6 mt -61.16 -34.99 75.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.675 -0.641 . . . . 0.44 109.47 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.75 -0.594 . . . . 0.82999999999999996 109.652 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.17 -44.85 87.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 109.234 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -70.82 -16.92 62.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.793 -0.567 . . . . 0.55000000000000004 109.919 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.79 64.77 0.09 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.611 0.72 . . . . 2.1499999999999999 109.381 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 57' ' ' LEU . 90.8 t -88.78 116.92 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.783 -0.821 . . . . 0.56999999999999995 108.783 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 164.15 13.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.539 -0.726 . . . . 2.1099999999999999 110.113 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.91 137.7 51.82 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.95999999999999996 109.616 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 62.46 34.19 15.59 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.817 -0.552 . . . . 0.93999999999999995 109.796 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -86.58 157.01 19.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.48 -0.762 . . . . 0.45000000000000001 109.341 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 121.96 40.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.462 -0.774 . . . . 1.0600000000000001 109.633 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.75 163.39 15.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -107.76 139.55 42.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.57999999999999996 109.534 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 42' ' ' ILE . 61.8 tp -112.83 140.0 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.571 -0.706 . . . . 0.40999999999999998 109.814 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 158.19 43.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.176 -0.675 . . . . 0.67000000000000004 109.176 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.77 135.1 49.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.417 -0.802 . . . . 0.79000000000000004 110.176 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.832 -1.08 . . . . 1.23 109.729 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.114 0.483 . . . . 1.6799999999999999 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.2 pt -128.45 159.44 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.644 -0.66 . . . . 0.57999999999999996 110.155 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -101.99 121.39 42.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.06 -0.718 . . . . 0.72999999999999998 109.06 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 66' ' ' THR . 3.1 t -113.53 154.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.586 -0.696 . . . . 0.44 109.919 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.19 127.72 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.905 -0.776 . . . . 0.46999999999999997 108.905 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG12 ' CB ' ' A' ' 68' ' ' LEU . 26.7 m -116.03 135.74 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.45000000000000001 109.733 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -101.37 126.35 48.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.80000000000000004 109.576 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 3.8 m-20 -82.68 173.2 12.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.68 -0.637 . . . . 0.67000000000000004 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 10' ' ' LEU . 1.7 ptp85 -59.49 -35.86 74.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.634 -0.666 . . . . 1.22 110.203 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -82.96 -171.91 3.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.424 -0.798 . . . . 1.6299999999999999 109.623 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.31 65.3 4.03 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.25 -1.14 . . . . 0.81000000000000005 110.25 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -154.53 150.53 27.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.895 . . . . 3.3599999999999999 109.893 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 153.41 50.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.598 -0.689 . . . . 1.1899999999999999 109.921 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.14 139.68 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.56000000000000005 109.757 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -108.32 145.04 35.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.263 -0.643 . . . . 3.1699999999999999 109.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.56 138.19 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.44 109.701 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -98.67 124.26 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.526 -0.734 . . . . 1.0900000000000001 109.364 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -151.21 167.28 28.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.518 -0.738 . . . . 0.76000000000000001 109.606 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.92000000000000004 109.407 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.05 -18.13 65.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.51000000000000001 110.17 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.44 -22.54 41.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.68000000000000005 109.768 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.85 157.59 32.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.563 -0.71 . . . . 0.64000000000000001 109.837 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -89.27 172.27 9.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.592 -0.693 . . . . 0.59999999999999998 110.312 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 51' ' ' LEU . 84.0 t -60.87 -30.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.391 -0.596 . . . . 0.41999999999999998 109.391 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 29' ' ' LYS . . . -60.14 -53.33 46.62 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.857 -1.697 . . . . 0.39000000000000001 108.857 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.59 -37.09 82.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.786 -0.832 . . . . 0.80000000000000004 109.305 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 57' ' ' LEU . 32.5 t80 -60.61 -45.9 92.3 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.419 -0.585 . . . . 0.57999999999999996 109.419 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -69.86 -31.67 69.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.797 -0.564 . . . . 1.05 109.734 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' GLY . 2.4 mttm -64.57 -44.16 91.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 3.0 109.646 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 ' SG ' ' A' ' 18' ' ' CYS . 60.0 t -68.74 -34.11 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.635 -0.666 . . . . 0.40000000000000002 109.333 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 3.6 mt -71.0 -50.54 33.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.68999999999999995 109.644 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 p -52.9 -22.65 5.79 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.594 -0.691 . . . . 0.40000000000000002 111.313 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.66 -42.48 58.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.105 -0.997 . . . . 0.68000000000000005 110.457 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 12.1 pt20 -82.22 -39.95 22.35 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.516 -0.74 . . . . 1.1299999999999999 111.359 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' OG1' ' A' ' 37' ' ' THR . 3.0 pt -87.4 -24.02 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.109 -0.994 . . . . 0.54000000000000004 110.412 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.94 40.02 74.32 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.057 -1.617 . . . . 0.48999999999999999 109.057 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.646 ' OG1' HD12 ' A' ' 35' ' ' ILE . 1.5 m -109.22 -5.39 15.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.955 -0.732 . . . . 0.51000000000000001 110.081 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER 66.96 154.53 0.13 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.576 -0.702 . . . . 1.71 109.859 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.42 -18.97 22.53 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.657 2.238 . . . . 0.73999999999999999 111.062 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -84.07 -19.41 34.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.749 . . . . 1.0600000000000001 110.207 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB3' HG22 ' A' ' 37' ' ' THR . 1.6 tttt -108.34 6.32 26.33 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.359 -0.838 . . . . 1.72 110.532 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 70' ' ' LEU . 65.6 mt -104.26 128.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.101 -1.0 . . . . 0.42999999999999999 109.504 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.96 110.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.169 -0.678 . . . . 0.57999999999999996 109.169 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -99.3 136.91 38.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.603 -0.685 . . . . 0.93999999999999995 109.471 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt-30 -131.0 147.8 52.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.85999999999999999 109.983 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -130.55 105.42 7.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.81999999999999995 109.602 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.31 46.13 93.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.223 -1.151 . . . . 0.83999999999999997 110.223 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.47 43.98 85.19 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.014 -1.235 . . . . 0.89000000000000001 110.014 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -144.02 136.29 26.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.618 -0.931 . . . . 1.2 108.998 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.61 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.475 -0.766 . . . . 0.81000000000000005 110.339 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 44' ' ' LEU . 25.4 mt -91.29 133.12 35.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.715 -0.846 . . . . 0.60999999999999999 108.715 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -115.85 150.02 37.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.532 -0.73 . . . . 2.3900000000000001 110.472 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.05 -26.16 67.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.009 -0.432 . . . . 0.68999999999999995 111.111 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.67 -13.11 62.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.96999999999999997 110.986 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.41 142.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.59999999999999998 109.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 80.8 p -77.5 152.62 34.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.72 -0.612 . . . . 0.53000000000000003 110.289 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 27' ' ' PHE . 59.5 mt -61.58 -35.61 78.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.73 -0.606 . . . . 0.46999999999999997 109.433 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.38 -34.28 75.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.781 -0.574 . . . . 1.21 109.629 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -42.78 93.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.62 -0.675 . . . . 1.54 109.235 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 28.9 m-85 -73.1 -15.72 61.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.778 -0.576 . . . . 0.5 110.226 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER 83.85 63.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.678 0.751 . . . . 1.48 109.315 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.535 HG13 HG21 ' A' ' 66' ' ' THR . 68.1 t -108.73 104.14 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.505 -0.924 . . . . 0.60999999999999999 108.505 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -111.95 -175.31 2.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.637 -0.664 . . . . 1.26 110.356 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 8.0 t70 -65.21 137.4 57.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.544 -0.723 . . . . 0.84999999999999998 110.061 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.69 36.6 19.44 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.183 0.516 . . . . 0.82999999999999996 110.356 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.535 HG21 HG13 ' A' ' 62' ' ' VAL . 10.1 t -92.42 149.96 21.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.238 -0.914 . . . . 0.47999999999999998 109.283 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.55 140.1 33.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.534 -0.729 . . . . 1.1899999999999999 110.068 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -138.85 176.17 8.93 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.55 -0.537 . . . . 0.57999999999999996 109.55 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.1 mp0 -113.3 147.16 38.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.494 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 42' ' ' ILE . 62.5 tp -135.56 131.24 35.69 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.45000000000000001 109.663 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -137.24 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.121 -0.696 . . . . 1.2 109.121 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -98.07 125.57 43.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.53 -0.731 . . . . 1.21 109.577 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD12 ' HE2' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 118.657 -0.687 . . . . 1.22 110.09 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 2.7 ttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.191 0.519 . . . . 1.49 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.34 162.7 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.35999999999999999 109.922 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.1 112.58 21.09 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.117 -0.697 . . . . 0.92000000000000004 109.117 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' HG22 ' A' ' 66' ' ' THR . 32.5 m -111.58 170.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.581 -0.699 . . . . 0.34000000000000002 110.28 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.25 144.16 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.722 -0.611 . . . . 0.46999999999999997 109.654 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HB2' ' A' ' 68' ' ' LEU . 27.9 m -118.86 145.96 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.653 -0.655 . . . . 0.41999999999999998 109.758 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.32 124.75 52.86 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.107 -0.701 . . . . 0.53000000000000003 109.107 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.34 -67.73 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 0.69999999999999996 110.153 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.07 55.36 1.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.652 -0.655 . . . . 1.24 109.394 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.556 -0.715 . . . . 1.52 109.49 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.37 -56.85 0.35 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.514 -1.434 . . . . 0.77000000000000002 109.514 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 111.12 16.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.812 -0.816 . . . . 1.99 109.512 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -112.5 125.44 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.749 -0.594 . . . . 1.0700000000000001 109.927 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 35' ' ' ILE . 3.5 t -116.38 146.52 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 145.21 35.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 2.9300000000000002 109.626 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 27' ' ' PHE . 7.3 p -150.63 142.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.618 -0.676 . . . . 0.40999999999999998 109.558 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 137.55 45.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.469 -0.769 . . . . 2.0499999999999998 110.32 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 p -161.48 156.07 23.04 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.149 -0.686 . . . . 0.51000000000000001 109.149 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.59 146.82 28.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.386 -0.821 . . . . 0.94999999999999996 109.466 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -24.39 67.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.551 -0.718 . . . . 0.48999999999999999 109.711 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -18.11 36.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.559 -0.713 . . . . 0.92000000000000004 109.897 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.23 163.03 13.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.811 . . . . 0.69999999999999996 109.63 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -93.91 168.62 10.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.525 -0.734 . . . . 1.3999999999999999 110.263 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 91.3 t -61.25 -31.41 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.245 -0.65 . . . . 0.38 109.245 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.25 -45.01 93.15 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -38.95 92.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.746 -0.855 . . . . 0.80000000000000004 108.775 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.2 t80 -57.98 -46.39 85.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.287 -0.634 . . . . 0.38 109.287 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -69.46 -29.57 67.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.744 -0.597 . . . . 0.96999999999999997 110.236 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -70.03 -43.37 71.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.538 -0.726 . . . . 2.3199999999999998 110.007 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 16' ' ' VAL . 40.3 t -74.23 -38.79 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.37 108.866 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 35' ' ' ILE . 29.6 tp -67.42 -42.17 83.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.746 -0.596 . . . . 0.52000000000000002 109.963 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.4 p -55.91 -23.83 33.84 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.673 -0.642 . . . . 0.35999999999999999 110.908 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -73.85 -33.25 64.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 0.82999999999999996 109.842 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -47.75 12.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.55 -0.719 . . . . 0.53000000000000003 110.202 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' LEU . 13.1 pt -82.46 -24.34 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.529 -0.732 . . . . 0.51000000000000001 110.87 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.24 43.71 78.59 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 108.377 -1.889 . . . . 0.39000000000000001 108.377 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -115.64 -3.08 12.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.942 -0.74 . . . . 0.47999999999999998 110.125 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.1 mt-30 68.05 153.97 0.14 Allowed Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.555 -0.716 . . . . 2.4199999999999999 110.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 6.8 3.25 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.664 2.242 . . . . 1.3799999999999999 111.977 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -106.1 -20.24 13.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.153 -0.967 . . . . 1.48 110.088 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.34 10.67 19.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.345 -0.847 . . . . 2.3700000000000001 110.673 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 70' ' ' LEU . 82.8 mt -101.38 131.17 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.029 -1.044 . . . . 0.5 110.407 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.99 108.46 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.982 -1.118 . . . . 0.48999999999999999 107.982 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.96 146.63 25.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.519 -0.738 . . . . 0.66000000000000003 110.173 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 5.5 mt-30 -134.79 138.86 44.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -56.72 3.5 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.684 -0.635 . . . . 1.3200000000000001 109.635 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.69 70.22 0.22 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.57 12.63 62.45 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.062 -1.215 . . . . 1.1599999999999999 110.062 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 137.82 31.71 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.502 -0.999 . . . . 1.27 109.217 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.39 151.04 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.553 -0.717 . . . . 0.68999999999999995 109.934 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 60' ' ' TYR . 14.8 mt -104.17 130.62 51.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.132 -0.692 . . . . 0.46000000000000002 109.132 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -102.13 145.51 29.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.676 -0.64 . . . . 3.04 110.094 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.5 p-10 -61.93 -24.65 67.11 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.9 -0.5 . . . . 0.59999999999999998 110.135 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -69.38 -14.48 62.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.574 -0.704 . . . . 0.97999999999999998 110.819 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 52' ' ' LYS . 4.4 mp -108.12 142.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.2 -0.937 . . . . 0.5 109.486 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -77.07 152.15 35.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.711 -0.618 . . . . 0.83999999999999997 110.164 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 62' ' ' VAL . 50.2 mt -60.34 -36.54 78.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.776 -0.578 . . . . 0.46000000000000002 109.443 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.47 -36.6 71.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.771 -0.58 . . . . 1.5900000000000001 109.769 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -64.87 -45.9 84.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.69999999999999996 109.415 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' HD22 ' A' ' 51' ' ' LEU . 32.5 m-85 -71.36 -16.95 62.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.739 -0.601 . . . . 0.63 109.976 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.39 76.42 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.574 0.702 . . . . 1.1899999999999999 109.437 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.564 HG21 HD22 ' A' ' 57' ' ' LEU . 95.8 t -102.95 113.6 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.751 -0.833 . . . . 0.48999999999999999 108.751 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.1 163.02 15.03 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.706 -0.621 . . . . 1.6599999999999999 110.191 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.87 140.98 53.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.549 -0.72 . . . . 0.54000000000000004 109.289 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.89 31.09 19.99 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.768 -0.583 . . . . 0.82999999999999996 110.034 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 HG22 ' CG1' ' A' ' 4' ' ' VAL . 12.5 t -86.56 156.69 19.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.374 -0.829 . . . . 0.40999999999999998 109.625 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -100.46 118.19 36.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.57999999999999996 109.46 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.653 ' HB2' HG12 ' A' ' 6' ' ' VAL . 1.4 mt -110.94 173.19 6.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.753 -0.592 . . . . 1.0800000000000001 109.748 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -106.13 138.81 41.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.076 -0.712 . . . . 0.65000000000000002 109.076 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.592 HD11 HG23 ' A' ' 42' ' ' ILE . 56.1 tp -122.2 130.5 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.42999999999999999 109.433 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -137.94 148.21 45.04 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.312 -0.625 . . . . 1.1000000000000001 109.312 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.9 m-85 -101.83 117.74 35.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.97999999999999998 109.871 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.369 -0.824 . . . . 1.3 109.528 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.164 0.507 . . . . 1.53 109.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 10.3 pt -121.6 161.8 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.678 -0.639 . . . . 0.46999999999999997 109.914 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -114.38 117.44 31.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.632 -0.667 . . . . 0.91000000000000003 109.312 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 66' ' ' THR . 10.9 m -117.78 153.78 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.496 -0.752 . . . . 0.40999999999999998 110.009 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.21 134.48 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.533 -0.729 . . . . 0.5 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 68' ' ' LEU . 31.2 m -116.19 132.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.47999999999999998 109.829 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.07 132.3 54.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.635 -0.665 . . . . 0.62 109.252 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -79.27 -56.12 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.96999999999999997 110.001 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -128.79 -63.06 0.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.684 -0.635 . . . . 1.48 109.664 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.36 -63.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.561 -0.712 . . . . 1.5900000000000001 109.84 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.21 51.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.16 -1.176 . . . . 0.78000000000000003 110.16 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 129.35 37.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -1.018 . . . . 2.5800000000000001 110.074 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.33 124.44 8.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.87 109.72 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.68 145.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.578 -0.701 . . . . 0.62 109.541 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.83 139.24 41.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.602 -0.686 . . . . 1.77 109.468 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.8 p -146.57 146.5 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.673 -0.642 . . . . 0.47999999999999998 109.787 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -116.98 149.72 39.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.444 -0.785 . . . . 2.79 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.17 162.45 15.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.58 -0.7 . . . . 0.76000000000000001 109.531 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -83.96 144.82 28.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.383 -0.823 . . . . 0.72999999999999998 109.306 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.25 -21.31 66.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.59 -0.694 . . . . 0.5 109.933 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.53 -22.59 40.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.78000000000000003 109.857 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 155.79 35.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.62 109.783 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.85 170.81 9.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.58 -0.7 . . . . 0.66000000000000003 110.2 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 80.0 t -62.41 -28.93 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.40999999999999998 109.409 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.6 85.22 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.001 -1.64 . . . . 0.34999999999999998 109.001 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.75 -38.42 86.57 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.799 -0.824 . . . . 0.81999999999999995 108.783 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' ' 44' ' ' LEU . 32.1 t80 -59.61 -42.31 92.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.26 -0.644 . . . . 0.40000000000000002 109.26 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 44' ' ' LEU . 8.5 mttm -68.86 -34.5 75.56 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.644 -0.66 . . . . 0.91000000000000003 109.939 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.75 -42.1 86.71 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.617 -0.677 . . . . 2.4700000000000002 110.146 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.28 -35.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.236 -0.915 . . . . 0.46999999999999997 109.285 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 16' ' ' VAL . 1.1 mt -72.71 -47.3 48.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.721 . . . . 0.68000000000000005 109.62 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.4 p -54.28 -25.69 25.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.876 -0.515 . . . . 0.40999999999999998 111.015 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.46 -34.91 68.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.243 -0.911 . . . . 0.81999999999999995 109.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.56 -52.27 6.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.593 -0.692 . . . . 0.69999999999999996 110.46 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.7 pt -78.99 -22.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.328 -0.858 . . . . 0.44 110.979 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.99 40.18 88.86 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.833 -1.707 . . . . 0.40000000000000002 108.833 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.654 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.0 m -111.38 -4.0 15.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.819 -0.812 . . . . 0.37 110.411 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.2 OUTLIER 66.3 156.26 0.13 Allowed Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.583 -0.698 . . . . 1.24 110.141 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.79 -15.56 23.9 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.48 2.12 . . . . 0.67000000000000004 110.892 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -82.01 -23.8 35.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 1.71 110.138 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.4 OUTLIER -111.97 13.03 20.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.991 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 70' ' ' LEU . 50.9 mt -106.73 126.53 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.169 -0.957 . . . . 0.37 109.504 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 57.8 t -119.18 102.82 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.349 -0.982 . . . . 0.45000000000000001 108.349 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' ' 27' ' ' PHE . 5.2 mt -98.86 144.45 28.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.48999999999999999 110.155 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.8 mt-30 -131.3 137.34 48.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.622 -0.674 . . . . 0.96999999999999997 109.83 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HG3' ' HB3' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -73.37 -56.27 5.28 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.614 -0.679 . . . . 1.78 109.489 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.43 65.77 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.865 -1.694 . . . . 0.78000000000000003 108.865 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.78 -5.42 58.22 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.08 -1.208 . . . . 0.94999999999999996 110.08 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 p -124.67 141.31 52.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.482 -1.01 . . . . 0.65000000000000002 109.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -80.03 142.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 0.56000000000000005 110.299 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD11 HD21 ' A' ' 68' ' ' LEU . 18.8 mt -92.72 139.14 30.87 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.952 -0.759 . . . . 0.55000000000000004 108.952 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -117.4 145.59 44.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.504 -0.748 . . . . 2.25 110.089 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.5 p-10 -59.03 -28.36 66.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.906 -0.496 . . . . 0.68999999999999995 111.096 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.36 -12.84 61.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.407 -0.808 . . . . 1.1799999999999999 111.238 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.16 143.3 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.162 -0.961 . . . . 0.64000000000000001 109.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 78.5 p -77.34 153.4 33.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.674 -0.642 . . . . 0.46000000000000002 110.358 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' A' ' 27' ' ' PHE . 44.8 mt -61.95 -33.41 74.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.433 -0.58 . . . . 0.59999999999999998 109.433 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.39 -34.6 77.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.437 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -40.97 94.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.668 -0.645 . . . . 1.3700000000000001 109.28 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 37.0 m-85 -73.32 -16.21 61.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.826 -0.546 . . . . 0.56000000000000005 110.366 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER 77.82 64.15 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.615 0.721 . . . . 1.3500000000000001 109.634 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG13 HG21 ' A' ' 66' ' ' THR . 48.4 t -103.15 117.86 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.887 -0.783 . . . . 0.47999999999999998 108.887 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -110.78 -178.27 3.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.733 . . . . 1.51 110.377 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 1.9 t70 -72.24 140.84 48.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.699 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 60.19 41.7 16.41 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.161 0.505 . . . . 0.70999999999999996 110.026 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.743 HG22 HG12 ' A' ' 4' ' ' VAL . 7.4 t -95.59 158.06 15.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.4 -0.813 . . . . 0.41999999999999998 109.435 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.27 128.26 44.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 1.3100000000000001 109.598 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.34 159.07 34.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.72 -0.613 . . . . 1.3200000000000001 109.759 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 45' ' ' GLN . 1.9 mp0 -106.14 152.41 23.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.492 -0.755 . . . . 0.62 109.428 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 42' ' ' ILE . 51.2 tp -134.75 139.94 45.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.522 -0.736 . . . . 0.40999999999999998 109.691 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 69.4 m-85 -145.0 142.52 29.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.998 -0.741 . . . . 1.3100000000000001 108.998 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG21 ' A' ' 37' ' ' THR . 20.9 m-85 -98.83 109.21 22.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.191 -0.943 . . . . 0.60999999999999999 109.737 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 118.378 -0.82 . . . . 1.1399999999999999 109.547 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.177 0.513 . . . . 1.9399999999999999 109.671 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.67 162.51 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.73 -0.606 . . . . 0.41999999999999998 109.775 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -113.0 111.28 21.9 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 1.01 108.868 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 66' ' ' THR . 32.9 m -107.87 159.27 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.502 -0.748 . . . . 0.40999999999999998 110.294 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HG2' ' A' ' 15' ' ' ARG . 13.1 t -113.91 132.39 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.123 -0.695 . . . . 0.40999999999999998 109.123 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 31' ' ' LEU . 32.8 m -114.17 138.19 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.47999999999999998 109.721 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.427 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -125.76 123.14 38.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.708 -0.62 . . . . 0.45000000000000001 109.522 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -87.85 147.84 24.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.616 -0.678 . . . . 0.62 109.685 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 71' ' ' TYR . 8.1 mmt-85 -65.97 -37.63 86.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.713 -0.617 . . . . 1.24 110.039 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -48.35 81.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.581 -0.7 . . . . 1.21 109.416 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.99 61.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.011 -1.236 . . . . 0.62 110.011 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.52 100.56 3.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.966 . . . . 0.90000000000000002 109.525 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -104.28 118.62 37.07 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.943 -0.762 . . . . 1.03 108.943 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG21 ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -137.04 173.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.62 -0.675 . . . . 0.76000000000000001 109.94 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HG2' HG22 ' A' ' 5' ' ' VAL . 13.4 mtt180 -127.17 135.25 50.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.521 -0.737 . . . . 3.1299999999999999 110.141 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.52 134.33 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.681 -0.637 . . . . 0.40000000000000002 109.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -103.43 134.98 45.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.297 -0.877 . . . . 1.97 110.235 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 158.26 43.38 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.576 -0.702 . . . . 0.75 109.57 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -79.6 148.89 31.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.363 -0.836 . . . . 1.0900000000000001 109.784 179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.79 -22.6 67.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.604 -0.685 . . . . 0.46000000000000002 109.504 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.93 -21.27 40.6 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.584 -0.697 . . . . 0.82999999999999996 109.902 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.8 148.45 51.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 82.1 p -81.28 163.15 23.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.687 . . . . 0.57999999999999996 110.401 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.04 -33.46 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.969 -0.752 . . . . 0.48999999999999999 108.969 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.42 -46.81 93.31 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.852 -1.699 . . . . 0.33000000000000002 108.852 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.93 -37.77 88.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.899 -0.765 . . . . 0.97999999999999998 108.947 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 4' ' ' VAL . 47.2 t80 -60.48 -42.25 95.87 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.202 -0.666 . . . . 0.5 109.202 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -69.08 -29.51 67.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.594 . . . . 0.81000000000000005 109.768 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.13 -42.59 75.82 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.463 -0.773 . . . . 1.9399999999999999 109.41 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.79 -33.79 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 109.124 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 6' ' ' VAL . 24.1 tp -72.67 -44.17 62.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.654 . . . . 0.51000000000000001 109.833 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.4 p -55.24 -19.69 8.91 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.5 -0.75 . . . . 0.37 111.222 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 mt -71.66 -41.88 68.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.094 -1.004 . . . . 1.0700000000000001 110.339 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.44 -35.68 27.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.369 -0.832 . . . . 0.56000000000000005 111.089 -179.097 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 31' ' ' LEU . 9.0 pt -88.93 -22.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.063 -1.023 . . . . 0.44 110.623 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.9 44.75 91.25 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.567 -1.813 . . . . 0.39000000000000001 108.567 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 72' ' ' TYR . 3.7 m -118.26 1.18 11.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.861 -0.787 . . . . 0.40999999999999998 110.518 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' THR . 0.9 OUTLIER 66.12 153.58 0.13 Allowed Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 110.255 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.97 -6.86 18.61 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.705 2.27 . . . . 0.72999999999999998 111.28 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.51 -19.9 19.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.378 -0.827 . . . . 1.4299999999999999 110.293 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.92 13.92 24.48 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.276 -0.89 . . . . 2.3300000000000001 110.513 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 70' ' ' LEU . 70.8 mt -107.02 130.96 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.153 -0.967 . . . . 0.45000000000000001 109.97 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.12 106.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.969 -1.123 . . . . 0.53000000000000003 107.969 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -98.63 150.89 21.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.478 -0.764 . . . . 0.77000000000000002 110.474 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -135.77 131.82 35.98 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.543 -0.54 . . . . 0.91000000000000003 109.543 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.37 89.29 5.4 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.46 109.245 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.49 0.62 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.727 -1.349 . . . . 0.80000000000000004 109.727 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.52 47.52 1.01 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.393 -1.483 . . . . 0.75 109.393 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.89 137.25 17.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.693 -0.886 . . . . 1.1200000000000001 109.595 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.47 129.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.591 -0.693 . . . . 0.64000000000000001 109.312 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 46' ' ' LYS . 33.6 mt -87.75 132.62 34.08 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.249 -0.649 . . . . 0.54000000000000004 109.249 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 144.43 48.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.69 -0.631 . . . . 2.7599999999999998 109.763 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.63 -26.61 65.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.861 -0.524 . . . . 0.66000000000000003 110.34 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -68.06 -17.95 64.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.668 -0.645 . . . . 1.1399999999999999 110.557 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.476 HD13 ' OH ' ' A' ' 60' ' ' TYR . 3.6 mp -110.48 149.4 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.345 -0.847 . . . . 0.64000000000000001 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -87.17 155.41 20.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.707 . . . . 0.69999999999999996 110.285 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.55 -34.05 72.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.762 -0.586 . . . . 0.60999999999999999 109.645 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.57 -38.14 80.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 2.02 109.85 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -63.58 -43.35 97.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.584 -0.698 . . . . 0.68000000000000005 109.496 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 55' ' ' ILE . 50.6 m-85 -72.66 -17.17 61.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.722 -0.611 . . . . 0.53000000000000003 110.209 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 70.17 66.96 0.22 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.612 -0.68 . . . . 2.0600000000000001 109.727 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.07 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.799 . . . . 0.45000000000000001 108.981 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.79 161.68 17.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.85999999999999999 110.266 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.34 134.36 46.67 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.669 -0.644 . . . . 0.68999999999999995 109.327 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 63.28 35.31 12.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.199 0.523 . . . . 0.56999999999999995 109.886 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 4' ' ' VAL . 14.6 t -88.34 159.84 17.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -0.792 . . . . 0.40000000000000002 109.535 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.65 114.24 27.19 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 1.1699999999999999 109.708 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 4' ' ' VAL . 2.9 mt -106.23 156.66 18.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.784 -0.573 . . . . 0.80000000000000004 109.599 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -98.31 141.79 30.77 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.936 -0.764 . . . . 1.0900000000000001 108.936 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD11 HG23 ' A' ' 42' ' ' ILE . 35.9 tp -115.7 133.49 55.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.983 -0.747 . . . . 0.39000000000000001 108.983 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 9' ' ' ARG . 2.6 m-85 -134.79 140.03 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.304 -0.628 . . . . 1.1699999999999999 109.304 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 37' ' ' THR . 21.4 m-85 -102.17 125.37 48.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.67000000000000004 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 117.623 -1.179 . . . . 1.6299999999999999 109.961 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.617 -0.512 . . . . 1.3799999999999999 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 pt -116.94 160.57 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 0.39000000000000001 110.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.78 130.04 55.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.8 -0.815 . . . . 0.85999999999999999 108.8 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 66' ' ' THR . 30.5 m -135.11 161.59 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.445 -0.785 . . . . 0.34000000000000002 110.357 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' ' 15' ' ' ARG . 15.9 m -117.02 145.13 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.775 -0.578 . . . . 0.44 109.544 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 70' ' ' LEU . 1.7 t -125.7 114.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.977 -0.749 . . . . 0.46000000000000002 108.977 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.15 129.25 44.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.63 109.678 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.89 -43.05 72.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.678 -0.639 . . . . 0.88 109.719 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.29 -63.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.658 -0.651 . . . . 2.0499999999999998 109.417 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.46 113.93 0.87 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.7 -0.625 . . . . 1.23 109.353 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -60.03 0.36 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.837 -1.305 . . . . 0.80000000000000004 109.837 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 125.47 29.16 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.591 -0.946 . . . . 0.80000000000000004 109.792 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.2 154.52 43.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.636 -0.665 . . . . 2.3599999999999999 110.117 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.01 136.52 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.407 -0.808 . . . . 0.83999999999999997 110.131 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.652 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -99.47 122.29 42.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.151 -0.685 . . . . 1.5900000000000001 109.151 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 31' ' ' LEU . 11.9 p -139.91 137.28 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.516 -0.74 . . . . 0.45000000000000001 109.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 139.69 38.85 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.401 -0.812 . . . . 2.6899999999999999 110.481 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.82 152.35 24.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.69 -0.631 . . . . 0.72999999999999998 109.756 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.14 148.98 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.51 -0.744 . . . . 0.90000000000000002 109.235 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -64.38 -21.42 66.63 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -0.762 . . . . 0.41999999999999998 110.241 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -79.09 -23.69 43.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.414 -0.804 . . . . 0.88 109.8 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.77 155.54 29.94 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.594 -0.691 . . . . 0.58999999999999997 109.721 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.14 169.04 10.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.81000000000000005 110.519 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 69.9 t -58.63 -35.92 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.97 -50.0 69.87 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.008 -1.637 . . . . 0.32000000000000001 109.008 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.77 -37.35 86.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.791 -0.829 . . . . 0.71999999999999997 108.967 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -60.05 -46.92 87.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.193 -0.669 . . . . 0.45000000000000001 109.193 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.74 -31.86 70.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.739 -0.601 . . . . 0.92000000000000004 109.748 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -41.72 98.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.645 -0.659 . . . . 2.6800000000000002 109.536 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.05 -36.44 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.501 -0.749 . . . . 0.37 109.268 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 16' ' ' VAL . 3.9 mt -69.65 -51.27 36.26 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -0.776 . . . . 0.58999999999999997 109.712 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -51.46 -21.69 2.56 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.791 -0.568 . . . . 0.53000000000000003 111.345 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.91 -42.84 56.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.095 -1.003 . . . . 0.75 110.139 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -82.9 -34.98 26.52 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.398 -0.814 . . . . 0.67000000000000004 111.425 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' LEU . 1.6 pt -92.33 -26.91 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 O-C-N 121.06 -1.025 . . . . 0.57999999999999996 110.539 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.0 42.09 52.98 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.08 -1.608 . . . . 0.47999999999999998 109.08 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 41' ' ' LYS . 2.0 m -111.11 -7.72 14.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.869 -0.783 . . . . 0.46000000000000002 110.058 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' THR . 1.5 mp0 65.97 156.47 0.13 Allowed Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.641 -0.662 . . . . 2.0899999999999999 109.883 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.07 -17.22 22.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.402 2.068 . . . . 0.85999999999999999 110.694 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -83.2 -22.78 33.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 1.3700000000000001 110.31 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.15 3.91 26.24 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.237 -0.914 . . . . 1.9399999999999999 110.387 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 70' ' ' LEU . 72.1 mt -105.16 131.75 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.112 -0.993 . . . . 0.45000000000000001 109.781 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.93 110.14 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.622 -0.881 . . . . 0.45000000000000001 108.622 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.81 150.25 22.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.436 -0.79 . . . . 0.51000000000000001 110.268 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -137.65 144.99 42.13 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.43 -0.581 . . . . 0.90000000000000002 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HE2' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -89.5 -62.16 1.54 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.466 -0.771 . . . . 0.92000000000000004 109.367 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.48 66.93 0.32 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.15 -1.58 . . . . 0.90000000000000002 109.15 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 7.46 64.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.042 -1.223 . . . . 1.01 110.042 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.9 p -132.95 141.75 48.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.449 -1.03 . . . . 0.51000000000000001 109.251 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.41 142.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.543 -0.723 . . . . 0.47999999999999998 109.927 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 44' ' ' LEU . 38.4 mt -92.76 121.93 34.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.46000000000000002 109.355 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.09 140.79 29.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.781 -0.575 . . . . 2.7000000000000002 110.115 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 14.5 m-20 -60.4 -28.15 68.02 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.908 -0.495 . . . . 0.65000000000000002 110.274 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -69.5 -22.45 63.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.637 -0.664 . . . . 2.0699999999999998 110.467 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CE2' ' A' ' 60' ' ' TYR . 33.4 mm -86.74 147.04 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.37 -0.831 . . . . 0.51000000000000001 109.916 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.5 OUTLIER -86.46 151.83 23.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.727 -0.608 . . . . 0.52000000000000002 109.612 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 62' ' ' VAL . 80.8 mt -60.11 -35.81 76.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.548 -0.72 . . . . 0.42999999999999999 109.35 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.5 mt-10 -63.8 -35.18 79.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.695 -0.628 . . . . 0.69999999999999996 109.58 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.61 -45.23 83.94 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.633 -0.667 . . . . 0.70999999999999996 109.335 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 55' ' ' ILE . 8.5 m-85 -71.15 -16.27 62.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.805 -0.559 . . . . 0.41999999999999998 110.135 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 75.8 70.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 109.761 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 57' ' ' LEU . 94.3 t -98.4 112.6 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.52000000000000002 108.594 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.4 168.38 10.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.634 -0.666 . . . . 0.98999999999999999 110.438 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.21 137.67 51.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.7 -0.625 . . . . 0.81999999999999995 109.611 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.46 34.23 15.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.241 0.543 . . . . 0.82999999999999996 109.801 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.584 HG22 HG12 ' A' ' 4' ' ' VAL . 11.5 t -87.96 156.29 19.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.432 -0.793 . . . . 0.41999999999999998 109.606 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.62 124.44 43.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.534 -0.729 . . . . 1.5 109.562 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.545 HD21 ' HE2' ' A' ' 46' ' ' LYS . 3.6 mt -115.93 165.9 12.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.828 -0.545 . . . . 0.63 109.719 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 144.26 34.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.669 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 42' ' ' ILE . 38.5 tp -124.48 149.52 46.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.593 -0.692 . . . . 0.45000000000000001 109.819 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -152.21 143.54 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.128 -0.693 . . . . 1.1299999999999999 109.128 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 37' ' ' THR . 31.2 m-85 -101.39 105.14 16.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.91000000000000003 109.85 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.348 -0.834 . . . . 1.3300000000000001 109.417 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.715 -0.476 . . . . 1.48 109.715 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 24.2 pt -117.69 162.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.636 -0.665 . . . . 0.42999999999999999 109.753 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 106.3 14.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.68999999999999995 109.229 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.556 ' CG1' HG22 ' A' ' 66' ' ' THR . 28.3 m -109.64 165.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.664 -0.647 . . . . 0.37 109.732 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.07 146.99 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.54000000000000004 109.873 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB3' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -123.67 138.64 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.621 -0.674 . . . . 0.89000000000000001 109.957 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -125.74 138.31 53.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.678 -0.639 . . . . 0.83999999999999997 109.535 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 1.1 m-20 -78.14 -80.79 0.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.56000000000000005 110.016 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -55.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.547 -0.72 . . . . 1.72 110.145 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -62.11 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.69 . . . . 1.6499999999999999 109.622 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.92 55.11 0.14 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.729 -1.349 . . . . 1.0 109.729 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.76 107.42 10.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.755 -0.85 . . . . 1.8100000000000001 109.406 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.81 117.44 28.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.576 -0.703 . . . . 2.0299999999999998 109.695 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -124.79 152.81 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.57 -0.706 . . . . 1.1299999999999999 109.838 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.73 150.78 29.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.555 -0.715 . . . . 1.5800000000000001 109.67 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 27' ' ' PHE . 10.6 p -153.85 138.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.49 -0.756 . . . . 0.5 109.841 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -107.4 135.22 49.26 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.563 -0.71 . . . . 2.73 110.2 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.4 p -158.83 159.13 34.74 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.644 -0.66 . . . . 0.58999999999999997 109.475 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -83.36 146.38 28.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.251 -0.906 . . . . 0.64000000000000001 109.68 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -21.2 66.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.691 -0.631 . . . . 0.57999999999999996 109.999 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG3' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -80.48 -21.49 41.95 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.77 . . . . 0.72999999999999998 109.73 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.83 160.12 26.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.55000000000000004 109.664 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -92.69 171.48 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.668 -0.645 . . . . 0.70999999999999996 110.351 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 53' ' ' ASP . 61.8 t -60.41 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.0 -0.741 . . . . 0.39000000000000001 109.0 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -43.71 95.18 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.023 -1.631 . . . . 0.33000000000000002 109.023 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -65.57 -36.81 84.86 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.739 -0.859 . . . . 0.51000000000000001 108.765 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 16' ' ' VAL . 5.1 t80 -58.95 -49.0 79.52 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.142 -0.688 . . . . 0.40000000000000002 109.142 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 70.1 mttt -67.09 -28.22 68.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.843 -0.536 . . . . 1.04 110.059 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -68.88 -46.67 67.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.53 -0.731 . . . . 2.1699999999999999 110.018 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.02 -35.24 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.638 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 35' ' ' ILE . 27.8 tp -71.12 -44.74 65.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.687 . . . . 0.51000000000000001 109.849 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 83.2 p -54.83 -28.12 47.17 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.745 -0.597 . . . . 0.40000000000000002 111.042 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 33' ' ' LEU . 1.2 mm? -70.06 -34.6 73.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.293 -0.879 . . . . 0.70999999999999996 110.006 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -82.65 -51.84 7.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.71999999999999997 110.591 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 31' ' ' LEU . 10.3 pt -77.41 -22.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.344 -0.848 . . . . 0.54000000000000004 110.856 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.91 40.41 84.56 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.883 -1.687 . . . . 0.5 108.883 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 72' ' ' TYR . 1.6 m -112.68 -0.42 15.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.997 -0.708 . . . . 0.47999999999999998 110.294 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' THR . 35.4 mt-30 66.13 153.26 0.12 Allowed Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.571 -0.706 . . . . 2.1899999999999999 110.059 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 32.0 Cg_endo -72.93 -17.79 24.96 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.732 2.288 . . . . 0.79000000000000004 111.502 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -86.2 -17.23 35.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.474 -0.766 . . . . 1.05 110.273 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.62 12.9 21.23 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.187 -0.946 . . . . 1.25 110.546 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 70' ' ' LEU . 72.8 mt -110.6 136.21 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.107 -0.995 . . . . 0.56000000000000005 109.747 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.0 121.89 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.922 -0.77 . . . . 0.68999999999999995 108.922 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 51' ' ' LEU . 11.5 mt -100.44 141.64 33.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.469 -0.769 . . . . 0.89000000000000001 109.938 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 5.5 mt-30 -132.66 128.18 36.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.1899999999999999 109.572 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.768 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.47 86.5 4.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 1.0 109.225 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -85.41 0.91 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.435 -1.466 . . . . 1.02 109.435 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.0 48.35 0.93 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.0 p -152.34 140.14 19.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.65 -0.912 . . . . 0.71999999999999997 109.636 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.08 129.69 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.78000000000000003 109.334 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.768 HD21 ' HB2' ' A' ' 46' ' ' LYS . 23.9 mt -91.2 132.17 36.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.655 -0.653 . . . . 0.52000000000000002 109.369 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.5 146.75 35.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.683 -0.636 . . . . 1.6799999999999999 110.039 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 5.9 p-10 -61.58 -25.83 67.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.834 -0.541 . . . . 0.54000000000000004 110.344 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -68.59 -14.48 63.04 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.575 -0.703 . . . . 0.92000000000000004 110.809 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.12 144.11 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.201 -0.937 . . . . 0.55000000000000004 109.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -78.01 153.29 32.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.628 . . . . 0.67000000000000004 110.209 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 62' ' ' VAL . 47.9 mt -62.3 -36.27 81.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.579 -0.701 . . . . 0.47999999999999998 109.349 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.75 -33.22 71.39 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.718 -0.614 . . . . 1.3200000000000001 109.73 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -44.7 91.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.635 -0.666 . . . . 1.6200000000000001 109.211 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CG ' HD22 ' A' ' 51' ' ' LEU . 48.3 m-85 -73.18 -16.82 61.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 0.68999999999999995 109.777 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 75.69 64.37 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.513 0.673 . . . . 1.6699999999999999 109.758 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 57' ' ' LEU . 99.1 t -92.42 117.42 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.752 -0.833 . . . . 0.65000000000000002 108.752 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -97.73 168.85 10.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.714 -0.616 . . . . 1.5600000000000001 110.211 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' HA ' ' HB ' ' A' ' 2' ' ' ILE . 6.2 p-10 -70.95 141.59 51.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.66000000000000003 109.687 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.41 32.63 18.97 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.7 -0.625 . . . . 0.87 109.878 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.556 HG22 ' CG1' ' A' ' 4' ' ' VAL . 11.8 t -88.48 159.31 18.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.799 . . . . 0.42999999999999999 109.775 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.11 119.8 38.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.755 . . . . 1.0600000000000001 109.581 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.573 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -114.99 163.02 16.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.787 -0.571 . . . . 0.97999999999999998 109.681 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -102.81 139.37 38.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.467 -0.77 . . . . 0.85999999999999999 109.623 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 53.3 tp -115.13 132.71 56.52 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.402 0.62 . . . . 0.42999999999999999 109.697 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.23 151.21 51.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.178 -0.675 . . . . 1.0900000000000001 109.178 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' A' ' 37' ' ' THR . 28.9 m-85 -110.77 120.64 43.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.536 -0.728 . . . . 0.75 109.661 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.811 -1.09 . . . . 2.2400000000000002 109.451 -179.949 . . . . . . . . 1 1 . 1 stop_ save_